Glaucoma suspect

H7_GLAUCSUSP

ocular hypertension: Abnormally high intraocular pressure.

Endpoint definition

↥

Report an error or suggest an improvement for this endpoint codes

Endpoint definition steps	FinnGen
Phenotype data	519972
1. Apply sex-specific rule None	519972
2. Check conditions None	519972
3. Check pre-conditions, main-only, mode, registry filters Registry filters: Hospital discharge: ICD-10 — H40.0 Hospital discharge: ICD-9 — 3650 Hospital discharge: ICD-8 — 37597 Cause of death: ICD-10 — H40.0 Cause of death: ICD-9 — 3650 Cause of death: ICD-8 — 37597 2 out of 7 registries used, show all original rules.	17126
4. Check minimum number of events None	17126
5. Include endpoints None	17126
6. Filter based on genotype QC (FinnGen only)	16604

Control definitions (FinnGen only)

Control exclude: H7_GLAUCOMA

Extra metadata

Level in the ICD hierarchy: 3
First used in FinnGen datafreeze: DF2
Parent code in ICD-10: H40
Name in latin: Suspicio glaucomatis

NAME	H7_GLAUCSUSP
CONTROL_EXCLUDE	H7_GLAUCOMA
CONTROL_PRECONDITIONS
CONTROL_CONDITIONS
SEX
INCLUDE
PRE_CONDITIONS
CONDITIONS
OUTPAT_ICD
OUTPAT_OPER
HD_MAINONLY
HD_ICD_10_ATC
HD_ICD_10	H400
HD_ICD_9	3650
HD_ICD_8	37597
HD_ICD_10_EXCL
HD_ICD_9_EXCL
HD_ICD_8_EXCL
COD_MAINONLY
COD_ICD_10	H400
COD_ICD_9	3650
COD_ICD_8	37597
COD_ICD_10_EXCL
COD_ICD_9_EXCL
COD_ICD_8_EXCL
OPER_NOM
OPER_HL
OPER_HP1
OPER_HP2
KELA_REIMB
KELA_REIMB_ICD
KELA_ATC_NEEDOTHER
KELA_ATC
KELA_VNRO_NEEDOTHER
KELA_VNRO
CANC_TOPO
CANC_TOPO_EXCL
CANC_MORPH
CANC_MORPH_EXCL
CANC_BEHAV

Similar endpoints

↥

List of similar endpoints to Glaucoma suspect based on the number of shared cases.

Similar with more cases:

Similar with less cases:

None

Case counts by codes

↥

FinnGen case counts by registry codes:

Upset plot

Full data table

Summary Statistics

↥

-FinRegistry-

Key figures

	All	Female	Male
Number of individuals
Whole population	116607	73712	42352
Only index persons	106382	67668	38714
Unadjusted period prevalence (%)
Whole population	1.77	2.11	1.18
Only index persons	2.12	2.49	1.48
Median age at first event (years)
Whole population	65.41	65.92	64.57
Only index persons	65.11	65.57	64.31

-FinnGen-

Key figures

	All	Female	Male
Number of individuals	16604	10202	6402
Unadjusted period prevalence (%)	3.35	3.62	2.93
Median age at first event (years)	65.18	64.23	66.69

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

CodeWAS

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log₁₀(p-value) ≥ 6.

Matched cohort

Matched cases
17126: Matched controls
171256

Code

Vocabulary

Description

Odds Ratio

-log₁₀(p)

N matched cases

N matched controls

WX140

NOMESCO Finland

Parabulbar anesthesy

3.5

319.0

1164

3490

XCK00

NOMESCO Finland

Perimetry

22.2

307.7

4773

2934

S01EC01

ATC

acetazolamide; systemic

14.6

307.7

869

626

CS434

NOMESCO Finland

Visual field testing with Humphrey automated perimetry

35.4

307.7

1993

634

CS1H4

NOMESCO Finland

Retinal nerve fibre layer imaging

250.4

307.7

2299

106

S01EC54

ATC

brinzolamide, combinations; ophthalmic

59.8

307.7

684

119

S01EA05

ATC

brimonidine; ophthalmic

90.7

307.7

1423

171

CHD00

NOMESCO Finland

Laser trabeculoplasty

583.2

307.7

885

H40.8

ICD-10 Finland

Other glaucoma

178.8

307.7

177

H40.5

ICD-10 Finland

Glaucoma secondary to other eye disorders

1921.8

307.7

530

H40.10

ICD-10 Finland

Capsular glaucoma with pseudoexfoliation on the anterior lens capsule

331.5

307.7

1621

H25.1

ICD-10 Finland

Senile nuclear cataract

2.2

307.7

6490

37494

XCH05

NOMESCO Finland

Eye pressure longterm registration

181.3

307.7

779

H20.1

ICD-10 Finland

Chronic iridocyclitis

10.2

307.7

399

XCW10

NOMESCO Finland

Assessment of vision

8.6

307.7

544

648

S01ED01

ATC

timolol; ophthalmic

20.4

307.7

1841

1004

H40.0

ICD-10 Finland

Glaucoma suspect

6292.8

307.7

16549

777

XCH00

NOMESCO Finland

Eye pressure measurement

9.1

307.7

2380

2998

CK2X4

NOMESCO Finland

Optical coherence tomography (OCT) of ocular fundus

6.5

307.7

4140

8059

CS494

NOMESCO Finland

Other visual field testing

21.0

307.7

1506

781

S01EC04

ATC

brinzolamide; ophthalmic

42.5

307.7

2341

635

114

Kela drug reimbursment

Glaucoma

44.8

307.7

6273

2181

CS5Z4

NOMESCO Finland

Specialised imaging for glaucoma

42.7

307.7

2169

579

S01CA01

ATC

dexamethasone and antiinfectives; ophthalmic

2.0

307.7

7056

45061

Z01.0

ICD-10 Finland

Examination of eyes and vision

4.6

307.7

5747

17097

ZXA10

NOMESCO Finland

Bilateral

2.2

307.7

4105

21564

CS3P4

NOMESCO Finland

Optic nerve head stereophotography

109.0

307.7

850

CHC05

NOMESCO Finland

Iridotomy

79.2

307.7

1311

179

CJE20

NOMESCO Finland

Phakoemulsification with implantation of artificial lens in posterior chamber

2.2

307.7

7583

44829

37597

ICD-8 Finland

Glaucoma, Suspicio glaucomatis

+∞

307.7

331

XCK10

NOMESCO Finland

Photography of fundus of eye

4.2

307.7

3207

8819

S01ED02

ATC

betaxolol; ophthalmic

39.1

307.7

435

114

H40.11

ICD-10 Finland

Low pressure glaucoma

144.2

307.7

1404

106

S01EE05

ATC

tafluprost; ophthalmic

32.0

307.7

2287

820

H40.9

ICD-10 Finland

Glaucoma, unspecified

98.7

307.7

978

105

S01EA03

ATC

apraclonidine; ophthalmic

13.0

307.7

385

302

S01EX03, ,

ATC

36.5

307.7

944

273

S01EE03

ATC

bimatoprost; ophthalmic

37.6

307.7

1207

345

CK2S4

NOMESCO Finland

Plain photography of ocular fundus

4.7

307.7

2198

5165

S01XA20

ATC

artificial tears and other indifferent preparations; ophthalmic

2.0

307.7

8764

59112

CHD65

NOMESCO Finland

Nonpenetrating glaucoma surgery

+∞

307.7

379

CK2P4

NOMESCO Finland

Optic nerve head light layer imaging (OCT)

60.5

307.7

344

F93

ICPC

Glaucoma

39.5

307.7

249

CHD05

NOMESCO Finland

Selective lasertrabeculoplasty

1375.6

307.7

3145

CS444

NOMESCO Finland

Visual field testing with Octopus automated perimetry

28.5

307.7

2442

993

H40.22

ICD-10 Finland

Chronic glaucoma with closed ventricular angle

3719.4

307.7

374

S01EE01

ATC

latanoprost; ophthalmic

33.3

307.7

4295

1702

Z96.1

ICD-10 Finland

Presence of intraocular lens

3.6

307.7

4423

15011

S01EE04

ATC

travoprost; ophthalmic

29.0

307.7

1080

397

CS2P4

NOMESCO Finland

Optic nerve head imaging

52.1

307.7

637

127

H40

ICD-10 Finland

Glaucoma

27.4

307.7

505

190

S01ED51

ATC

timolol, combinations; ophthalmic

30.7

307.7

4972

2255

S01EB01

ATC

pilocarpine; ophthalmic

26.5

307.7

238

XCW99

NOMESCO Finland

Other investigative procedure of eye

5.7

307.7

4366

9730

H40.13

ICD-10 Finland

Chronic glaucoma with open ventricular angle

277.4

307.7

3580

163

S01EC03

ATC

dorzolamide; ophthalmic

36.5

307.7

640

182

3650A

ICD-9 Finland

Glaucoma, Borderline glaucoma [glaucoma suspect][SUSPICIO GLAUCOMATIS (AVOKULMA)]

+∞

307.7

422

H20.0

ICD-10 Finland

Acute and subacute iridocyclitis

3.8

301.3

953

2594

CJB10

NOMESCO Finland

Laser discission of secondary cataract

2.4

281.4

2137

9503

SPAT1009

SPAT

Measurement of intraocular pressure

6.2

268.2

467

774

CHD15

NOMESCO Finland

Trabeculectomy and iridectomy

2334.5

248.3

240

H26.4

ICD-10 Finland

After-cataract

2.2

232.4

2345

11693

TCW99

NOMESCO Finland

Other minor procedure in eye surgery

5.7

223.8

426

769

CHF05

NOMESCO Finland

Transscleral laser coagulation of ciliary body

445.5

221.2

221

WX100

NOMESCO Finland

Conjunctival surface anesthesia

2.0

211.9

2699

14637

CHD35

NOMESCO Finland

Laser goniopuncture

1956.3

209.6

203

H40.20

ICD-10 Finland

Acute glaucoma with closed ventricular angle

933.9

188.9

185

CKD65

NOMESCO Finland

Pars plana or pars plicata vitrectomy

3.8

185.2

578

1553

H40.1

ICD-10 Finland

Primary open-angle glaucoma

30.5

180.0

118

CHD50

NOMESCO Finland

Shunt operation on anterior chamber

+∞

177.4

170

CKD05

NOMESCO Finland

Puncture of vitreous body with injection of medication

2.5

163.9

1091

4523

CS424

NOMESCO Finland

Visual field testing with Goldmann perimetry

6.9

158.4

244

356

CD2S4

NOMESCO Finland

Photography of eye

7.8

158.0

218

281

H52.1

ICD-10 Finland

Myopia

3.4

156.9

576

1723

F38

ICPC

Eye, Other laboratory test NEC

4.7

148.2

346

746

H34.8

ICD-10 Finland

Other retinal vascular occlusions

3.5

147.5

511

1472

H40.19

ICD-10 Finland

Other primary glaucoma with open ventricular angle

714.5

144.2

142

CFW99

NOMESCO Finland

Other operation on conjunctiva

45.0

143.9

CHD99

NOMESCO Finland

Other filtering operation

1420.3

142.9

139

3651A

ICD-9 Finland

Glaucoma, Open-angle glaucoma[GLAUCOMA SIMPLEX (AVOKULMA)]

+∞

141.8

136

XCD10

NOMESCO Finland

Electrophysiological examination of eye

3.3

137.4

540

1685

H04.10

ICD-10 Finland

Dry eye syndrome

1.9

134.0

2013

11403

CKC12

NOMESCO Finland

Photocoagulation of retina

2.6

132.7

810

3216

H33.0

ICD-10 Finland

Retinal detachment with retinal break

3.0

125.5

578

1979

S01EE51

ATC

latanoprost and netarsudil; ophthalmic

37.7

121.5

CKD40

NOMESCO Finland

Endophotocoagulation of retina

4.2

121.0

327

791

H40.4

ICD-10 Finland

Glaucoma secondary to eye inflammation

1146.7

116.8

114

F43

ICPC

Eye, Other diagnostic procedure

3.4

111.8

403

1191

S01EA02

ATC

dipivefrine; ophthalmic

146.0

109.2

116

H40.12

ICD-10 Finland

Pigmentary glaucoma

223.4

107.7

111

H3603, E103,

ICD-10 Finland

5.6

102.9

196

354

E10.3

ICD-10 Finland

Type 1 diabetes mellitus, With ophthalmic complications

3.2

94.3

386

1234

SPAT1301

SPAT

No procedures

1.4

90.2

5185

39991

CK2M4

NOMESCO Finland

Macular light layer imaging (OCT)

4.8

89.2

202

425

H40.3

ICD-10 Finland

Glaucoma secondary to eye trauma

873.2

88.8

TCG40

NOMESCO Finland

Measurement of higher-grade errors of refraction

6.3

87.9

148

237

SPAT1312

SPAT

General health counselling

1.4

87.9

4865

37232

CHB10

NOMESCO Finland

Puncture of anterior chamber of eye with irrigation

6.9

87.3

135

198

CA1ME

NOMESCO Finland

Ultrasound oculometry

5.1

87.1

183

361

Z3229

NOMESCO Finland

Other healthcare associate professional

1.8

85.8

1411

8162

SPAT1263

SPAT

Sampling

1.4

84.8

6622

53662

E10.7

ICD-10 Finland

Type 1 diabetes mellitus, With multiple complications

3.0

84.4

373

1247

CKD20

NOMESCO Finland

Removal of vitreous body substitute

6.3

83.7

141

226

H35.38

ICD-10 Finland

Preretinal fibrosis of the macula

2.2

83.5

702

3209

H25.0

ICD-10 Finland

Senile incipient cataract

1.9

83.4

1206

6705

H26.2

ICD-10 Finland

Complicated cataract

3.7

83.2

267

731

SPAT1256

SPAT

Intramuscular and subcutaneous injection

1.4

82.2

6737

54937

H36.03

ICD-10 Finland

Proliferative diabetic retinopathy

5.1

79.5

169

337

CKD10

NOMESCO Finland

Insufflation of vitreous cavity

2.9

79.3

375

1302

WX142

NOMESCO Finland

Sub-tenon anesthesy

5.3

79.2

158

298

H3600, E103,

ICD-10 Finland

4.6

77.2

184

404

A10AB01

ATC

insulin (human); parenteral

2.5

76.5

510

2107

H16.0

ICD-10 Finland

Corneal ulcer

2.1

76.2

710

3381

H43.1

ICD-10 Finland

Vitreous haemorrhage

2.6

75.3

436

1683

37510

ICD-8 Finland

Glaucoma, Chronicum simplex

+∞

75.0

H57.1

ICD-10 Finland

Ocular pain

2.3

74.5

559

2435

T85.2

ICD-10 Finland

Mechanical complication of intraocular lens

6.0

73.5

130

219

T89

ICPC

Diabetes insulin dependent

2.3

72.0

545

2383

SPAT1310

SPAT

Counselling related to known health issue

1.4

71.7

4921

38777

H35.39

ICD-10 Finland

Degeneration of macula and posterior pole

2.3

71.3

560

2487

H21.0

ICD-10 Finland

Hyphaema

7.7

70.7

130

SPAT1262

SPAT

Handing over of treatment supplies

1.5

68.4

2845

20498

A10AA01, ,

ATC

2.7

68.3

373

1398

CKD15

NOMESCO Finland

Injection of vitreous substitute

6.0

68.2

120

201

H27.8

ICD-10 Finland

Other specified disorders of lens

6.4

67.4

111

174

E10.9

ICD-10 Finland

Type 1 diabetes mellitus, Without complications

2.2

65.4

542

2462

A10AB04

ATC

insulin lispro; parenteral

2.4

63.2

439

1847

H3601, E103,

ICD-10 Finland

4.5

62.1

152

341

CKD93

NOMESCO Finland

Extended combined procedure on vitreous body and retina

5.2

61.4

126

244

SPAT1153

SPAT

Removal of sutures

1.3

61.0

5104

41231

H27.1

ICD-10 Finland

Dislocation of lens

5.7

59.8

111

196

WX720

NOMESCO Finland

Own respiration

1.9

59.6

749

3971

A10AA02, ,

ATC

2.3

59.1

480

2161

A98

ICPC

Health maint/preventive medicine

1.6

58.1

15899

152086

H36.01

ICD-10 Finland

Diabetic maculopathy

3.2

58.0

230

722

CHC03

NOMESCO Finland

Laser iridoplasty

293.0

57.3

CG2T4

NOMESCO Finland

Topography assessment of cornea

3.9

56.6

168

436

S01BC03

ATC

diclofenac; ophthalmic

2.4

56.2

379

1574

TCA20

NOMESCO Finland

Peribulbar therapeutic injection into orbit

9.3

55.3

H04AA01

ATC

glucagon; nasal, parenteral

2.9

55.3

270

955

CKD70

NOMESCO Finland

Excision of preretinal or epiretinal membrane

2.7

55.2

306

1156

A10AC01

ATC

insulin (human); parenteral

1.7

54.6

1097

6685

H36.00

ICD-10 Finland

Diabetic background retinopathy

3.0

54.0

240

806

TCG20

NOMESCO Finland

Laser suture lysis in cornea or sclera

+∞

53.1

H36.09*E10.3

ICD-10 Finland

Insulin-dependent diabetes mellitus - Diabetic retinopathy

4.5

52.9

130

293

SPAT1253

SPAT

Initiation, adjustment, discontinuation or repetition of medication

1.3

52.6

4564

36891

SPAT1249

SPAT

Treatment-related counselling outside office

1.3

51.8

5849

48970

CKD92

NOMESCO Finland

Combined vitrectomy and retinal procedure

3.1

51.1

219

720

A10AB05

ATC

insulin aspart; parenteral

1.6

49.7

1105

6907

F29

ICPC

Eye symptom/complaint other

1.6

49.3

1380

9111

2500B

ICD-9 Finland

Diabetes mellitus without mention of complication[DIABETES MELLITUS SINE COMPLICATIONE ,TYYPPI I]

2.8

49.3

249

897

CJ2M4

NOMESCO Finland

Scans and measurement printouts for intraocular lens power calculation

3.1

48.9

207

676

CS444, ,

SPAT

9.1

48.6

H20.9

ICD-10 Finland

Iridocyclitis, unspecified

3.4

48.5

179

538

A10AE05

ATC

insulin detemir; parenteral

1.8

48.4

768

4377

SPAT1260

SPAT

Consultation of another employee

1.4

48.4

2721

20552

H40.21

ICD-10 Finland

Intermittent glaucoma with closed ventricular angle

479.3

48.4

H35.30

ICD-10 Finland

Kuhnt-Junius degeneration

1.7

48.2

982

6001

CKD60

NOMESCO Finland

Anterior vitrectomy

3.5

48.1

165

473

3651B

ICD-9 Finland

Glaucoma, Open-angle glaucoma[GLAUCOMA CAPSULARE (AVOKULMA)]

+∞

47.9

SPAT1033

SPAT

Irrigation or wax removal of outer auditory canal

1.4

47.6

3057

23577

OAB50, ,

SPAT

1.7

47.4

841

4950

CKC10

NOMESCO Finland

Local photocoagulation of retina

2.5

46.8

297

1200

215

Kela drug reimbursment

Diabetes, non-insulin-treated

1.3

46.1

3769

30111

H27.0

ICD-10 Finland

Aphakia

6.4

45.9

120

CKD91

NOMESCO Finland

Extended vitrectomy through pars plana

2.7

45.6

252

952

H43.8

ICD-10 Finland

Other disorders of vitreous body

1.5

44.4

1484

10174

ZXC20

NOMESCO Finland

Use of chemical agents

2.4

43.8

312

1329

H40.6

ICD-10 Finland

Glaucoma secondary to drugs

153.7

43.8

S01BA07

ATC

fluorometholone; ophthalmic

2.7

43.6

244

927

H18.1

ICD-10 Finland

Bullous keratopathy

7.2

43.5

SPAT1325

SPAT

Vaccination

1.3

43.1

5305

44637

ZXA05

NOMESCO Finland

Left side

1.3

42.5

3881

31420

H52.2

ICD-10 Finland

Astigmatism

2.6

42.2

239

914

CKC15

NOMESCO Finland

Panretinal photocoagulation

3.5

41.5

143

412

E10.2

ICD-10 Finland

Type 1 diabetes mellitus, With renal complications

3.8

41.2

127

339

H26.02

ICD-10 Finland

Presenil cataract

2.1

41.1

411

2010

WX704

NOMESCO Finland

Intubation

1.6

40.9

1154

7624

S01BA01

ATC

dexamethasone; ophthalmic

1.9

40.8

517

2747

H52.0

ICD-10 Finland

Hypermetropia

2.4

40.4

279

1173

H20.8

ICD-10 Finland

Other iridocyclitis

4.8

40.3

188

H53.1

ICD-10 Finland

Subjective visual disturbances

1.6

40.0

982

6281

F99

ICPC

Eye/adnexa disease other

3.6

39.0

128

357

H25.8

ICD-10 Finland

Other senile cataract

1.4

39.0

1819

13270

A10AE04

ATC

insulin glargine; parenteral

1.5

38.8

1362

9420

H21.1

ICD-10 Finland

Other vascular disorders of iris and ciliary body

9.6

38.5

E10.1

ICD-10 Finland

Type 1 diabetes mellitus, With ketoacidosis

3.8

38.3

116

306

H53.4

ICD-10 Finland

Visual field defects

2.2

38.2

321

1467

A10AE06

ATC

insulin degludec; parenteral

2.0

37.6

437

2255

TCF00

NOMESCO Finland

Subconjunctival therapeutic injection

7.2

37.2

H90.3

ICD-10 Finland

Sensorineural hearing loss, bilateral

1.3

37.2

2811

22120

S18

ICPC

Laceration/cut

1.2

37.0

7061

62113

SPAT1097

SPAT

Recording of ECG

1.4

36.7

2298

17583

Z50.9

ICD-10 Finland

Care involving use of rehabilitation procedure, unspecified

1.8

36.7

585

3339

CFB00

NOMESCO Finland

Suture of conjunctiva

10.0

36.2

XCD20

NOMESCO Finland

Photoangiography of eye

2.3

35.3

267

1168

H35.36

ICD-10 Finland

Macular cyst

3.1

35.1

145

468

H3603, E113,

ICD-10 Finland

3.2

34.8

141

450

CJF45

NOMESCO Finland

Removal and implantation of artificial lens in anterior chamber with iridectomy or iridotomy

6.9

34.7

H40.29

ICD-10 Finland

Other [primary] glaucoma with closed ventricular angle

+∞

34.4

XCH00, ,

SPAT

9.8

33.8

E10

ICD-10 Finland

Type 1 diabetes mellitus

2.5

33.8

210

842

WX725

NOMESCO Finland

Noninvasive ventilation

1.6

33.4

750

4695

CKC20

NOMESCO Finland

Cryopexy of undetached retina

5.3

33.1

125

-44

ICPC

Preventive immunization/medic

1.5

33.0

1238

8665

Z01.8

ICD-10 Finland

Other specified special examinations

1.3

32.6

3250

26477

ZXA00

NOMESCO Finland

Right side

1.3

32.6

4070

34063

UJF32

NOMESCO Finland

Coloscopy

1.3

32.5

4080

34165

103

Kela drug reimbursment

Diabetes, insulin-treated

1.3

32.2

4059

34001

SPAT1223

SPAT

Implementation of physical therapy rehabilitation plan

1.2

31.7

4405

37284

FM1EE

NOMESCO Finland

Extensive structural and functional ultrasound examination of heart

1.3

31.7

3471

28586

C08CA01

ATC

amlodipine; oral

1.2

31.6

6204

54438

25000

ICD-8 Finland

Diabetes mellitus, Sine complicatione

2.0

31.2

351

1793

SAA01

NOMESCO Finland

Simple examination of mouth

1.2

30.8

10190

93923

H13

ICPC

Plugged feeling ear

1.3

30.8

2881

23264

SAA02

NOMESCO Finland

Basic examination of mouth

1.2

30.6

9166

83663

T90

ICPC

Diabetes non-insulin dependent

1.3

30.3

3605

29956

CJF30

NOMESCO Finland

Reduction of dislocation of artificial lens

5.3

29.8

111

CHF15

NOMESCO Finland

Cryotherapy of ciliary body

82.7

29.7

SFA20

NOMESCO Finland

Two-surface restoration

1.2

29.6

7969

71923

N02BE01

ATC

paracetamol; systemic, rectal

1.3

29.5

14475

138618

R44

ICPC

Respiratory, Preventive immunization/medic

2.2

29.5

250

1148

3650B

ICD-9 Finland

Glaucoma, Borderline glaucoma [glaucoma suspect][SUSPICIO GLAUCOMATIS (AHDASKULMA)]

+∞

29.2

N03AX12

ATC

[U] gabapentin; oral

1.3

29.1

2346

18560

UDC00

NOMESCO Finland

Ear microscopy

1.5

29.0

1031

7138

C10AA07

ATC

rosuvastatin; oral

1.2

28.7

4803

41374

R51.80

ICD-10 Finland

Headache

1.3

28.4

1889

14545

H35.31

ICD-10 Finland

Senile macular degeneration (atrophic)(exudative)

1.6

28.2

683

4352

H30.2

ICD-10 Finland

Posterior cyclitis

4.9

28.2

128

H3601, E113,

ICD-10 Finland

2.3

28.2

219

971

WX400

NOMESCO Finland

Inhalation anesthesy

1.7

28.1

506

2992

TCG00

NOMESCO Finland

Protection of cornea and sclera with soft lens

5.0

27.9

118

CHC00

NOMESCO Finland

Iridotomy

77.7

27.7

H01.0

ICD-10 Finland

Blepharitis

1.5

27.6

767

5046

WX110

NOMESCO Finland

Infiltration anesthesia

1.2

27.3

10297

95482

S01FA04

ATC

cyclopentolate; ophthalmic

2.6

26.8

155

601

SDA02

NOMESCO Finland

Periodontal treatment, brief

1.2

26.6

4670

40350

3708

FHL

Trabeculectomy or equivalent

140.2

26.6

N08.39*E10.2

ICD-10 Finland

Insulin-dependent diabetes mellitus - Diabetic nephropathy

3.2

26.5

105

331

TCG10

NOMESCO Finland

Removal of sutures from cornea

3.5

26.5

253

CH2X4

NOMESCO Finland

Optical coherence tomography (OCT) of iris and iridocorneal angle

8.2

26.5

R42

ICD-10 Finland

Dizziness and giddiness

1.2

26.3

3490

29290

M75.1

ICD-10 Finland

Rotator cuff syndrome

1.2

26.3

3587

30196

CG2X4

NOMESCO Finland

Optical coherence tomography (OCT) of cornea

3.3

26.3

303

QAA25

NOMESCO Finland

Destruction of lesion of head or neck

1.8

26.2

404

2285

S01BA04

ATC

prednisolone; ophthalmic

1.9

26.2

306

1585

CA1CG

NOMESCO Finland

Eye and orbita extensive MRI examination with high intensity magnet

3.1

26.1

108

350

S01EX

ATC

Other antiglaucoma preparations

+∞

26.0

S01EX05

ATC

netarsudil; ophthalmic

+∞

26.0

XF400

NOMESCO Finland

ECG with 12 standard connections

0.7

26.0

1401

18535

S01BC05

ATC

ketorolac; ophthalmic

1.6

25.9

538

3303

CKC60

NOMESCO Finland

Local buckling of sclera using implant

3.3

25.8

287

H02.4

ICD-10 Finland

Ptosis of eyelid

1.8

25.7

416

2386

F27

ICPC

Fear of eye disease

2.6

25.6

153

603

CA1AE

NOMESCO Finland

Eye and orbita ultrasound examination

3.6

25.3

223

SFA10

NOMESCO Finland

One-surface restoration

1.2

25.2

7479

67700

37520

ICD-8 Finland

Glaucoma, Secondary

+∞

25.0

177

Kela drug reimbursment

Insulin glargine 300 U / ml

2.1

24.8

242

1175

I10

ICD-10 Finland

Essential (primary) hypertension

1.2

24.5

10070

93604

SPAT1028

SPAT

Ultrasound examination of paranasal sinuses

1.5

24.5

686

4519

C10AX09

ATC

ezetimibe; oral

1.3

24.2

2235

17962

C09CA01

ATC

losartan; oral

1.2

24.2

3937

33701

E0000UV, ,

ATC

1.2

24.2

5902

52473

QXA25

NOMESCO Finland

Destruction of lesion of skin, site unspecified

1.7

23.4

404

2361

A02BC03

ATC

lansoprazole; oral

1.2

23.4

4298

37207

J01DB01

ATC

cefalexin; oral

1.2

23.3

12787

121584

E10.00

ICD-10 Finland

Insulin-dependent diabetes diabetic hypoglycemic coma

2.7

23.2

121

446

AA1AD

NOMESCO Finland

CT of head and brain

1.2

23.0

4147

35827

O24.0

ICD-10 Finland

Diabetes mellitus in pregnancy: Pre-existing diabetes mellitus, insulin-dependent

3.0

22.8

330

S01GX01

ATC

cromoglicic acid; ophthalmic

1.3

22.7

2445

20008

D82

ICPC

Teeth/gum disease

1.2

22.7

4593

40100

EB1HA

NOMESCO Finland

Panorama tomography of teeth and jaws or similar X-ray examination

1.2

22.6

5695

50682

CHD10

NOMESCO Finland

Trabeculectomy

230.3

22.6

CHB99

NOMESCO Finland

Other operation on anterior chamber and anterior chamber angle

32.3

22.4

CM2S4

NOMESCO Finland

Follow-up photography of age-related macular degeneration lesions

2.8

22.2

112

406

H18.2

ICD-10 Finland

Other corneal oedema

4.7

22.1

106

XCH05, ,

SPAT

21.4

22.1

D07AC01

ATC

betamethasone; topical

1.2

21.9

5125

45291

H33.3

ICD-10 Finland

Retinal breaks without detachment

1.6

21.9

467

2889

-1, ,

NOMESCO Finland

1.2

21.8

4052

35078

G04CA02

ATC

tamsulosin; oral

1.2

21.8

3039

25578

F01

ICPC

Eye pain

1.8

21.6

349

2004

H11.3

ICD-10 Finland

Conjunctival haemorrhage

1.5

21.5

584

3822

H16.9

ICD-10 Finland

Keratitis, unspecified

2.1

21.5

202

969

S01AD03

ATC

aciclovir; ophthalmic

1.6

21.4

467

2904

H44.2

ICD-10 Finland

Degenerative myopia

5.1

21.4

WX002

NOMESCO Finland

Sedation and analgesia

1.2

21.4

2783

23245

H3600, E113,

ICD-10 Finland

2.2

20.9

174

796

SPAT1292

SPAT

Other function in accordance with SHToL (Finnish classification of nursing interventions)

1.3

20.9

1281

9730

EB1SA

NOMESCO Finland

Dental X-ray, bite-wing X-ray on one side of the mouth

1.2

20.8

5640

50421

WX144

NOMESCO Finland

Subconjunctival anesthesy

2.2

20.7

167

754

M79.6

ICD-10 Finland

Pain in limb

1.2

20.7

5991

53827

S01CA02

ATC

prednisolone and antiinfectives; ophthalmic

2.2

20.7

169

767

CFD10

NOMESCO Finland

Repair of conjunctiva

8.7

20.6

C10AA05

ATC

atorvastatin; oral

1.2

20.3

6545

59282

SPAT1250

SPAT

Comprehensive monitoring of chronic illness

1.2

20.3

4084

35573

SAA03

NOMESCO Finland

Extended examination of mouth

1.2

20.2

4976

44096

H19.1*B00.5

ICD-10 Finland

Herpesviral keratoconjunctivitis

2.5

20.1

127

515

H3603, E107,

ICD-10 Finland

8.4

20.1

WZB00

NOMESCO Finland

Telephone prescription or other care instructions

1.2

20.1

3702

31981

Z94.7

ICD-10 Finland

Corneal transplant status

3.3

20.1

234

K02.1

ICD-10 Finland

Caries of dentine

1.2

20.0

7761

71278

D07AB02

ATC

hydrocortisone butyrate; topical

1.2

19.9

4035

35150

E11.3

ICD-10 Finland

Type 2 diabetes mellitus, with ophthalmic complications

1.7

19.8

377

2264

H28.0*E10.3

ICD-10 Finland

Other specified diabetes mellitus - Diabetic cataract

5.4

19.7

E10.4

ICD-10 Finland

Type 1 diabetes mellitus, With neurological complications

2.7

19.6

100

365

CGG45

NOMESCO Finland

Full thickness transplantation of cornea using homograft

4.8

19.6

H44.5

ICD-10 Finland

Degenerated conditions of globe

16.3

19.6

H15.1

ICD-10 Finland

Episcleritis

2.1

19.5

176

832

F05

ICPC

Visual disturbance other

1.7

19.4

393

2399

H26.3

ICD-10 Finland

Drug-induced cataract

2.9

19.4

323

R4180

NOMESCO Finland

Podiatric therapy

2.2

19.3

163

750

R01AD09

ATC

mometasone; nasal

1.2

19.1

6027

54429

H02

ICPC

Hearing complaint

1.3

19.0

2053

16779

S01FA01

ATC

atropine; ophthalmic

3.3

19.0

212

CKD50

NOMESCO Finland

Endodiathermy of retina

5.0

19.0

H36.09

ICD-10 Finland

Diabetic retinopathy (E10-E14+ with common fourth character .3)

3.4

18.9

193

A06AC01

ATC

ispaghula (psylla seeds); oral

1.2

18.7

3916

34179

EB1AA

NOMESCO Finland

Intraoral radiographic dental examination

1.2

18.6

7599

69908

NF1BA

NOMESCO Finland

Hip extensive X-ray examination

1.5

18.6

517

3404

WYA05

NOMESCO Finland

Emergency visit or other similar visit involving procedures

1.2

18.6

6244

56621

H53.9

ICD-10 Finland

Visual disturbance, unspecified

1.6

18.5

453

2900

CKC30

NOMESCO Finland

Cryopexy of detached retina

3.0

18.4

278

BEF00

NOMESCO Finland

Continuous subcutaneous glucose monitoring

2.9

18.3

279

SPAT1081

SPAT

Cardiorespiratory global assessment

1.4

18.3

794

5701

PA7AD

NOMESCO Finland

CT angiography of head and neck vasculature

1.6

18.3

472

3058

SPAT1149

SPAT

Suture or treatment of traumatic wound

1.3

18.2

1710

13745

Z83.5

ICD-10 Finland

Family history of eye and ear disorders

4.7

18.2

Z01.5

ICD-10 Finland

Diagnostic skin and sensitization tests

1.3

18.2

1053

7929

N06AX11

ATC

mirtazapine; oral

1.2

18.0

4740

42143

M54.5

ICD-10 Finland

Low back pain

1.2

18.0

4807

42787

CKD94

NOMESCO Finland

Combined vitrectomy and procedure on lens through pars plana

1.9

18.0

207

1070

A02BC05

ATC

esomeprazole; systemic

1.2

18.0

5978

54126

R3120

NOMESCO Finland

Training in mobility skills

3.3

17.8

196

H54.4

ICD-10 Finland

Blindness, monocular

4.2

17.8

109

CKC70

NOMESCO Finland

Circular buckling of sclera

3.5

17.8

172

Z01.9

ICD-10 Finland

Special examination, unspecified

1.4

17.7

757

5422

CFW10

NOMESCO Finland

Conjunctival manipulation with a needle (needling)

+∞

17.7

SPAT1306

SPAT

Counselling and guidance related to nutrition and weight management

1.3

17.6

1824

14829

GD1AA

NOMESCO Finland

Thorax X-ray examination

1.2

17.6

7042

64594

H33.4

ICD-10 Finland

Traction detachment of retina

4.7

17.5

WZC00, ,

SPAT

1.3

17.4

1207

9325

SPAT1377

SPAT

Polysomnography

1.6

17.4

390

2445

R01AD12

ATC

fluticasone furoate; nasal

1.2

17.4

3710

32409

R4110

NOMESCO Finland

Physiotherapy

0.8

17.4

2991

34672

ZXC50

NOMESCO Finland

Cryotherapy

1.6

17.3

442

2858

R01AD58

ATC

fluticasone, combinations; nasal

1.2

17.2

2730

23212

UJD10

NOMESCO Finland

Esophagoscopy, gastroscopy and duodenoscopy

1.2

17.2

4285

37908

G47.3

ICD-10 Finland

Sleep apnoea

1.2

17.2

2858

24409

C08CA13

ATC

lercanidipine; oral

1.2

17.1

2138

17743

L17

ICPC

Foot/toe symptom/complaint

1.2

17.1

4073

35892

OAB42, ,

SPAT

1.3

17.1

1175

9070

VALMI, ,

NOMESCO Finland

1.2

17.0

2863

24482

M03BX02

ATC

tizanidine; oral

1.1

17.0

8737

81490

G44.2

ICD-10 Finland

Tension-type headache

1.3

16.9

1664

13451

Z2221

NOMESCO Finland

Medical doctor

0.8

16.7

2795

32509

WX780

NOMESCO Finland

Remote monitoring CPAP

1.5

16.6

475

3147

SPAT1016

SPAT

Examination of vision

1.5

16.6

521

3520

SDA01

NOMESCO Finland

Periodontal treatment, very brief

1.2

16.6

3316

28785

J02AC01

ATC

fluconazole; systemic

1.2

16.5

5311

47891

H18.8

ICD-10 Finland

Other specified disorders of cornea

2.6

16.5

347

CA1TM

NOMESCO Finland

Calculation of intraocular lens power

1.7

16.4

269

1553

WX105

NOMESCO Finland

Surface analgesia on skin or mucosa

1.3

16.3

1140

8818

H10.3

ICD-10 Finland

Acute conjunctivitis, unspecified

1.4

16.3

714

5139

H02.3

ICD-10 Finland

Blepharochalasis

1.3

16.1

932

7014

S01XA18

ATC

ciclosporin; ophthalmic

2.4

16.1

104

428

SPAT1043

SPAT

Audiometry

1.3

16.1

1494

11990

SHB00

NOMESCO Finland

Preparing and fitting the occlusal splint in the mouth

1.4

16.0

897

6718

R06AX27

ATC

desloratadine; oral

1.2

15.8

3332

29048

H18.5

ICD-10 Finland

Hereditary corneal dystrophies

2.1

15.5

138

650

Z87.1

ICD-10 Finland

Personal history of diseases of the digestive system

1.1

15.5

5873

53510

A10AD01

ATC

insulin (human); parenteral

1.9

15.5

203

1096

R07.4

ICD-10 Finland

Chest pain, unspecified

1.2

15.4

4104

36436

R09

ICPC

Sinus symptom/complaint

1.4

15.4

872

6542

-1, ,

SPAT

1.6

15.4

396

2566

E11.9

ICD-10 Finland

Type 2 diabetes mellitus, without complications

1.2

15.4

3493

30626

TPH04

NOMESCO Finland

Cathetrisation of vein

1.2

15.4

3027

26223

SPAT1305

SPAT

Counselling and guidance related to physical exercise

1.3

15.3

1254

9905

S01FA02

ATC

scopolamine; ophthalmic

2.3

15.3

118

525

Z50.8

ICD-10 Finland

Care involving use of other rehabilitation procedures

1.3

15.3

901

6801

H53.0

ICD-10 Finland

Amblyopia ex anopsia

2.4

15.2

403

L08

ICPC

Shoulder symptom/complaint

1.2

15.2

2966

25677

L04AX03

ATC

methotrexate; systemic

1.3

15.1

1210

9527

D31.3

ICD-10 Finland

Benign neoplasm: Choroid

1.8

15.1

218

1213

SFA30

NOMESCO Finland

Three-surface restoration

1.1

15.1

5666

51571

SXA05, ,

NOMESCO Finland

2.2

15.0

121

548

SPAT1053

SPAT

Memory test

1.2

15.0

2254

19040

E10.8

ICD-10 Finland

Type 1 diabetes mellitus, With unspecified complications

2.1

14.9

136

647

UDQ12

NOMESCO Finland

Flexible laryngoscopy

1.4

14.9

691

5021

H30.9

ICD-10 Finland

Chorioretinal inflammation, unspecified

4.8

14.9

N02BF01

ATC

gabapentin; oral

1.3

14.9

1035

7998

M51.1

ICD-10 Finland

Lumbar and other intervertebral disc disorders with radiculopathy

1.2

14.9

1813

14996

M45

ICD-10 Finland

Ankylosing spondylitis

1.8

14.7

217

1218

KMAK, ,

NOMESCO Finland

1.1

14.6

6643

61207

E10.6

ICD-10 Finland

Type 1 diabetes mellitus, With other specified complications

2.8

14.6

254

37512

ICD-8 Finland

Glaucoma, Chronicum capsulare

+∞

14.6

EB1VA, ,

NOMESCO Finland

1.3

14.6

1438

11618

UDH02

NOMESCO Finland

Rhinopharyngoscopy

1.4

14.6

760

5630

R10.4

ICD-10 Finland

Other and unspecified abdominal pain

1.2

14.5

4853

43791

SPAT1058

SPAT

PEF monitoring instruction

1.3

14.5

1071

8349

A02BC02

ATC

pantoprazole; systemic

1.1

14.5

10559

100266

S01KA02

ATC

hypromellose; ophthalmic

1.7

14.4

246

1438

N40

ICD-10 Finland

Hyperplasia of prostate

1.2

14.2

2664

22961

L03

ICPC

Low back symptom/complaint

1.2

14.2

3650

32289

SDA03

NOMESCO Finland

Periodontal treatment

1.1

14.0

5068

45950

K03.82

ICD-10 Finland

Split tooth for reasons other than trauma

1.2

14.0

3074

26855

J01FA10

ATC

azithromycin; systemic

1.1

13.9

7674

71501

QAA05

NOMESCO Finland

Incision for biopsy of skin of head or neck

1.6

13.9

328

2084

ZX198

NOMESCO Finland

Other local administration

2.0

13.9

139

686

XQ848

NOMESCO Finland

Dermatological photography

1.5

13.8

362

2359

CL2S4

NOMESCO Finland

Ocular fundus photography for diabetic retinopathy screening

1.7

13.7

272

1657

Z3231

NOMESCO Finland

Registered nurse

1.2

13.6

3707

32924

SDE02

NOMESCO Finland

Periodontal treatment by dental hygienist

1.2

13.6

2950

25736

R29.8

ICD-10 Finland

Other and unspecified symptoms and signs involving the nervous and musculoskeletal systems

1.3

13.6

1032

8072

SCA01

NOMESCO Finland

Preventive oral health care, short

1.2

13.6

3251

28586

TPH07

NOMESCO Finland

Cathetrisation of artery

1.2

13.5

1524

12497

H57.9

ICD-10 Finland

Disorder of eye and adnexa, unspecified

2.1

13.5

121

573

J01CA04

ATC

amoxicillin; systemic

1.1

13.5

12082

115956

Q15.0

ICD-10 Finland

Congenital glaucoma

140.1

13.4

E11.7

ICD-10 Finland

Type 2 diabetes mellitus, with multiple complications

1.4

13.4

674

4965

SPAT1156

SPAT

Guidance concerning treatment of rash and skin

1.2

13.4

1915

16093

NA7EA

NOMESCO Finland

Scoliosis X-ray examination

1.9

13.4

166

883

D48.5

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Skin

1.3

13.4

879

6743

H36.09*E11.3

ICD-10 Finland

Non-insulin-dependent diabetes mellitus - Diabetic retinopathy

2.3

13.3

429

WX723

NOMESCO Finland

CPAP therapy

1.5

13.2

430

2931

H31.4

ICD-10 Finland

Choroidal detachment

13.8

13.2

L86

ICPC

Back syndrome with radiating pain

1.3

13.2

758

5701

J01EE02

ATC

sulfadiazine and trimethoprim; systemic

1.2

13.1

3242

28570

N03AX16

ATC

[U] pregabalin

1.2

13.1

3257

28720

E85.80

ICD-10 Finland

Meretoja sick

5.9

13.0

WX402

NOMESCO Finland

General anaesthesia

1.2

13.0

2627

22773

ZYC01, ,

SPAT

1.3

13.0

955

7440

SPAT1210

SPAT

Application of cast or individual aid

1.4

13.0

500

3521

H44.4

ICD-10 Finland

Hypotony of eye

19.0

12.9

A02BC01

ATC

omeprazole; systemic

1.2

12.8

3886

34766

XQ845

NOMESCO Finland

Dermatoscopy

1.7

12.8

236

1412

H35.0

ICD-10 Finland

Background retinopathy and retinal vascular changes

2.5

12.7

291

N02AE01

ATC

buprenorphine; parenteral, sublingual, transdermal

1.2

12.6

2060

17526

2501B

ICD-9 Finland

Diabetes mellitus, Diabetes with ketoacidosis[DIABETES MELLITUS CUM KETOACIDOSI ,TYYPPI I]

4.0

12.6

313

Kela drug reimbursment

Abatacept, adalimumab, anakinra, certolizumab pegol, etanercept, golimumab, infliximab, ixekizumab, sarilumab, secukinumab, tocilizumab and ustekinumab (rheumatoid diseases)

1.6

12.6

296

1882

L57.0

ICD-10 Finland

Actinic keratosis

1.2

12.5

1560

12926

3711

FHL

Cyclodiateria or cryocoagulation

+∞

12.5

H40.2

ICD-10 Finland

Primary angle-closure glaucoma

+∞

12.5

S05.1

ICD-10 Finland

Contusion of eyeball and orbital tissues

1.9

12.5

147

769

JLE03

NOMESCO Finland

Allogenic total transplantation of pancreas with pancreaticoenterostomy

17.3

12.5

R06AE07

ATC

cetirizine; oral

1.1

12.3

5902

54389

SAD02

NOMESCO Finland

Assessment of need for oral health care, extensive

1.5

12.3

358

2388

H17.8

ICD-10 Finland

Other corneal scars and opacities

3.2

12.3

142

ZYC01

NOMESCO Finland

Remote contact by phone

1.4

12.2

641

4755

R06.5

ICD-10 Finland

Mouth breathing

1.3

12.2

969

7622

I49.9

ICD-10 Finland

Cardiac arrhythmia, unspecified

1.2

12.2

1552

12885

M01AH05

ATC

etoricoxib; oral

1.1

12.2

8753

82585

ZX114, ,

SPAT

1.9

12.2

144

754

H44.0

ICD-10 Finland

Purulent endophthalmitis

4.2

12.2

S82

ICPC

Naevus/mole

1.2

12.2

1646

13750

WX700

NOMESCO Finland

Respiratory and circulatory monitoring

1.2

12.2

2142

18343

H54.1

ICD-10 Finland

Severe visual impairment, binocular

4.4

12.1

M08.4

ICD-10 Finland

Pauciarticular juvenile arthritis

4.0

12.1

M01AC06

ATC

meloxicam; systemic, rectal

1.1

12.1

5208

47665

JL9AE

NOMESCO Finland

Ultrasound examination of pancreas transplant

26.7

12.0

R5210

NOMESCO Finland

Assessment of the improvements needed in the living environment

3.2

12.0

149

L04AX01

ATC

azathioprine; systemic

1.4

12.0

463

3263

KA2AT

NOMESCO Finland

Biopsy of transplanted kidney with ultrasound guidance

2.5

12.0

276

H01.80

ICD-10 Finland

Prolonged inflammation in the edge of the eyelid

2.0

11.8

117

576

KE1BE

NOMESCO Finland

Rectal ultrasound examinaiton of prostata

1.3

11.8

954

7520

C09CA06

ATC

candesartan; oral

1.2

11.8

3214

28512

D86.8

ICD-10 Finland

Sarcoidosis of other and combined sites

2.3

11.7

383

C02AC05

ATC

moxonidine; oral

1.4

11.7

597

4413

CBB11

NOMESCO Finland

Resection of lax skin in upper eyelid

1.5

11.6

350

2350

G04CB01

ATC

finasteride; oral

1.2

11.6

1314

10775

SCA02

NOMESCO Finland

Preventive oral health care

1.3

11.6

1010

8036

TCA15

NOMESCO Finland

Retrobulbar therapeutic injection into orbit

30.0

11.6

Z3226

NOMESCO Finland

Physiotherapist

0.8

11.6

1804

21194

UKC02

NOMESCO Finland

Cystoscopy

1.2

11.6

2156

18548

F28

ICPC

Limited function/disability (F)

2.3

11.5

379

SHA01

NOMESCO Finland

Stomatognathic treatment, simple

1.3

11.5

1114

8980

I49.3

ICD-10 Finland

Ventricular premature depolarization

1.3

11.5

890

6981

K03.64

ICD-10 Finland

Dental calculus supragingival

1.1

11.5

3649

32713

CHB30

NOMESCO Finland

Goniotomy

+∞

11.5

3656X

ICD-9 Finland

Glaucoma associated with other ocular disorders[GLAUCOMA SECUNDARIA ALIA SEU NUD]

+∞

11.5

S01EB02

ATC

carbachol; ophthalmic

120.1

11.4

WZA90

NOMESCO Finland

Other medical or dental certificate

1.2

11.4

2867

25272

H18.4

ICD-10 Finland

Corneal degeneration

2.4

11.4

295

J05AB01

ATC

aciclovir; systemic

1.2

11.3

2832

24952

H35.4

ICD-10 Finland

Peripheral retinal degeneration

2.1

11.3

453

R01AD08

ATC

fluticasone; nasal

1.1

11.3

3557

31863

H26.1

ICD-10 Finland

Traumatic cataract

3.0

11.3

160

DM1AI

NOMESCO Finland

Cone beam CT of paranasal sinus

1.6

11.3

249

1561

N02AJ06

ATC

codeine and paracetamol; systemic

1.1

11.3

5660

52226

J01.0

ICD-10 Finland

Acute maxillary sinusitis

1.2

11.3

2740

24089

S06.0

ICD-10 Finland

Concussion

1.2

11.2

1266

10378

H35.9

ICD-10 Finland

Retinal disorder, unspecified

2.4

11.1

299

H02.0

ICD-10 Finland

Entropion and trichiasis of eyelid

1.6

11.1

273

1757

CBG00

NOMESCO Finland

Epilation of cilia by electrolysis

2.9

11.0

173

EB4VA, ,

NOMESCO Finland

1.3

11.0

1067

8602

-69

ICPC

Other reason for encounter NEC

1.4

11.0

465

3333

346

Kela drug reimbursment

Dulaglutide, exenatide, liraglutide, lixisenatide and semaglutide (adults)

1.3

11.0

605

4527

L04AA06

ATC

mycophenolic acid; systemic

1.7

10.9

196

1166

H22.1*M45

ICD-10 Finland

Iridocyclitis in ankylosing spondylitis

4.6

10.9

H35.37

ICD-10 Finland

Macular holes

1.7

10.9

192

1137

H47.2

ICD-10 Finland

Optic atrophy

2.7

10.9

202

WVA20, ,

SPAT

1.5

10.9

292

1916

CKD95

NOMESCO Finland

Extended combined vitectomy and lens procedure through pars plana

2.8

10.8

180

C01DA08

ATC

isosorbide dinitrate; oral, oral aerosol, sublingual, transdermal

1.1

10.8

3628

32619

R03BA08

ATC

ciclesonide; inhalant

1.3

10.8

1019

8187

CG2S4

NOMESCO Finland

Photography of cornea

2.7

10.8

214

SPAT1225

SPAT

Implementation of podiatry rehabilitation plan

1.5

10.7

307

2043

L04AB04

ATC

adalimumab; parenteral

1.7

10.7

201

1211

KA2AE

NOMESCO Finland

Ultrasound examination transplanted kidney

2.3

10.6

342

Z01.2

ICD-10 Finland

Dental examination

1.1

10.6

5800

53733

N08.39

ICD-10 Finland

Glomerular disorders in diabetes mellitus microalbuminuria

2.5

10.6

263

CJF15

NOMESCO Finland

Secondary implantation of skleral fixed artificial lens in posterior chamber

4.1

10.6

L04AD02

ATC

tacrolimus; systemic

2.1

10.6

472

NH3EA

NOMESCO Finland

Feet X-ray examination with load

1.6

10.6

225

1399

3793A

ICD-9 Finland

Other disorders of eye, Aphakia and other disorders of lens[APHAKIA]

5.3

10.6

R10.3

ICD-10 Finland

Pain localized to other parts of lower abdomen

1.2

10.6

2623

23086

H44.1

ICD-10 Finland

Other endophthalmitis

4.2

10.5

M08.3

ICD-10 Finland

Juvenile polyarthritis (seronegative)

3.4

10.5

105

G45.3

ICD-10 Finland

Amaurosis fugax

1.6

10.5

243

1542

KAS10

NOMESCO Finland

Allogenic transplantation of kidney from cadaver donor

2.1

10.5

441

XJH00

NOMESCO Finland

Transanal ultrasonography

1.3

10.5

694

5334

Z97.8

ICD-10 Finland

Presence of other specified devices

2.4

10.4

295

FN1BC

NOMESCO Finland

Extensive angiography of hear and/or coronary arteries

1.3

10.4

637

4840

CHD30

NOMESCO Finland

Laser trabeculectomy

110.1

10.4

C10AA01

ATC

simvastatin; oral

1.1

10.4

6717

62789

171

Kela drug reimbursment

Degludekinsuliini

3.4

10.4

106

NA3AA

NOMESCO Finland

Lumbar spine X-ray examination without contrast

1.2

10.4

1281

10605

SPAT1100

SPAT

Long-term monitoring of blood pressure

1.3

10.3

906

7219

TQX10

NOMESCO Finland

Biopsy of skin and subcutaneous tissue

1.2

10.3

1266

10471

CWD00

NOMESCO Finland

Reoperation for superficial heamorrhage in eye and adjacent structures

16.0

10.3

202

Kela drug reimbursment

Connective tissue diseases, rheumatoid arthritis and comparable disease

1.2

10.3

1414

11834

H10.1

ICD-10 Finland

Acute atopic conjunctivitis

1.6

10.2

249

1600

SPAT1130

SPAT

Esophagoscopy, gastroscopy and duodenoscopy

1.5

10.2

344

2368

JAETT, ,

NOMESCO Finland

2.3

10.2

330

SFC01

NOMESCO Finland

Additional procedure necessary for restorative treatment

1.1

10.1

3333

29913

CJG15

NOMESCO Finland

Extraction of dislocated lens with implantation of artificial lens in anterior chamber and iridectomy or iridotomy

7.4

10.1

HAMTE, ,

NOMESCO Finland

2.1

10.1

460

R23.8

ICD-10 Finland

Other and unspecified skin changes

1.2

10.1

2611

23040

SHA02

NOMESCO Finland

Stomatognathic treatment, basic

1.3

10.1

647

4950

G56.0

ICD-10 Finland

Carpal tunnel syndrome

1.2

10.1

1732

14792

ZXH06, ,

SPAT

1.4

10.1

503

3707

H19.8*E85.80

ICD-10 Finland

Reticular keratitis in Meretoja's patients

7.9

10.1

M01AX05

ATC

glucosamine; oral

1.1

10.1

3037

27101

WX702

NOMESCO Finland

Supraglottic ventilation device

1.3

10.0

640

4892

NB1AE

NOMESCO Finland

Shoulder ultrasound examination

1.6

10.0

218

1363

N02AA59

ATC

codeine, combinations excl. psycholeptics; systemic

1.1

10.0

6201

57791

R03AC02

ATC

salbutamol; inhalant

1.1

10.0

7613

71738

CA1CM

NOMESCO Finland

Eye and orbita extensive MRI examination with 3 Tesla magnet

3.1

10.0

134

FM1AE

NOMESCO Finland

Standard cardiac ultrasound examination

0.9

10.0

1966

22649

D07CA01

ATC

hydrocortisone and antibiotics; topical

1.2

9.9

1517

12818

K85

ICPC

Elevated blood pressure

1.2

9.9

2313

20252

25002

ICD-8 Finland

Diabetes mellitus, Retinopathia diabetica

3.0

9.9

135

M51.3

ICD-10 Finland

Other specified intervertebral disc degeneration

1.3

9.8

959

7742

CKC65

NOMESCO Finland

Removal of buckling implant from sclera

4.9

9.8

A10BA02

ATC

metformin; oral

1.1

9.8

3997

36368

H3602, E103,

ICD-10 Finland

4.0

9.7

M54.2

ICD-10 Finland

Cervicalgia

1.3

9.7

880

7039

K07.60

ICD-10 Finland

Snapping jaw

1.4

9.7

475

3489

CBJ40

NOMESCO Finland

Resection of levator muscle of eyelid

2.1

9.7

421

M02AA07

ATC

piroxicam; topical

1.1

9.7

5306

49105

XKD00

NOMESCO Finland

Uroflowmetry

1.2

9.6

1939

16781

H35.8

ICD-10 Finland

Other specified retinal disorders

2.3

9.6

319

SCC01

NOMESCO Finland

Fluoride application or other respective small prophylactic procedure

1.5

9.6

288

1936

C79.8

ICD-10 Finland

Secondary malignant neoplasm of other specified sites

0.6

9.6

212

3300

FC1AC

NOMESCO Finland

Angiography of thoracal aortta

2.1

9.6

410

M48.0

ICD-10 Finland

Spinal stenosis

1.2

9.6

1767

15184

CJF00

NOMESCO Finland

Secondary implantation of artificial lens in anterior chamber

4.3

9.6

Z94.0

ICD-10 Finland

Kidney transplant status

1.9

9.5

113

595

P20

ICPC

Memory disturbance

1.2

9.5

2014

17498

R06.0

ICD-10 Finland

Dyspnoea

1.1

9.4

3774

34278

CK2A4

NOMESCO Finland

Autofluorescence imaging of ocular fundus

2.8

9.4

155

Z71.2

ICD-10 Finland

Person consulting for explanation of investigation findings

0.9

9.4

2952

32891

F13

ICPC

Eye sensation abnormal

1.5

9.4

312

2143

H35.7

ICD-10 Finland

Separation of retinal layers

1.9

9.4

105

543

N06AX21

ATC

duloxetine; oral

1.2

9.4

1384

11660

J01AA02

ATC

doxycycline; systemic

1.1

9.4

11949

115475

SPAT1203

SPAT

Injection therapy, other than intramuscular or subcutaneous

1.3

9.4

516

3864

AA1CG

NOMESCO Finland

Extensive MRI examination of brain with high intensity magnet

1.3

9.3

905

7299

K05.10

ICD-10 Finland

Gingivitis (chronic) NOS

1.2

9.3

1574

13420

SDA04

NOMESCO Finland

Demanding periodontal treatment

1.1

9.3

3235

29132

H10.0

ICD-10 Finland

Mucopurulent conjunctivitis

1.3

9.2

693

5417

H04.5

ICD-10 Finland

Stenosis and insufficiency of lacrimal passages

1.5

9.2

259

1718

H01

ICPC

Ear pain/earache

1.2

9.2

1214

10115

H34.1

ICD-10 Finland

Central retinal artery occlusion

2.2

9.2

326

J32.0

ICD-10 Finland

Chronic maxillary sinusitis

1.3

9.1

836

6697

281

Kela drug reimbursment

Abatacept, adalimumab, anakinra, certolizumab pegol, etanercept, golimumab, infliximab, ixekizumab, sarilumab, secukinumab and tocilizumab

1.5

9.1

263

1755

SHA03

NOMESCO Finland

Stomatognathic treatment, demanding

1.5

9.1

286

1942

L88

ICPC

Rheumatoid/seropositive arthritis

1.4

9.1

488

3640

SPAT1285

SPAT

Provision of consultation response

1.3

9.1

636

4927

S05.0

ICD-10 Finland

Injury of conjunctiva and corneal abrasion without mention of foreign body

1.6

9.1

192

1194

H3603, E106,

ICD-10 Finland

11.4

9.0

SAD01

NOMESCO Finland

Assessment of need for oral health care, standard

1.2

9.0

1428

12106

TCH12

NOMESCO Finland

Sample aspiration from anterior chambre

10.0

9.0

H3603, E109,

ICD-10 Finland

10.0

9.0

TNH11

NOMESCO Finland

Injection of diagnostic or therapeutic substance in ankle joint or foot joint

1.8

9.0

119

650

CK2Y4

NOMESCO Finland

OCT video recording of ocular fundus

2.4

9.0

235

EBA10

NOMESCO Finland

Operative extraction of tooth

1.2

8.9

1075

8876

3643

FHL

Vitrectomy through pars Plana

3.8

8.9

R05

ICPC

Cough

1.1

8.9

3081

27716

SAAJP, ,

NOMESCO Finland

3.5

8.9

S19

ICPC

Skin injury other

1.4

8.9

447

3300

R10.1

ICD-10 Finland

Pain localized to upper abdomen

1.2

8.9

2185

19205

196

Kela drug reimbursment

Paricalcitol and cinacalcet

2.4

8.8

231

-, ,

ICD-10 Finland

1.5

8.8

272

1841

285

Kela drug reimbursment

Dulaglutide, exenatide, liraglutide, lixisenatide and semaglutide (adults)

1.3

8.8

631

4904

KA9AE

NOMESCO Finland

Ultrasound examination transplanted kidney

3.1

8.8

118

CBB10

NOMESCO Finland

Excision of redundant skin of eyelid

1.5

8.8

300

2072

SPAT1094

SPAT

Continuous Positive Airway Pressure

1.8

8.8

126

706

WW200, ,

SPAT

1.1

8.8

2948

26472

A10BJ06

ATC

semaglutide; parenteral

1.3

8.7

511

3861

R01BA52

ATC

pseudoephedrine, combinations; oral

1.1

8.7

3976

36370

A12AX

ATC

Calcium, combinations with vitamin D and/or other drugs

1.1

8.7

5264

48902

H50.1

ICD-10 Finland

Divergent concomitant strabismus

2.1

8.7

346

CGG60

NOMESCO Finland

Reinforcement of sclera using graft

50.0

8.7

CJF10

NOMESCO Finland

Secondary implantation of artificial lens in posterior chamber

3.5

8.6

SPAT1148

SPAT

Treatment of chronic ulcer or burn

1.2

8.6

1807

15683

H54.6

ICD-10 Finland

Moderate visual impairment, monocular

2.7

8.6

158

NA6AA

NOMESCO Finland

Sacro-iliac joint X-ray examination

2.6

8.5

181

Z01.4

ICD-10 Finland

Gynaecological examination (general)(routine)

1.2

8.5

1813

15754

L60.0

ICD-10 Finland

Ingrowing nail

1.3

8.5

513

3893

AA1BG

NOMESCO Finland

Standard MRI examination of brain with high intensity magnet

1.2

8.5

986

8108

G04CA01

ATC

alfuzosin; oral

1.2

8.5

1383

11750

CK2L4

NOMESCO Finland

Wide-field/panoramic imaging of ocular fundus

2.1

8.5

363

190

Kela drug reimbursment

Lanthanum carbonate, sevelamer and sucroferric oxyhydroxide

2.0

8.4

465

NH3AA

NOMESCO Finland

Foot and toes X-ray examination

1.2

8.4

1034

8554

G04CB02

ATC

dutasteride; oral

1.2

8.4

848

6869

LX1AE

NOMESCO Finland

Gynecological ultrasound examination as part of clinical examination

1.2

8.4

983

8092

3702

FHL

Trabeculotomy

90.1

8.4

F16

ICPC

Eyelid symptom/complaint

1.3

8.4

575

4443

K03.0

ICD-10 Finland

Excessive attrition of teeth

1.4

8.4

298

2075

R01AD01

ATC

beclometasone; nasal

1.2

8.4

1814

15788

E10.5

ICD-10 Finland

Type 1 diabetes mellitus, With peripheral circulatory complications

2.4

8.4

237

L30.9

ICD-10 Finland

Dermatitis, unspecified

1.1

8.3

2477

22057

CS434, ,

SPAT

+∞

8.3

3652B

ICD-9 Finland

Glaucoma, Primary angle-closure glaucoma[KROONINEN AHDASKULMAGLAUKOOMA]

+∞

8.3

H54.2

ICD-10 Finland

Moderate visual impairment, binocular

1.8

8.3

108

587

L82

ICD-10 Finland

Seborrhoeic keratosis

1.1

8.3

2464

21937

DFF05, ,

SPAT

1.8

8.3

119

667

CM2X4

NOMESCO Finland

Follow-up OCT of age-related macular degeneration lesions

1.9

8.3

503

WX290

NOMESCO Finland

Other blockage of nerve

1.1

8.3

5317

49521

SPAT1211

SPAT

Application of soft bandage

1.2

8.3

1082

9010

N05CF01

ATC

zopiclone; oral

1.1

8.3

4654

43049

N06

ICPC

Sensation disturbance other

1.8

8.3

112

617

2504B

ICD-9 Finland

Diabetes mellitus, Diabetes with renal manifestations[DIABETES MELLITUS CUM COMPLICATIONE OCULI ,TYYPPI I]

3.0

8.3

117

CHC10

NOMESCO Finland

Peripheral iridectomy

10.7

8.3

130

Kela drug reimbursment

Malignant tumour

0.8

8.2

759

9400

CA1BG

NOMESCO Finland

Eye and orbita MRI examination with high intensity magnet

2.6

8.2

173

WX006

NOMESCO Finland

Intravenous sedation or analgesia without general anesthesia

1.3

8.2

662

5227

K80

ICPC

Cardiac arrhythmia NOS

1.2

8.2

1054

8763

CG2Z4

NOMESCO Finland

Specialised imaging of cornea

3.3

8.2

I20.99

ICD-10 Finland

Angina pectoris, unspecified

1.2

8.1

834

6771

M54.6

ICD-10 Finland

Pain in thoracic spine

1.3

8.1

772

6214

37872

ICD-8 Finland

Other diseases of eye, Aphakia artefacta, acquisita

4.4

8.1

QDH

NOMESCO Finland

Operations on toe nails

4.4

8.1

SPAT1101

SPAT

Orthostatic test

1.3

8.1

577

4483

R02

ICPC

Shortness of breath/dyspnoea

1.2

8.1

1696

14722

Z96.6

ICD-10 Finland

Presence of orthopaedic joint implants

1.3

8.0

580

4516

WZB00, ,

SPAT

1.3

8.0

714

5705

A10AD04

ATC

insulin lispro; parenteral

2.4

8.0

205

EB1AA, ,

SPAT

0.7

8.0

424

5634

J01MA02

ATC

ciprofloxacin; systemic

1.1

8.0

5538

51753

TCC40

NOMESCO Finland

Closure of lacrimal canaliculus with plug

2.6

8.0

164

Z20.2

ICD-10 Finland

Contact with and exposure to infections with a predominantly sexual mode of transmission

1.8

8.0

118

668

R05

ICD-10 Finland

Cough

1.1

8.0

2759

24808

H33.5

ICD-10 Finland

Other retinal detachments

1.9

8.0

496

J01AA07

ATC

tetracycline; systemic

1.2

8.0

1542

13301

ZXE00

NOMESCO Finland

One hour or less

1.1

7.9

5218

48632

Z71.3

ICD-10 Finland

Dietary counselling and surveillance

1.3

7.9

462

3491

E11.8

ICD-10 Finland

Type 2 diabetes mellitus, with unspecified complications

1.2

7.9

1366

11667

M01AH03

ATC

valdecoxib; oral

1.3

7.9

736

5915

SPAT1307

SPAT

Psychosocial counselling and guidance

1.3

7.9

422

3151

0147, ,

NOMESCO Finland

13.0

7.9

H50.52

ICD-10 Finland

Exophoria

1.8

7.9

101

548

S01GX08

ATC

ketotifen; ophthalmic

1.4

7.8

409

3041

FP4B5

NOMESCO Finland

ECG, prolonged recording (24 h)

1.6

7.8

172

1082

XF600, ,

SPAT

1.4

7.8

320

2286

L01

ICPC

Neck symptom/complaint

1.2

7.8

1849

16196

L13

ICPC

Hip symptom/complaint

1.1

7.8

2567

23002

WVA30, ,

SPAT

1.3

7.8

620

4886

C07AA05

ATC

propranolol; systemic

1.1

7.8

2363

21061

205

Kela drug reimbursment

Chronic hypertension

1.1

7.8

4050

37282

H54.5

ICD-10 Finland

Severe visual impairment, monocular

2.2

7.8

270

Z01.1

ICD-10 Finland

Examination of ears and hearing

1.2

7.8

1835

16069

H81

ICPC

Excessive ear wax

1.1

7.8

2339

20836

XG470

NOMESCO Finland

Measurement of diffusion capastity of the lungs

1.4

7.8

301

2130

H02AB06

ATC

prednisolone; systemic

1.1

7.8

6844

64673

R06AE09

ATC

levocetirizine; oral

1.2

7.8

1548

13384

L02.4

ICD-10 Finland

Cutaneous abscess, furuncle and carbuncle of limb

1.4

7.7

335

2417

CGG99

NOMESCO Finland

Other reconstructive operations on cornea and sclera

6.9

7.7

G04CA52

ATC

tamsulosin and dutasteride; systemic

1.2

7.7

1123

9447

SPAT1317

SPAT

Planned health check-up monitoring, health check-up performed based on individual need

1.3

7.7

652

5179

D01

ICPC

Abdominal pain/cramps general

1.2

7.7

1287

10966

K08.2

ICD-10 Finland

Atrophy of edentulous alveolar ridge

1.6

7.7

150

917

UDM02

NOMESCO Finland

Sinoscopy

1.5

7.7

220

1470

R01AD11

ATC

triamcinolone; nasal

1.2

7.6

975

8101

G03CA03

ATC

estradiol; nasal, systemic, rectal, transdermal, vaginal

1.1

7.6

7166

67897

S01BC01

ATC

indometacin; ophthalmic

4.5

7.6

D07AA02

ATC

hydrocortisone; topical

1.2

7.6

1513

13077

M65.3

ICD-10 Finland

Trigger finger

1.3

7.6

517

3995

QDB10, ,

SPAT

1.5

7.6

194

1265

M01AX01

ATC

nabumetone; oral

1.3

7.6

518

4007

SPAT1202

SPAT

Intra-articular injection

1.3

7.6

403

3008

D01AC20

ATC

imidazoles/triazoles in combination with corticosteroids; topical

1.1

7.5

3023

27420

Y88.3

ICD-10 Finland

Sequelae of surgical and medical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

1.4

7.5

337

2446

S08

ICPC

Skin colour change

1.3

7.5

659

5257

JN4BD

NOMESCO Finland

Extensive body CT

0.8

7.5

1001

11932

N05BA04

ATC

oxazepam; oral

1.1

7.5

3416

31218

SP000, ,

NOMESCO Finland

2.5

7.5

182

3719

FHL

Other measure in this category

80.1

7.4

H221, M083,

ICD-10 Finland

80.1

7.4

NF1AE

NOMESCO Finland

Hip joint ultrasound examination

1.4

7.4

260

1810

S02.5

ICD-10 Finland

Fracture of tooth

1.4

7.4

273

1918

CBN00

NOMESCO Finland

Eversion suture of eyelid

2.4

7.4

189

SDPHK, ,

NOMESCO Finland

3.2

7.4

Y83.1

ICD-10 Finland

Surgical operation with implant of artificial internal device as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

1.6

7.4

175

1123

L03.0

ICD-10 Finland

Cellulitis of finger and toe

1.2

7.3

875

7222

127

Kela drug reimbursment

Transplant complication

1.6

7.3

142

867

H02AB02

ATC

dexamethasone; systemic

0.8

7.3

1069

12640

C10AA03

ATC

pravastatin; oral

1.2

7.3

953

7938

H47.0

ICD-10 Finland

Disorders of optic nerve, not elsewhere classified

2.1

7.3

291

H221, M084,

ICD-10 Finland

+∞

7.3

3651D

ICD-9 Finland

Glaucoma, Open-angle glaucoma[GLAUCOMA PIGMENTOSUM]

+∞

7.3

N06AA09

ATC

amitriptyline; systemic

1.2

7.3

1257

10739

64091

ICD-8 Finland

Medical termination of pregnancy, Weakness (medical-social reason)

0.7

7.3

300

4139

Z90.0

ICD-10 Finland

Acquired absence of part of head and neck

3.6

7.3

S29

ICPC

Skin symptom/complaint other

1.1

7.3

2497

22435

SPAT1141

SPAT

Excision of skin or mucous membrane lesion

1.3

7.3

515

4003

-30

ICPC

Medical examin/health eval complete

1.4

7.3

326

2369

DMB20

NOMESCO Finland

Functional endoscopic opening of maxillary antrum

1.3

7.3

524

4083

H17.9

ICD-10 Finland

Corneal scar and opacity, unspecified

2.9

7.2

110

CBB30

NOMESCO Finland

Excision of lesion of eyelid

1.4

7.2

352

2591

J01FF01

ATC

clindamycin; systemic

1.1

7.2

3501

32089

TKC22

NOMESCO Finland

Catheterisation instruction

1.5

7.2

240

1652

-31

ICPC

Medical examin/health eval partial

1.2

7.2

804

6591

YHMAS, ,

NOMESCO Finland

2.0

7.2

373

J01DA09

ATC

[U] cefadroxil

1.1

7.2

3267

29838

CK9F4

NOMESCO Finland

Fluorescein angiography (FAG) of choroid and retina

1.9

7.2

415

SPAT1217

SPAT

Assessment of need for services (elderly/care support)

1.2

7.2

1015

8521

M70.6

ICD-10 Finland

Trochanteric bursitis

1.2

7.2

1818

16009

CS2P4, ,

SPAT

30.0

7.1

R1100

NOMESCO Finland

General evaluation of the need for rehabilitation

1.7

7.1

111

639

S01GX09

ATC

olopatadine; ophthalmic

1.4

7.1

268

1889

N04BC05

ATC

pramipexole; oral

1.2

7.1

976

8168

SPAT1229

SPAT

Assessment of need for aid

1.2

7.1

1037

8728

TND11

NOMESCO Finland

Injection of diagnostic or therapeutic substance in joint, wrist or hand

1.6

7.1

143

882

E78.01

ICD-10 Finland

Pure hypercholesterolaemia

1.1

7.1

3373

30880

L87

ICPC

Bursitis/tendinitis/synovitis NOS

1.6

7.1

169

1085

SPAT1144

SPAT

Treatment of reopened or infected surgical wound

1.2

7.1

870

7203

SPAT1240

SPAT

Therapeutic discussion

1.2

7.1

940

7842

D06BX01

ATC

metronidazole; topical

1.2

7.1

1256

10756

M54.4

ICD-10 Finland

Lumbago with sciatica

1.1

7.1

2144

19110

G04BD12

ATC

mirabegron; oral

1.2

7.1

1634

14291

W01

ICD-10 Finland

Fall on same level from slipping, tripping and stumbling

1.1

7.0

4424

41093

Z04.8

ICD-10 Finland

Examination and observation for other specified reasons

1.2

7.0

1512

13150

SPAT1352

SPAT

Inspection, maintenance and instruction for use of hearing aid

1.6

7.0

167

1072

R87.8

ICD-10 Finland

Abnormal findings in specimens from female genital organs, other abnormal findings

2.1

7.0

309

S21

ICPC

Skin texture symptom/complaint

1.2

7.0

1805

15908

A01

ICPC

Pain general/multiple sites

1.2

7.0

1133

9628

NG1DA

NOMESCO Finland

X-ray of knees

1.5

7.0

200

1337

WYA10

NOMESCO Finland

Emergency care or similar visit

1.2

7.0

767

6278

K11.71

ICD-10 Finland

Xerostomy (dry mouth)

1.7

7.0

121

718

H93.1

ICD-10 Finland

Tinnitus

1.2

7.0

781

6405

H25.9

ICD-10 Finland

Senile cataract, unspecified

1.5

7.0

193

1281

D22.5

ICD-10 Finland

Melanocytic naevi of trunk

1.3

7.0

565

4467

ND2BA

NOMESCO Finland

Hand and fingers extensive X-ray examination

1.5

7.0

238

1648

WZC30, ,

SPAT

1.3

7.0

632

5065

R20.2

ICD-10 Finland

Paraesthesia of skin

1.2

7.0

732

5964

H47.3

ICD-10 Finland

Other disorders of optic disc

2.4

7.0

176

L04AC16

ATC

guselkumab; systemic

3.4

7.0

K59.00

ICD-10 Finland

Constipation caused by slow bowel passage (SCT)

1.4

6.9

248

1732

CKD99

NOMESCO Finland

Other intraoclular operations on vitreous body and retina

4.4

6.9

R53

ICD-10 Finland

Malaise and fatigue

1.1

6.9

3083

28120

CJG40

NOMESCO Finland

Extraction of dislocated lens with implantation of artificial scleral fixed lens in posterior chamber and iridectomy or iridotomy

6.3

6.9

H22.1*D86.8

ICD-10 Finland

Iridocyclitis in sarcoidosis

6.3

6.9

E000002, ,

ATC

1.2

6.9

1160

9888

S01GX02

ATC

levocabastine; ophthalmic

1.3

6.9

581

4616

R21

ICPC

Throat symptom/complaint

1.1

6.9

2001

17780

H53.2

ICD-10 Finland

Diplopia

1.4

6.9

349

2586

PA2DG

NOMESCO Finland

Very extensive MRI examination of vessels in the head with high intensity magnet

5.8

6.9

H19.1

ICD-10 Finland

Herpesviral keratitis and keratoconjunctivitis

2.5

6.9

165

L20

ICPC

Joint symptom/complaint NOS

1.3

6.9

401

3035

M46.9

ICD-10 Finland

Inflammatory spondylopathy, unspecified

1.8

6.9

514

CBJ41

NOMESCO Finland

Shortening of superior tarsal muscle (Müller's muscle)

2.9

6.9

108

KEB00

NOMESCO Finland

Biopsy of prostate

1.7

6.9

117

692

CBA10

NOMESCO Finland

Biopsy of eyelid

1.7

6.9

117

692

R74

ICPC

Upper respiratory infection acute

1.1

6.8

3277

30010

C08CA02

ATC

felodipine; oral

1.2

6.8

1290

11105

SPAT1131

SPAT

Colonoscopy

1.3

6.8

367

2745

K59.09

ICD-10 Finland

Constipation, unspecified

1.2

6.8

831

6876

TDA90, ,

SPAT

1.3

6.8

610

4882

N02AB03

ATC

fentanyl; nasal, sublingual, transdermal

0.7

6.8

317

4286

N02AX02

ATC

tramadol; systemic, rectal

1.1

6.8

6126

57849

CKD00

NOMESCO Finland

Puncture of vitreous body for decompression

9.3

6.8

CHD20

NOMESCO Finland

Posterior sclerotomy

40.0

6.8

H10.9

ICD-10 Finland

Conjunctivitis, unspecified

1.3

6.7

619

4969

H06.2*E05.9

ICD-10 Finland

Dysthyroid exophthalmos

2.0

6.7

314

FN1AC

NOMESCO Finland

Angiography of heart and/or coronary arteries

1.1

6.7

3153

28837

H29

ICPC

Ear symptom/complaint other

1.2

6.7

1442

12540

AAB00

NOMESCO Finland

Extirpation of intracranial lesion

1.6

6.7

143

896

E000007, ,

ATC

1.3

6.7

551

4367

S01

ICPC

Pain/tenderness of skin

1.3

6.7

515

4048

CHW99

NOMESCO Finland

Other operation on anterior chamber, anterior chamber angle, iris or ciliary body

7.1

6.7

QDA25

NOMESCO Finland

Destruction of lesion of skin of lower limb

2.1

6.7

302

XQ855, ,

SPAT

1.8

6.7

556

290

Kela drug reimbursment

Apixaban, dabigatran, edoxaban and rivaroxaban for the treatment of atrial fibrillation

1.1

6.6

2376

21395

NHL14

NOMESCO Finland

Shortening or lengthening of achilles tendon

1.9

6.6

413

K04.00

ICD-10 Finland

Hyperemia of pulp

1.3

6.6

372

2802

A45

ICPC

General and Unspecified, Observ/health educat/advice/diet

1.5

6.6

167

1088

WZA00

NOMESCO Finland

Concise certificate

1.2

6.6

651

5269

Z03.9

ICD-10 Finland

Observation for suspected disease or condition, unspecified

1.1

6.6

2278

20467

XX9LA

NOMESCO Finland

Complementary kinetic X-ray examination without contrast

1.8

6.6

492

R07.2

ICD-10 Finland

Precordial pain

1.4

6.6

240

1683

WX199

NOMESCO Finland

Other local analgesia

1.3

6.6

390

2960

SGC00

NOMESCO Finland

Medication, disinfection of root canals

1.2

6.6

1049

8904

M01AH01

ATC

celecoxib; oral

1.1

6.6

2424

21867

TDW99

NOMESCO Finland

Other minor procedure in surgery of ear, nose and larynx

1.4

6.6

337

2504

O80.0

ICD-10 Finland

Spontaneous vertex delivery

0.8

6.5

890

10591

3641A

ICD-9 Finland

Disorders of iris and ciliary body, Chronic iridocyclitis

8.7

6.5

N06AB10

ATC

escitalopram; oral

1.1

6.5

2166

19413

WX404

NOMESCO Finland

Intravenous generell anesthesy

0.9

6.5

2076

23161

D35.2

ICD-10 Finland

Benign neoplasm: Pituitary gland

1.7

6.5

101

582

A02BA02

ATC

ranitidine; systemic

1.1

6.5

2639

23938

H03AA01

ATC

levothyroxine sodium; systemic

1.1

6.5

3215

29484

CBJ30

NOMESCO Finland

Plastic repair of levator aponeurosis of eyelid

2.1

6.5

285

NH3FA

NOMESCO Finland

Weight-bearing X-ray of foot

1.5

6.5

199

1351

N06AX16

ATC

venlafaxine; oral

1.2

6.5

1478

12912

CKE60

NOMESCO Finland

Brachytherapy of choroid and retina

3.0

6.5

K24

ICPC

Fear of heart disease

1.4

6.5

304

2229

C01CA24

ATC

epinephrine; parenteral

1.3

6.5

557

4441

R00.1

ICD-10 Finland

Bradycardia, unspecified

1.3

6.4

404

3092

L73.9

ICD-10 Finland

Follicular disorder, unspecified

2.3

6.4

208

N06AX26

ATC

vortioxetine; oral

1.2

6.4

633

5124

SLT, ,

NOMESCO Finland

69.9

6.4

74420

ICD-8 Finland

Congenital anomalies of eye, Buphthalmus (glaucoma)

69.9

6.4

S01EB03

ATC

ecothiopate; ophthalmic

69.9

6.4

M25.5

ICD-10 Finland

Pain in joint

1.1

6.4

4001

37130

K04.0

ICD-10 Finland

Pulpitis

1.2

6.4

795

6595

351

Kela drug reimbursment

Apixaban, dabigatran, edoxaban and rivaroxaban for the treatment of atrial fibrillation

1.1

6.4

2127

19069

K86

ICPC

Hypertension uncomplicated

1.1

6.4

1771

15690

J01CR02

ATC

amoxicillin and beta-lactamase inhibitor; systemic

1.1

6.4

6878

65396

AA3AD

NOMESCO Finland

CT of face

1.8

6.4

440

L12

ICPC

Hand/finger symptom/complaint

1.1

6.4

1903

16943

3626

FHL

Extracapsular cataract surgery and implantation of an artificial lens

1.6

6.3

136

855

F60.31

ICD-10 Finland

Emotionally unstable personality disorder, borderline condition

1.8

6.3

529

E10.09

ICD-10 Finland

Insulin-dependent diabetes mellitus - With coma

5.9

6.3

QXB05, ,

SPAT

1.8

6.3

435

CHF30

NOMESCO Finland

Cyclodialysis

+∞

6.2

CD994, ,

SPAT

+∞

6.2

37598

ICD-8 Finland

Glaucoma, Aliud definitum

+∞

6.2

3659X

ICD-9 Finland

Glaucoma, Unspecified glaucoma

+∞

6.2

CHD60

NOMESCO Finland

Deep sclerectomy without implant

+∞

6.2

37500

ICD-8 Finland

Glaucoma, Primary, acute

+∞

6.2

165

Kela drug reimbursment

Preservative-free combination of bimatoprost and timolol

+∞

6.2

S01AX11

ATC

[U] ofloxacin

1.3

6.2

370

2810

R1220

NOMESCO Finland

Psychological examination of need and possibilities to rehabilitation

2.0

6.2

303

E10.01

ICD-10 Finland

Insulin-dependent diabetes diabetic coma with hyperglycemia

3.8

6.2

H30.0

ICD-10 Finland

Focal chorioretinal inflammation

3.8

6.2

H33.1

ICD-10 Finland

Retinoschisis and retinal cysts

1.9

6.2

379

PA7CD

NOMESCO Finland

CT angiography of neck and brain, extensive

1.6

6.2

119

726

CHB60

NOMESCO Finland

Anterior synechiolysis

26.7

6.2

H81.1

ICD-10 Finland

Benign paroxysmal vertigo

1.2

6.2

1307

11349

N01

ICPC

Headache

1.2

6.2

985

8357

C07AB02

ATC

metoprolol; systemic

1.1

6.2

2861

26132

SFA40

NOMESCO Finland

Restoration involving the entire crown of the tooth

1.1

6.2

2836

25892

FPE20

NOMESCO Finland

Implantation of transvenous cardiac pacemaker with atrial and ventricular electrodes

1.3

6.2

524

4168

M53.1

ICD-10 Finland

Cervicobrachial syndrome

1.2

6.2

1233

10661

R4110, ,

SPAT

1.2

6.2

1060

9053

C05AA08

ATC

fluocortolone; rectal, topical

1.1

6.2

1722

15257

BEF00, ,

SPAT

2.0

6.2

311

A10BK03

ATC

empagliflozin; oral

1.2

6.2

1144

9835

NA1BG

NOMESCO Finland

Cervical spine MRI examination with high intensity magnet

1.3

6.2

535

4270

AA1DG

NOMESCO Finland

Very extensive MRI examination of brain with high intensity magnet

1.4

6.2

280

2043

G45.9

ICD-10 Finland

Transient cerebral ischaemic attack, unspecified

1.2

6.1

1044

8913

Z5132

NOMESCO Finland

Nursing associate professional

2.0

6.1

312

H02AB09

ATC

hydrocortisone; systemic

1.4

6.1

221

1549

H36.02

ICD-10 Finland

Preproliferative diabetic retinopathy

2.6

6.1

121

D23.1

ICD-10 Finland

Benign neoplasm: Skin of eyelid, including canthus

1.3

6.1

413

3194

H01.1

ICD-10 Finland

Noninfectious dermatoses of eyelid

2.1

6.1

265

XF603

NOMESCO Finland

Direct intraarterial blood pressure measurement

0.7

6.1

262

3585

WF049

NOMESCO Finland

Radiotherapy of metastasis

0.7

6.1

230

3214

H91.1

ICD-10 Finland

Presbycusis

1.2

6.1

863

7249

F32.9

ICD-10 Finland

Depressive episode, unspecified

1.2

6.1

1200

10370

R51.81

ICD-10 Finland

Facial pain NOS

1.4

6.1

235

1668

DNB20

NOMESCO Finland

Endoscopic ethmoidectomy

1.4

6.1

247

1769

S94

ICPC

Ingrowing nail

1.5

6.1

175

1175

T82

ICPC

Obesity

1.3

6.0

354

2685

E11.4

ICD-10 Finland

Type 2 diabetes mellitus, with neurological complications

1.4

6.0

260

1880

R51

ICD-10 Finland

Headache

1.3

6.0

505

4014

E66.01

ICD-10 Finland

Obesity due to excess calories

1.2

6.0

823

6890

WZC00

NOMESCO Finland

Treatment plan or consultation

1.1

6.0

4746

44501

R39.1

ICD-10 Finland

Other difficulties with micturition

1.3

6.0

325

2437

LabWAS

↥

N Cases

N Controls

-log₁₀(p)

cases

controls

cases

controls

unit

-log₁₀(p)

N cases

N controls

(3029937) Albumin [Presence] in Urine by Test strip

5215

38310

1.52

125.64

4.8

4.4

0.00

estimate

0.53

1728

12427

(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip

6890

53879

1.47

120.38

4.6

4.2

—

(3044889) 12 lead EKG panel

11789

102345

1.49

117.99

4.4

4.0

—

(3004410) Hemoglobin A1c/Hemoglobin.total in Blood

14480

132312

1.61

105.79

6.9

6.1

41.13

40.21

mmol/mol

22.15

13257

121034

(3023103) Potassium [Moles/volume] in Serum or Plasma

15797

147986

1.87

102.46

19.4

18.6

3.99

3.98

mmol/l

5.71

15395

144045

(3019550) Sodium [Moles/volume] in Serum or Plasma

15757

147655

1.84

99.80

19.3

18.4

139.63

139.65

mmol/l

0.64

15371

143964

(3035350) Ketones [Presence] in Urine by Test strip

8504

71180

1.39

92.04

4.4

4.0

0.00

estimate

4.61

1880

13918

(3019150) Specific gravity of Urine by Refractometry

4224

31281

1.46

91.82

4.9

4.4

1.02

kg/l

0.09

560

4874

(40761511) CBC panel - Blood by Automated count

15493

144974

1.72

91.76

16.8

14.9

—

(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma

15247

142080

1.67

91.64

5.7

5.2

2.67

2.71

mmol/l

5.70

13817

129493

(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma

15886

149735

1.84

91.58

11.7

11.1

24.99

25.36

u/l

1.65

15258

143852

(3009542) Hematocrit [Volume Fraction] of Blood

16249

154342

2.03

90.69

24.5

23.4

40.25

39.78

0.54

14513

143420

(3019900) Cholesterol [Moles/volume] in Serum or Plasma

14957

138823

1.61

90.05

5.1

4.6

4.61

4.64

mmol/l

2.90

13687

126999

(3000963) Hemoglobin [Mass/volume] in Blood

16260

154523

2.03

89.99

24.7

23.4

133.74

133.67

g/l

0.25

16016

152018

(3026361) Erythrocytes [#/volume] in Blood

16258

154503

2.03

89.89

24.6

23.3

4.42

4.43

e12/l

1.22

15790

149519

(3035941) MCH [Entitic mass]

16256

154480

2.03

89.85

24.5

23.2

30.38

30.34

2.07

16009

151963

(3024731) MCV [Entitic volume]

16257

154493

2.03

89.84

24.5

23.2

91.37

91.39

0.24

16009

151977

(3010813) Leukocytes [#/volume] in Blood

16257

154505

2.03

89.63

24.5

23.3

6.73

6.75

e9/l

0.23

15766

149526

(3007461) Platelets [#/volume] in Blood

16250

154434

2.02

89.31

24.6

23.3

248.56

249.44

e9/l

0.96

15852

149961

(3009261) Glucose [Presence] in Urine by Test strip

8560

72110

1.37

86.98

4.4

4.0

0.00

estimate

0.05

1741

12661

(3021601) Nitrite [Presence] in Urine by Test strip

8456

71279

1.37

84.59

5.6

5.3

0.00

estimate

1.84

1785

12883

(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma

14814

137610

1.57

84.01

5.0

4.6

1.49

mmol/l

1.14

13389

125158

(3009201) Thyrotropin [Units/volume] in Serum or Plasma

14215

131124

1.49

80.75

5.4

5.0

2.25

2.11

mu/l

0.31

12802

118904

(3018251) Fasting glucose [Moles/volume] in Serum or Plasma

14871

138568

1.56

79.72

5.2

4.9

6.08

6.00

mmol/l

10.69

13285

125053

(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma

12177

109574

1.39

76.27

4.5

4.1

15.06

14.94

pmol/l

5.83

10888

98610

(3002385) Erythrocyte distribution width [Ratio]

13136

119853

1.41

74.78

19.4

18.7

15.12

15.29

0.23

12840

117734

(40761536) Microorganisms panel - Urine sediment

1836

11834

1.62

74.18

4.5

4.3

—

(3012516) Albumin [Mass/volume] in Urine

5660

45713

1.36

70.15

3.6

3.2

582.23

414.82

mg/l

1.39

3481

28407

(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma

4244

32843

1.39

68.40

1.8

1.7

62676499.75

29341420.29

pmol/l

1.91

3408

26676

(3020682) Albumin/Creatinine [Ratio] in Urine

5901

48170

1.34

67.45

4.2

3.8

9.11

8.90

mg/mmol

0.12

3615

29516

(3009508) Creatinine [Moles/volume] in Urine

5790

47159

1.34

67.07

3.5

3.1

7.02

7.12

mmol/l

0.93

4849

39128

(3013707) Erythrocyte sedimentation rate by Westergren method

11943

107998

1.35

66.37

4.7

4.2

13.22

13.55

mm/h

1.62

10963

99165

(3020460) C reactive protein [Mass/volume] in Serum or Plasma

15023

141296

1.51

66.35

16.2

15.8

23.29

24.67

mg/l

5.18

12101

113919

(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting

14249

132986

1.43

62.20

4.4

4.1

1.29

mmol/l

0.16

12784

119769

(3008152) Bicarbonate [Moles/volume] in Arterial blood

1522

9790

1.61

61.41

6.3

6.9

24.50

24.68

mmol/l

1.08

1432

9314

(3025839) Triglyceride [Moles/volume] in Serum or Plasma

4804

38509

1.34

60.38

1.8

1.6

1.32

1.35

mmol/l

2.05

3739

32068

(3041096) Erythrocytes [Presence] in Urine by Automated

4591

36724

1.34

58.04

4.0

3.7

—

(3047181) Lactate [Moles/volume] in Blood

856

4866

1.80

54.54

5.4

5.9

1.26

1.33

mmol/l

1.34

756

4303

(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma

12409

114103

1.32

53.33

7.6

7.7

77.40

79.55

u/l

5.75

11606

107136

(3015736) pH of Urine

6743

57360

1.29

53.29

4.0

3.7

5.87

5.84

0.27

293

3262

(3039000) Anion gap in Blood

654

3442

1.94

53.11

6.0

6.8

11.27

11.21

mmol/l

0.17

590

3084

(3018572) Chloride [Moles/volume] in Blood

654

3443

1.94

53.07

6.0

6.8

104.79

105.06

mmol/l

0.72

590

3085

(3018418) pH of Serum or Plasma

5615

46712

1.30

52.39

4.4

4.1

7.40

0.84

1178

8593

(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma

5636

47200

1.29

49.13

2.8

2.5

61.21

63.61

u/l

0.40

5166

43327

(3037467) Urinalysis macro (dipstick) panel - Urine

11085

100941

1.28

48.15

5.0

4.6

—

(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture

2134

15538

1.43

46.81

3.5

3.6

—

(3031040) Bacteria [#/volume] in Urine by Automated count

10767

98043

1.26

44.97

5.2

4.9

1996.65

1697.74

e6/l

0.21

232

1408

(3013826) Glucose [Moles/volume] in Serum or Plasma

9706

87572

1.25

42.73

5.1

4.7

6.94

6.77

mmol/l

8.73

9100

82341

(3022217) INR in Platelet poor plasma by Coagulation assay

8208

72997

1.24

39.94

16.5

16.4

1.28

1.31

inr

0.96

2722

20221

(3019060) Gas panel - Arterial blood

1492

10485

1.46

39.20

4.5

4.7

—

(3024561) Albumin [Mass/volume] in Serum or Plasma

7576

66931

1.24

38.74

4.9

4.7

35.35

35.08

g/l

4.06

6953

61830

(40761535) Cells panel - Urine sediment

1748

12748

1.41

37.46

3.7

3.6

—

(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum

3572

29074

1.29

36.68

1.3

1.2

1.63

1.72

u/ml

0.15

1044

7338

(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma

6696

58625

1.23

36.50

4.1

3.8

70.40

66.49

ng/l

0.08

4902

42470

(1761868) Lipid panel - Serum or Plasma

5169

44026

1.25

36.23

3.4

3.1

—

(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma

8666

78133

1.22

34.87

7.0

6.7

1.22

mmol/l

0.22

7091

66129

(3007930) Methemoglobin/Hemoglobin.total in Blood

966

6435

1.53

32.83

5.3

5.1

0.94

0.89

3.74

894

6033

(40760892) CBC W Ordered Manual Differential panel - Blood

7568

67587

1.21

32.61

6.8

6.4

—

(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma

6990

61966

1.22

32.39

2.4

2.2

79.27

1577.25

nmol/l

0.50

6195

54742

(3023081) Carboxyhemoglobin/Hemoglobin.total in Blood

969

6557

1.51

30.56

5.2

5.0

1.71

1.62

2.33

897

6149

(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma

5419

47116

1.22

29.79

2.2

2.1

198.98

206.88

u/l

0.25

5021

43909

(3001122) Ferritin [Mass/volume] in Serum or Plasma

6631

58868

1.21

29.25

3.1

2.9

130.40

142.40

ug/l

3.49

6017

53816

(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma

7871

71025

1.20

29.07

6.1

6.0

1.21

mmol/l

0.52

7158

64302

(3036481) Cortisol [Moles/volume] in Serum or Plasma

1701

12858

1.36

28.94

2.1

2.2

380.66

377.61

nmol/l

0.20

1545

11740

(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood

1689

12830

1.35

27.78

3.9

3.8

1.23

mmol/l

0.10

1416

11153

(43054914) Glucose tolerance 2 hours panel - Serum or Plasma

1818

14060

1.33

26.41

1.5

1.6

—

(3000850) Epithelial cells [#/volume] in Urine

3776

32143

1.22

24.63

2.9

2.6

5.21

5.66

e6/l

1.31

3391

28714

(46236098) ABO and Rh group [Type] in Blood by Confirmatory method

3089

36628

0.81

23.89

2.3

2.4

—

(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)

1560

11977

1.33

23.72

2.9

2.7

58.67

62.60

ml/min/173m2

3.72

615

4932

(3002173) Hemoglobin [Mass/volume] in Arterial blood

1872

14787

1.30

23.16

6.4

7.7

121.05

120.14

g/l

1.18

1798

14381

(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma

1796

14123

1.30

22.97

3.4

2.9

183.78

217.69

ng/l

3.30

1656

12955

(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma

8546

78645

1.17

22.59

5.6

6.2

11.23

11.47

umol/l

0.97

8030

74543

(3026008) Bacteria identified in Urine by Culture

5629

50171

1.18

21.75

3.5

3.4

—

(3025159) Blasts/100 leukocytes in Blood

1446

11145

1.32

21.33

4.1

0.94

0.40

0.67

359

3179

(3011397) Hemoglobin [Presence] in Urine by Test strip

4023

34864

1.20

21.30

4.4

3.9

—

(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma

4395

38424

1.19

21.08

2.4

2.3

2.93

3.05

mg/l

2.86

3810

32636

(3017181) Myelocytes/100 leukocytes in Blood

1589

12467

1.30

20.57

4.0

1.01

0.98

0.19

492

4418

(3007853) Bacteria identified in Skin by Aerobe culture

2129

17330

1.26

20.54

1.8

—

(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma

1519

19225

0.77

20.18

5.1

4.7

33.89

32.95

2.58

989

12761

(3019309) Folate [Moles/volume] in Red Blood Cells

3602

31061

1.20

19.90

1.8

1278.93

1157.82

nmol/l

11.79

2764

23098

(3016502) Oxygen saturation in Arterial blood

1990

16155

1.26

19.58

6.1

7.2

95.96

95.51

2.64

1887

15543

(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma

3888

33858

1.19

19.16

5.1

4.5

21.99

22.13

0.23

2003

17229

(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma

4785

42449

1.18

18.92

5.4

5.2

2.65

3.64

ug/l

3.91

4231

37858

(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma

5112

45661

1.17

18.46

3.4

3.2

34.61

34.68

u/l

0.01

4773

43074

(3006315) Basophils [#/volume] in Blood

7819

72217

1.15

17.84

6.1

5.8

0.04

e9/l

0.12

6883

61763

(3001604) Monocytes [#/volume] in Blood

7798

72017

1.15

17.79

6.1

5.8

0.59

0.60

e9/l

0.70

6875

61622

(3013115) Eosinophils [#/volume] in Blood

8049

74536

1.15

17.60

6.2

6.0

0.20

0.19

e9/l

0.73

7191

64639

(3019198) Lymphocytes [#/volume] in Blood

7972

73781

1.15

17.56

6.2

5.9

1.87

1.90

e9/l

0.43

7194

64544

(3013650) Neutrophils [#/volume] in Blood by Automated count

8986

83905

1.15

17.35

8.7

9.1

4.18

4.16

e9/l

0.29

8000

72770

(3021440) Promyelocytes/100 leukocytes in Blood

1488

11827

1.28

17.34

4.1

4.0

0.13

0.11

0.23

394

3805

(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma

2325

19446

1.23

17.31

8.1

7.6

—

(3034780) Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma

815

5947

1.39

17.12

2.2

1.9

40.34

39.02

u/l

1.04

722

5140

(3020891) Body temperature

845

6212

1.38

16.97

4.4

4.7

—

(3002179) Metamyelocytes/100 leukocytes in Blood

1429

11335

1.28

16.91

3.8

3.9

0.68

0.72

0.28

404

3808

(40762366) Oxygen capacity [Volume Fraction] in Arterial blood

1103

8450

1.33

16.90

7.6

9.3

—

(3021589) Normoblasts [#/volume] in Blood

6862

62979

1.15

16.72

11.1

10.0

0.00

e9/l

3.26

5774

51350

(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection

234

1296

1.82

16.46

1.2

—

(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma

2817

24130

1.20

16.33

1.3

36.08

37.77

iu/ml

0.21

944

7701

(40767503) Oxygen content in Capillary blood by calculation

490

3284

1.51

16.25

2.6

16.23

15.96

0.74

273

1694

(3008898) HLA-B27 [Presence]

520

3534

1.49

16.12

1.1

—

(43054903) Holo-transcobalamin II [Moles/volume] in Serum

7017

64638

1.14

15.95

2.0

2.1

95.88

95.54

pmol/l

0.22

3435

32820

(3020961) Endomysium IgA Ab [Titer] in Serum

790

5827

1.37

15.55

1.2

1.1

233.67

204.86

titre

0.11

133

(3003396) Base excess in Arterial blood by calculation

2152

18084

1.22

15.16

6.0

6.9

1.28

1.14

mmol/l

1.06

1640

14548

(1616796) Gas panel - Central venous blood

493

3375

1.47

14.77

3.9

3.7

—

(3010421) pH of Blood

567

4009

1.43

14.33

4.5

3.9

7.42

1.66

519

3648

(3021960) Folate [Moles/volume] in Serum or Plasma

4165

37230

1.16

14.09

1.6

21.17

20.58

nmol/l

1.44

3508

31431

(3050449) Albumin [Mass/time] in Urine collected for unspecified duration

523

3665

1.44

13.89

2.4

2.2

154.39

106.73

ug/min

0.95

279

2109

(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma

1501

12299

1.24

13.41

4.0

3.7

95.08

91.52

ng/l

0.64

1261

10434

(3033658) Prothrombin time (PT) actual/Normal

3400

38247

0.86

13.02

3.9

89.46

88.81

0.79

3298

37315

(3044640) Blood type and Crossmatch panel - Blood

4339

47946

0.87

12.88

2.4

2.5

—

(3019225) pH of Specimen

1332

16283

0.80

12.87

4.2

4.4

—

(3003338) MCHC [Mass/volume]

12016

115414

1.14

12.80

22.2

20.7

332.08

331.44

g/l

12.81

11955

114480

(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma

5210

47600

1.14

12.50

3.1

3.0

1446.51

1516.91

ng/l

0.48

4478

41061

(3027801) Oxygen [Partial pressure] in Arterial blood

2120

18113

1.19

12.38

6.1

6.9

12.30

12.19

kpa

0.41

2010

17242

(3027946) Carbon dioxide [Partial pressure] in Arterial blood

2121

18126

1.19

12.35

6.1

6.9

5.01

5.09

kpa

3.44

2006

17273

(3037522) Nuclear Ab [Titer] in Serum

2179

18707

1.19

12.03

1.4

1.3

517.17

540.68

titre

0.23

467

4137

(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum

2612

22817

1.17

11.68

1.3

11.52

14.06

u/ml

0.99

963

8287

(3022948) Iron [Moles/volume] in Serum or Plasma

2774

24356

1.17

11.62

2.8

2.5

12.24

12.52

umol/l

1.35

2555

22515

(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma

1143

14054

0.80

11.61

2.7

2.4

73.13

47.28

u/l

0.38

947

11973

(3030905) Polymorphonuclear cells [#/volume] in Blood

398

2759

1.45

11.28

3.6

3.3

4.38

4.19

e9/l

0.94

398

2753

(3005322) IgE [Units/volume] in Serum or Plasma

987

7867

1.27

11.21

1.3

178.64

231.68

u/ml

1.72

908

7200

(3012501) Base excess in Blood by calculation

484

3491

1.40

11.01

4.7

3.9

2.56

2.64

mmol/l

0.26

348

2430

(3013290) Carbon dioxide [Partial pressure] in Blood

484

3492

1.40

10.99

4.7

3.9

5.05

5.01

kpa

0.70

476

3404

(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma

9343

88768

1.12

10.94

3.2

3.1

50.16

51.41

u/l

0.64

8564

81515

(3030981) Hyaline casts [#/volume] in Urine by Automated count

1002

8025

1.26

10.94

3.2

2.8

0.29

0.30

e6/l

0.05

977

7826

(3018677) aPTT in Platelet poor plasma by Coagulation assay

2693

23707

1.16

10.84

2.0

29.56

29.86

1.53

2597

23004

(3027315) Oxygen [Partial pressure] in Blood

485

3515

1.39

10.74

4.7

3.9

8.61

8.52

kpa

0.58

477

3426

(3012110) Lysozyme [Mass/volume] in Serum or Plasma

519

3808

1.37

10.66

2.3

1.9

10.62

11.54

mg/l

1.73

480

3499

(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain

464

3346

1.40

10.59

1.5

—

(3015235) Bicarbonate [Moles/volume] in Capillary blood

529

3904

1.37

10.49

3.1

24.62

24.93

mmol/l

0.91

518

3816

(40766189) Gliadin peptide IgG Ab [Units/volume] in Serum by Immunoassay

470

3405

1.39

10.44

1.1

4.35

9.41

u/ml

1.01

322

(3018405) Lactate [Moles/volume] in Arterial blood

717

5546

1.31

10.32

3.8

4.0

1.27

1.38

mmol/l

2.14

707

5451

(3048689) Calprotectin [Mass/mass] in Stool

1855

15927

1.18

10.16

2.2

2.1

133.76

145.68

ug/g

0.69

1396

12403

(3004789) Transferrin [Mass/volume] in Serum or Plasma

2562

22592

1.16

10.02

2.8

2.5

2.31

g/l

0.22

2337

20790

(3000504) BK virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

166

2.84

10.01

6.7

4.8

—

(3028271) Lactate [Moles/volume] in Capillary blood

354

2458

1.45

10.00

1.9

1.73

1.70

mmol/l

0.21

348

2401

(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection

2031

17612

1.17

9.86

1.8

—

(3026493) Urate [Moles/volume] in Serum or Plasma

4283

39119

1.13

9.84

2.9

2.7

3950.84

5185.36

umol/l

1.29

3695

33613

(3008295) Osmolality of Serum or Plasma

234

1499

1.57

9.74

1.4

276.18

277.33

mosm/kgh2o

0.34

195

1119

(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection

2027

17597

1.17

9.70

1.8

—

(3006184) Hemoglobin [Mass/volume] in Capillary blood

486

3585

1.37

9.70

2.3

127.63

127.57

g/l

0.02

409

2535

(3030366) Cystatin C [Mass/volume] in Serum or Plasma

494

3658

1.36

9.62

3.4

2.9

1.65

1.64

mg/l

0.10

450

3290

(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection

120

643

1.87

9.60

1.1

—

(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep

2310

20331

1.16

9.22

1.4

—

(3007164) IgA [Mass/volume] in Serum or Plasma

2847

25433

1.14

9.20

1.5

2.46

2.51

g/l

0.70

1720

14587

(3015377) Calcium [Moles/volume] in Serum or Plasma

5677

52859

1.11

9.10

3.1

3.4

2.35

2.36

mmol/l

2.82

4968

45695

(3015171) Extractable nuclear Ab [Units/volume] in Serum

696

5478

1.28

8.82

1.3

1.2

1.10

0.93

u/ml

0.12

515

(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)

13738

133986

1.13

8.69

15.1

15.0

76.21

76.69

ml/min/173m2

1.90

11154

110997

(3023150) Myeloperoxidase Ab [Units/volume] in Serum

335

2370

1.42

8.62

1.3

1.4

—

(3000012) Reticulocyte production index

324

2294

1.42

8.32

2.1

—

(3025941) Bacteria identified in Stool by Culture

936

7697

1.23

8.11

1.3

—

(3003458) Phosphate [Moles/volume] in Serum or Plasma

2258

20019

1.15

8.09

6.5

5.5

1.04

mmol/l

0.36

2096

18457

(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood

522

4005

1.31

8.06

1.6

1.5

7.15

8.64

iu/ml

0.08

115

927

(40763571) Iron/Transferrin [Ratio] in Serum or Plasma

2392

21297

1.14

8.05

2.9

2.6

21.64

21.85

0.29

1873

18068

(3021901) Oxygen saturation in Capillary blood

389

2862

1.37

7.97

2.9

—

(3028626) Oxygen [Partial pressure] in Capillary blood

448

3370

1.34

7.95

3.0

2.9

8.04

7.97

kpa

0.45

440

3292

(3000034) Microalbumin [Mass/volume] in Urine

215

1425

1.52

7.78

3.0

65.97

44.21

mg/l

0.35

147

1006

(3040151) Glucose [Moles/volume] in Capillary blood

258

1776

1.46

7.74

9.2

11.9

7.54

7.49

mmol/l

0.08

215

1458

(3026782) Osmolality of Urine

3362

30672

1.12

7.60

3.2

3.0

511.78

533.72

mosm/kgh2o

7.56

2858

26206

(3022145) Colonoscopy Study observation

1888

16603

1.15

7.57

1.3

—

(3033306) Mononuclear cells/100 leukocytes in Cerebral spinal fluid

110

621

1.78

7.54

1.2

60.78

59.82

—

(3005719) IgG [Mass/volume] in Serum or Plasma

1240

10550

1.19

7.54

2.6

2.8

10.48

10.51

g/l

0.08

1103

9646

(40759040) C peptide [Moles/volume] in Serum or Plasma --post meal

187

1211

1.55

7.54

1.3

1.47

1.42

nmol/l

0.23

167

1089

(3014218) Bicarbonate [Moles/volume] standard in Arterial blood

678

8415

0.80

7.52

8.0

8.7

24.07

24.41

mmol/l

2.40

654

8122

(3007798) IgG/Albumin [Mass Ratio] in Cerebral spinal fluid

114

654

1.75

7.41

1.5

1.6

—

(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma

3349

30597

1.12

7.35

4.2

3.9

379.27

426.40

ng/l

0.29

2706

24975

(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay

483

3716

1.31

7.35

1.9

1.8

—

(3022803) Oxygen [Partial pressure] adjusted to patient's actual temperature in Arterial blood

461

1.89

7.32

2.5

2.6

—

(3045156) Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Arterial blood

461

1.89

7.32

2.5

2.6

—

(3000494) Fungus identified in Specimen by Culture

1923

16980

1.15

7.28

1.5

1.4

—

(3027273) Bicarbonate [Moles/volume] in Venous blood

919

7651

1.21

7.08

3.7

3.4

25.20

25.28

mmol/l

0.29

888

7436

(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection

8046

76803

1.09

7.04

2.6

—

(3004119) Hemoglobin [Mass/volume] in Venous blood

1109

9410

1.19

6.97

3.5

3.4

126.22

127.56

g/l

1.18

1075

9180

(3003181) Sodium [Moles/volume] in Urine

390

2936

1.34

6.94

1.4

60.89

62.46

mmol/l

0.36

325

2332

(40768446) Kidney Pathology biopsy report

491

1.84

6.94

1.9

1.6

—

(4062490) Immunoglobulin typing, IgG

204

1373

1.49

6.91

1.4

—

(3046870) Tissue transglutaminase IgG Ab [Units/volume] in Serum

682

5535

1.24

6.74

1.1

0.89

4.59

u/ml

—

(3006588) Cancer Ag 15-3 [Units/volume] in Serum or Plasma

199

2904

0.68

6.70

3.3

3.5

39.45

39.95

u/ml

0.02

190

2817

(3016251) Hemoglobin.gastrointestinal [Presence] in Stool

1024

8663

1.19

6.66

2.5

—

(3014326) Insulin-like growth factor-I [Moles/volume] in Serum or Plasma

138

859

1.61

6.65

2.1

1.9

16.72

16.30

nmol/l

0.27

130

799

(3022575) Varicella zoster virus IgG Ab [Units/volume] in Serum

484

1.82

6.63

1.1

1655.99

1524.44

miu/ml

0.56

484

(3026389) Candida sp identified in Specimen by Organism specific culture

300

2191

1.38

6.53

1.4

—

(3024139) IgG subclass 3 [Mass/volume] in Serum

202

1375

1.47

6.50

1.4

0.44

0.43

g/l

0.05

133

963

(3028192) IgG subclass 2 [Mass/volume] in Serum

202

1377

1.47

6.46

1.4

2.69

2.89

g/l

0.96

132

966

(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay

254

3525

0.72

6.45

1.3

—

(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay

254

3525

0.72

6.45

1.3

—

(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma

367

2773

1.33

6.41

3.8

3.0

—

(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection

309

2278

1.36

6.35

1.4

—

(3027135) IgG subclass 1 [Mass/volume] in Serum

201

1375

1.47

6.32

1.4

6.74

6.93

g/l

0.30

131

961

(4035726) Immunohistochemistry procedure

1223

14119

0.86

6.28

1.4

—

(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection

275

1997

1.38

6.22

1.3

1.4

—

(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma

1583

13964

1.15

6.07

2.5

2.4

6.18

6.96

ug/l

0.60

1382

11978

(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection

2797

25552

1.11

6.05

1.8

1.9

—

(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma

979

8324

1.19

6.04

1.2

130.26

139.17

iu/ml

0.30

380

3071

(3027475) Erythrocytes [#/volume] in Cerebral spinal fluid

379

2903

1.31

6.04

1.4

1240.46

1198.07

e6/l

0.02

328

2373

(4200892) Spirometry reversibility

1266

10999

1.16

5.99

1.5

1.4

—

(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum

161

1066

1.52

5.97

1.1

1.2

—

(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection

345

2614

1.33

5.94

1.4

—

(3016543) Leukocytes [#/volume] in Cerebral spinal fluid

378

2901

1.31

5.94

1.4

11.19

28.53

e6/l

2.02

311

2252

(3004490) Bicarbonate [Moles/volume] standard in Capillary blood

481

6032

0.79

5.91

3.9

24.88

24.98

mmol/l

0.37

438

5512

(3012095) Magnesium [Moles/volume] in Serum or Plasma

2746

25092

1.11

5.91

3.0

3.2

0.82

0.81

mmol/l

0.73

2552

23289

(44786774) Adalimumab [Mass/volume] in Serum or Plasma

318

1.95

5.83

1.8

1.9

10.82

9.22

mg/l

1.12

260

(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection

540

6651

0.81

5.66

1.8

2.0

—

(3009991) Angiotensin converting enzyme [Enzymatic activity/volume] in Cerebral spinal fluid

103

622

1.66

5.66

1.1

1.04

1.08

u/l

0.44

299

(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum

164

1105

1.49

5.62

2.3

—

(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection

131

842

1.56

5.59

1.4

1.5

—

(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma

3419

31677

1.10

5.57

1.8

1.7

1.24

1.33

mg/l

0.94

2606

24570

(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection

130

837

1.56

5.51

1.4

1.5

—

(3024474) Albumin [Mass/volume] in Cerebral spinal fluid

131

850

1.55

5.38

1.0

1.1

279.59

282.44

mg/l

0.05

112

739

(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture

2098

18988

1.12

5.35

1.4

—

(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection

175

1207

1.45

5.35

1.4

1.5

—

(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma

267

1982

1.35

5.33

2.0

5944.05

4147.47

u/l

0.43

741

(3020191) Ethanol [Moles/volume] in Serum or Plasma

144

956

1.51

5.32

1.4

1.22

1.25

promille

0.08

122

717

(3000570) Elastase.pancreatic [Mass/mass] in Stool

565

4625

1.23

5.24

1.5

1.4

259.67

271.05

ug/g

0.67

346

2744

(3024471) HLA-A [Type]

381

1.81

5.23

1.0

—

(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection

497

6116

0.81

5.20

1.7

1.8

—

(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection

1324

11664

1.15

5.20

1.6

—

(1175556) inFLIXimab Ab [Units/volume] in Serum by Immunoassay

284

1.94

5.12

3.1

2.3

119.97

175.45

au/ml

—

(3002030) Lymphocytes/100 leukocytes in Blood

7248

69470

1.08

5.07

6.5

6.2

27.18

27.13

0.13

6781

64672

(3007368) IgG [Mass/volume] in Cerebral spinal fluid

134

886

1.52

5.07

1.2

1.1

40.19

42.42

mg/l

0.27

108

741

(3022096) Basophils/100 leukocytes in Blood

6857

65622

1.07

4.97

6.4

6.1

0.68

0.67

0.16

6390

60744

(3023520) Reticulocytes [#/volume] in Blood

1530

13653

1.13

4.95

2.6

2.5

69.87

69.28

e9/l

0.23

1211

10313

(43055120) Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

353

2759

1.29

4.92

6.2

5.1

784.66

1621.07

iu/ml

0.56

425

(3042936) Bacteria identified in Isolate by Culture

2316

21182

1.11

4.86

2.2

2.0

—

(3006504) Eosinophils/100 leukocytes in Blood

7055

67670

1.07

4.73

6.4

6.1

2.89

2.84

0.94

6585

62757

(3024932) HLA-DR beta [Type]

372

1.78

4.72

1.1

—

(3051387) C reactive protein [Mass/volume] in Capillary blood

408

3265

1.26

4.70

3.7

3.6

27.64

27.73

mg/l

0.02

292

2070

(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection

837

9715

0.85

4.66

1.7

—

(3018095) Leukocytes [#/volume] in Urine

5603

53324

1.08

4.65

4.1

3.8

101.66

111.96

e6/l

0.40

4287

37807

(3010517) Carboxyhemoglobin/Hemoglobin.total in Venous blood

853

7344

1.17

4.60

2.8

1.28

1.22

0.99

847

7304

(3019069) Monocytes/100 leukocytes in Blood

7088

68053

1.07

4.57

6.7

6.4

8.72

8.67

0.71

6618

63215

(3018010) Neutrophils/100 leukocytes in Blood

7124

68411

1.07

4.56

6.3

6.0

57.89

57.79

0.28

6647

63626

(3042733) HLA Ab [Presence] in Serum

369

1.76

4.55

5.2

4.9

—

(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma

1007

8793

1.15

4.52

3.2

3.3

4.42

4.38

pmol/l

0.48

878

7729

(3035544) Cardiolipin IgG Ab [Units/volume] in Serum or Plasma

392

1.74

4.52

1.1

—

(3020044) Glucose [Moles/volume] in Cerebral spinal fluid

368

2926

1.26

4.50

1.3

1.2

3.88

3.78

mmol/l

0.87

350

2736

(3023419) Bacteria identified in Sputum by Culture

311

2424

1.29

4.47

2.3

2.5

—

(3006441) Cardiolipin IgM Ab [Presence] in Serum by Immunoassay

424

1.70

4.44

1.1

—

(3006576) Bicarbonate [Moles/volume] in Blood

509

1.63

4.40

7.5

6.5

25.66

25.08

mmol/l

0.59

454

(3010254) Herpes simplex virus identified in Specimen by Organism specific culture

322

1.80

4.38

1.1

—

(3019473) Protein [Mass/volume] in Cerebral spinal fluid

411

3321

1.24

4.38

1.3

515.36

540.65

mg/l

0.54

393

3140

(3002582) Erythrocytes [#/volume] in Urine

4859

46098

1.08

4.34

3.6

3.3

100.18

94.34

e6/l

0.07

3922

35216

(36660697) Celiac disease serology panel - Serum

1196

10601

1.14

4.33

1.2

—

(40760888) Immunoglobulin light chains.free panel - Serum

488

4022

1.22

4.31

3.3

—

(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count

2273

24683

0.91

4.30

3.2

3.0

3.59

2.98

e6/l

0.40

1354

13351

(36304419) Bacteria [Presence] in Urine

4338

41002

1.08

4.28

3.4

3.2

—

(3052851) Hemolysis interference index of Serum or Plasma

394

4858

0.81

4.27

3.6

3.3

—

(40768797) Stomach Pathology biopsy report

2292

21088

1.10

4.26

1.3

1.2

—

(3021387) Prolactin [Units/volume] in Serum or Plasma

346

2751

1.26

4.25

1.9

1.7

305.31

300.93

mu/l

0.08

310

2525

(3011363) Streptococcus pneumoniae Ag [Presence] in Urine

136

938

1.45

4.25

1.2

1.1

—

(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum

333

2638

1.27

4.22

1.3

161.08

212.47

miu/ml

2.37

134

1105

(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection

139

965

1.44

4.21

1.3

1.4

—

(3012565) Volume of 24 hour Urine

112

745

1.51

4.20

2.1

1887.91

1878.24

0.04

104

641

(3019420) Tryptase [Mass/volume] in Serum or Plasma

100

649

1.54

4.20

1.2

1.6

6.88

9.37

ug/l

1.48

584

(3046279) Procalcitonin [Mass/volume] in Serum or Plasma

750

6445

1.17

4.18

2.0

2.14

2.28

ug/l

0.13

666

5656

(36304052) Adalimumab Ab [Units/volume] in Serum or Plasma

249

1.89

4.13

1.6

50.10

69.81

au/ml

—

(3014148) Varicella zoster virus Ab [Titer] in Serum

175

1270

1.38

4.13

1.2

1.1

—

(3042299) inFLIXimab [Mass/volume] in Serum or Plasma

307

1.79

4.11

3.1

3.0

6.17

7.45

mg/l

0.99

252

(3039429) Cortisol [Moles/volume] in Saliva (oral fluid)

605

1.56

4.10

1.5

1.6

2.44

4.44

nmol/l

1.18

509

(3028026) IgM [Mass/volume] in Serum or Plasma

945

8278

1.15

4.09

1.8

1.9

1.40

1.36

g/l

0.17

844

7463

(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay

512

4265

1.21

4.08

1.9

1.7

—

(3019832) Treponema pallidum Ab [Presence] in Serum

701

6013

1.17

4.01

1.6

1.5

—

(42868691) Thyroxine (T4) free [Moles/volume] in Serum or Plasma by Dialysis

499

1.61

4.00

1.2

1.5

15.38

16.11

pmol/l

0.57

417

(3017044) Thyrotropin receptor Ab [Units/volume] in Serum

413

3378

1.23

3.97

1.7

4.90

7.25

iu/l

0.41

118

1173

(3033923) Metanephrine [Moles/time] in 24 hour Urine

341

1.73

3.93

1.1

0.61

0.66

umol/24h

0.28

157

(3023368) Bacteria identified in Blood by Culture

4465

42364

1.07

3.91

4.3

—

(3012413) Glucose [Moles/volume] in Serum or Plasma --2 hours post meal

144

1021

1.41

3.91

1.3

1.2

8.68

9.01

mmol/l

0.47

136

976

(3009340) Metanephrine [Moles/volume] in Serum or Plasma

243

1874

1.30

3.85

1.2

1.3

—

nmol/l

—

(3011985) Renin [Units/volume] in Plasma

254

1976

1.29

3.77

1.4

71.80

60.55

mu/l

0.38

224

1741

(40760109) Toxoplasma gondii IgG Ab avidity [Ratio] in Serum by Immunoassay

391

1.66

3.77

1.1

—

(3006245) CD3-CD19+ cells/100 cells in Blood

453

1.61

3.75

2.3

2.0

12.42

10.50

0.43

408

(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay

186

1392

1.34

3.66

1.1

—

(3016616) Dehydroepiandrosterone sulfate (DHEA-S) [Moles/volume] in Serum or Plasma

425

1.63

3.66

1.3

3.23

3.27

umol/l

0.05

393

(3019977) pH of Arterial blood

126

885

1.43

3.64

2.7

2.6

7.42

0.10

321

(3001079) Blood group antibody screen [Presence] in Serum or Plasma

7112

68641

1.06

3.62

2.6

—

(3001788) Aldosterone [Moles/volume] in Serum or Plasma

237

1839

1.29

3.61

1.3

325.80

363.31

pmol/l

0.26

215

1571

(3025577) Chromium [Mass/volume] in Blood

143

1029

1.39

3.61

2.2

2.0

2.34

2.39

ug/l

0.07

118

855

(3012215) Mononuclear cells/100 leukocytes in Synovial fluid

383

1.65

3.53

1.3

34.18

37.21

0.21

250

(40766800) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ T-cells [Units/volume] corrected for background in Blood

186

1401

1.33

3.52

1.2

1.1

2.28

2.08

iu/ml

—

(3038071) Oxygen [Partial pressure] in Mixed venous blood

294

1.74

3.48

11.5

7.9

—

(3020779) Urea [Moles/volume] in Serum or Plasma

1502

13684

1.11

3.43

8.6

6.9

10.49

10.37

mmol/l

0.25

1416

12946

(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood

132

948

1.40

3.39

2.3

2.0

—

(3026470) Cobalt [Mass/volume] in Blood

145

1058

1.37

3.39

1.9

2.0

3.80

3.75

ug/l

0.03

135

966

(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection

214

1654

1.30

3.39

1.4

1.5

—

(44813793) Dust mix specific IgE antibody measurement

125

890

1.41

3.38

1.1

—

(3022313) Gas panel - Capillary blood

601

6958

0.86

3.33

3.6

3.7

—

(3029338) Protein.monoclonal band 3 [Mass/volume] in Serum or Plasma by Electrophoresis

367

4431

0.82

3.32

2.0

2.4

0.00

g/l

1.23

324

4001

(3029379) Protein.monoclonal band 4 [Mass/volume] in Serum or Plasma by Electrophoresis

361

4363

0.82

3.31

2.0

2.4

0.00

g/l

-0.00

322

3986

(3028286) Albumin [Mass/volume] in Serum or Plasma by Electrophoresis

421

5015

0.84

3.30

1.9

2.3

37.87

37.36

g/l

1.03

351

4277

(1175426) CD3 cells/100 lymphocytes in Blood

139

1015

1.37

3.25

2.2

2.0

70.58

72.14

0.54

130

962

(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing

115

813

1.42

3.25

1.1

—

(3030467) Casts [#/volume] in Urine by Automated count

4455

42496

1.07

3.25

3.4

3.3

0.35

0.46

e6/l

3.49

3579

32351

(3011412) CD3 cells [#/volume] in Blood

172

1299

1.33

3.23

2.4

2.2

1.14

1.13

e9/l

0.06

157

1175

(3022907) Direct antiglobulin test.polyspecific reagent [Presence] on Red Blood Cells

385

1.61

3.23

1.2

1.1

—

(3027831) CD3-CD16+CD56+ (Natural killer) cells/100 cells in Blood

136

992

1.37

3.21

2.2

1.9

16.73

15.93

0.32

130

960

(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain

1008

0.64

3.19

1.6

1.4

—

(4034850) Laboratory test

560

4816

1.17

3.18

10.8

—

(3018658) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum

554

1.50

3.16

1.1

3.33

17.82

u/ml

—

(3016628) Fibrinogen Ag [Mass/volume] in Platelet poor plasma by Immunoassay

318

1.67

3.16

1.3

1.2

0.77

51.26

mg/l

1.26

240

(3004529) Oxygen [Partial pressure] adjusted to patient's actual temperature in Venous blood

802

7083

1.14

3.15

4.0

4.1

48.79

47.87

0.50

791

7008

(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay

271

2180

1.25

3.13

1.6

—

(3010130) Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma

272

2189

1.25

3.13

1.7

1.4

115.24

120.12

u/ml

0.43

484

(3020650) Glucose [Presence] in Urine

304

1.68

3.12

1.7

1.4

—

(3021513) Carbon dioxide [Partial pressure] in Mixed venous blood

350

1.63

3.12

11.2

8.1

—

(36305247) Microscopic observation [Identifier] in Isolate by Gram stain

519

4447

1.17

3.10

1.8

1.7

—

(3027945) Reticulocytes/100 erythrocytes in Blood

1951

18086

1.09

3.09

2.7

2.4

1.78

1.79

0.19

1711

15845

(3004451) EKG impression Narrative

113

805

1.41

3.08

1.3

—

(3032390) JC virus DNA [#/volume] (viral load) in Urine by NAA with probe detection

4.00

3.08

1.6

1.4

—

(3016038) Potassium [Moles/volume] in Urine

144

1068

1.35

3.08

1.1

1.2

30.45

34.75

mmol/l

1.87

127

896

(3014133) Dog dander IgE Ab [Units/volume] in Serum

155

1163

1.34

3.07

1.0

1.1

2.88

3.10

u/ml

0.07

521

(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma

302

2464

1.23

3.07

1.7

1.4

—

(3014037) CD3+CD4+ (T4 helper) cells/100 cells in Blood

111

789

1.41

3.07

2.7

39.04

39.05

0.00

453

(40768443) Skin Pathology biopsy report

782

6909

1.14

3.07

1.2

—

(3011391) Calcitriol [Moles/volume] in Serum or Plasma

152

1141

1.34

3.01

1.2

—

(3020630) Protein [Mass/volume] in Serum or Plasma

1477

13542

1.10

3.00

2.4

2.6

66.30

66.19

g/l

0.21

1337

12154

(3034037) Hematocrit [Volume Fraction] of Mixed venous blood

233

1.76

2.98

6.8

6.9

—

(3049714) Procollagen type I.N-terminal propeptide [Mass/volume] in Serum

603

1.46

2.97

1.7

1.9

49.61

56.32

ug/l

0.98

589

(3018921) Toxoplasma gondii IgA Ab [Units/volume] in Serum

371

1.59

2.95

1.1

—

(3028679) Herpes simplex virus Ab [Presence] in Serum

539

1.49

2.94

1.1

1.2

—

(3042631) Mycobacterium sp identified in Specimen

272

2212

1.23

2.88

2.7

2.6

—

(3003752) BK virus DNA [Units/volume] (viral load) in Urine by NAA with probe detection

3.71

2.87

1.8

1.5

—

(3017446) Testosterone [Moles/volume] in Serum or Plasma

914

8191

1.12

2.87

2.1

11.75

12.14

nmol/l

0.68

801

7195

(3023939) Sjogrens syndrome-A extractable nuclear Ab [Units/volume] in Serum

340

2830

1.21

2.86

1.3

1.2

50.48

46.22

u/ml

0.18

289

(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection

352

2942

1.20

2.83

1.7

—

(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection

407

3447

1.19

2.83

1.5

1.6

—

(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection

252

2038

1.24

2.81

1.4

1.5

—

(3048518) aPTT.lupus sensitive actual/normal (normalized LA screen)

702

1.41

2.81

1.2

1.1

1.11

1.06

ratio

0.83

243

(3011951) Aspergillus fumigatus IgE Ab [Units/volume] in Serum

125

922

1.36

2.80

1.1

1.3

0.73

1.42

u/ml

1.18

541

(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection

260

2112

1.23

2.79

1.3

1.4

—

(3046904) Somatotropin [Units/volume] in Serum or Plasma

4.45

2.79

1.4

2.6

4.64

1.91

mu/l

—

(3024830) Lactate dehydrogenase 4/Lactate dehydrogenase.total in Serum or Plasma by Electrophoresis

2.46

2.78

1.1

7.96

8.62

0.41

(3007858) Lactate dehydrogenase 3/Lactate dehydrogenase.total in Serum or Plasma by Electrophoresis

2.46

2.78

1.3

1.1

21.33

21.27

0.02

(3023919) Lactate dehydrogenase 2/Lactate dehydrogenase.total in Serum or Plasma by Electrophoresis

2.46

2.78

1.3

1.1

38.03

36.10

1.10

(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection

421

3587

1.18

2.74

1.5

1.6

—

(3027955) HFE gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal

152

1.91

2.74

1.1

1.0

—

(3036432) Mycobacterium tuberculosis genotype [Identifier] in Isolate

110

800

1.38

2.71

3.9

3.7

—

(3043849) Epstein Barr virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

260

2123

1.23

2.67

3.0

2.4

571.87

2068.98

u/ml

1.48

127

(3052592) Norovirus Ag [Presence] in Stool

326

1.60

2.67

1.2

1.4

—

(3036669) Protein S actual/normal in Platelet poor plasma by Coagulation assay

502

1.48

2.67

1.1

99.66

94.58

0.76

385

(3034459) Mononuclear cells/100 leukocytes in Pleural fluid

197

1.78

2.66

1.5

1.4

76.69

73.55

0.24

166

(42529188) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma by Immunoassay

242

1.70

2.65

1.1

—

(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma

1634

17612

0.92

2.64

4.0

3.9

17.98

23.52

ug/l

0.33

1336

14445

(3017704) Immunofixation for Urine

119

884

1.35

2.58

1.5

1.6

—

(40768806) Pleura Pathology biopsy report

135

1766

0.76

2.56

1.5

—

(3007449) CD3+CD8+ (T8 suppressor) cells/100 cells in Blood

458

1.49

2.55

2.1

1.9

28.25

30.07

0.55

426

(3025271) CD3-CD16+CD56+ (Natural killer) cells [#/volume] in Blood

115

852

1.35

2.54

2.3

2.4

0.24

0.23

e9/l

0.09

104

744

(3000620) Complement C3 [Mass/volume] in Serum or Plasma

495

4302

1.16

2.53

1.7

1.6

1.20

1.18

g/l

0.71

475

4057

(3010838) Calcium [Moles/time] in 24 hour Urine

332

2798

1.19

2.49

1.9

1.8

4.64

4.95

mmol/24h

1.05

298

2411

(3010726) Horse dander IgE Ab [Units/volume] in Serum

172

1355

1.27

2.46

1.1

1.85

1.22

u/ml

0.27

660

(40761539) Cells [Type] in Urine sediment by Light microscopy

382

1.52

2.44

1.2

—

(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma

605

5350

1.14

2.42

3.1

3.3

47.24

47.87

mg/l

0.02

455

4333

(3041145) Herpes simplex virus IgM Ab [Presence] in Serum by Immunoassay

689

1.38

2.42

1.1

—

(40757494) Bilirubin.total [Moles/volume] in Blood

112

834

1.35

2.42

2.1

13.40

25.79

umol/l

—

(3041365) Herpes simplex virus IgG Ab [Units/volume] in Serum by Immunoassay

152

1.84

2.41

1.1

—

(3024891) Influenza virus A+B Ag [Presence] in Specimen

287

3426

0.83

2.41

1.1

1.2

—

(21494755) Public health laboratory ask at order entry panel

770

8564

0.89

2.40

1.4

—

(3001405) CD3+CD8+ (T8 suppressor) cells [#/volume] in Blood

119

895

1.33

2.40

2.3

518.03

505.60

e6/l

0.10

103

751

(3016750) Collection duration of Urine

118

887

1.33

2.39

2.4

2.1

487.00

500.33

min

0.96

649

(3000919) Neutrophils/100 leukocytes in Pleural fluid

449

1.47

2.38

1.4

21.97

18.31

0.54

409

(3034860) Kappa light chains.free [Mass/volume] in Serum

605

5363

1.13

2.34

3.1

3.3

53.65

71.65

mg/l

0.79

457

4345

(3017143) Hepatitis C virus Ab [Presence] in Serum

1393

12899

1.09

2.32

1.7

1.5

—

(3042206) Streptococcus agalactiae Ag [Presence] in Vaginal fluid

371

0.51

2.31

1.1

1.2

—

(3042391) t(9;22)(q34.1;q11)(ABL1,BCR) e1a2 fusion transcript/control transcript [# Ratio] in Blood or Tissue by Molecular genetics method

2.04

2.31

6.8

4.5

—

(3023430) Cat dander IgE Ab [Units/volume] in Serum

140

1086

1.29

2.28

1.1

3.15

3.00

u/ml

0.03

418

(3034552) Adenosine deaminase [Enzymatic activity/volume] in Cerebral spinal fluid

2.12

2.28

1.1

1.0

2.85

3.44

u/l

—

(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection

658

0.64

2.27

2.0

—

(3009347) Lactate dehydrogenase isoenzymes [Interpretation] in Serum or Plasma

2.22

2.27

1.3

1.1

—

(3024980) IgG subclass 4 [Mass/volume] in Serum

264

2201

1.20

2.26

1.5

1.6

0.62

0.81

g/l

2.69

174

1669

(3007778) Kappa light chains/Lambda light chains [Mass Ratio] in Serum

586

5198

1.13

2.25

3.1

3.2

11.98

4.93

ratio

0.36

386

(3015635) Cytomegalovirus IgM Ab [Units/volume] in Serum or Plasma

290

2441

1.19

2.24

1.7

1.4

9.72

19.90

u/ml

—

(3000213) Normetanephrine [Moles/time] in 24 hour Urine

156

1.80

2.24

1.1

1.61

1.69

umol/24h

0.23

156

(3042111) Morphology [Interpretation] in Bone marrow Narrative

310

2625

1.18

2.24

1.6

1.5

—

(3013566) Clostridioides difficile [Presence] in Stool by Organism specific culture

643

0.64

2.23

1.3

1.2

—

(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection

616

5486

1.13

2.23

2.8

2.7

—

(3050099) BK virus DNA [#/volume] (viral load) in Specimen by NAA with probe detection

2.86

2.20

3.8

3.6

—

(3002079) Sodium [Moles/time] in 24 hour Urine

625

1.38

2.19

1.1

1.2

142.35

158.02

mmol/24h

1.30

625

(3035797) Protein.monoclonal band 2 [Mass/volume] in Serum or Plasma by Electrophoresis

412

4731

0.87

2.17

2.0

2.4

0.05

0.03

g/l

0.22

367

4289

(3004588) Protein electrophoresis panel - Serum or Plasma

1225

11318

1.09

2.17

2.4

—

(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection

650

0.65

2.16

1.9

2.0

—

(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection

650

0.65

2.16

1.9

2.0

—

(3017766) Complement C4 [Mass/volume] in Serum or Plasma

475

4172

1.14

2.14

1.7

1.6

0.24

0.23

g/l

0.27

454

3917

(3026179) Normetanephrine [Moles/volume] in Serum or Plasma

256

2141

1.20

2.14

1.2

1.3

0.63

1.88

nmol/l

1.03

250

2049

(3032836) C peptide [Moles/volume] in Serum or Plasma --fasting

318

2712

1.18

2.13

3.6

1.6

0.78

0.84

nmol/l

0.89

266

2250

(3030862) Granulocytes [#/volume] in Cerebral spinal fluid

412

1.46

2.11

1.1

1.3

23.38

22.71

—

(3024522) Salmonella sp identified in Specimen by Organism specific culture

167

2069

0.81

2.09

1.4

—

(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection

835

0.69

2.09

1.8

—

(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay

734

1.34

2.08

1.2

—

(3045414) Leukocytes [Presence] in Urine

745

6738

1.11

2.07

2.2

1.9

—

(3001893) Eosinophils/100 leukocytes in Pleural fluid

505

1.41

2.07

1.4

2.12

2.56

0.16

434

(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection

833

0.70

2.07

1.8

—

(3004775) Volume in Urine collected for unspecified duration

156

1246

1.25

2.05

2.6

2.2

754.79

650.75

1.18

104

834

(3027544) Mycobacterium sp identified in Sputum by Organism specific culture

125

1595

0.78

2.03

3.2

3.6

—

(3003327) Ova and parasites identified in Stool by Light microscopy

494

4369

1.13

2.03

1.6

1.7

—

(3030408) 3-Methoxytyramine [Moles/volume] in Serum or Plasma

255

2145

1.19

2.02

1.2

1.3

0.16

0.24

nmol/l

1.22

166

(3027923) C peptide [Moles/volume] in Serum or Plasma

100

756

1.32

2.01

1.4

1.21

1.16

nmol/l

0.16

585

(3024666) Lithium [Moles/volume] in Serum or Plasma

559

1.38

2.01

11.0

11.9

0.59

0.64

mmol/l

1.08

506

(3051611) Lipemic interference index of Serum or Plasma

138

1736

0.79

2.00

3.9

3.3

—

(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method

197

1620

1.22

1.99

1.1

—

(3037756) Immunofixation for Serum or Plasma

407

3559

1.15

1.99

1.5

1.6

—

(3018461) Alpha 1 globulin [Mass/time] in 24 hour Urine by Electrophoresis

193

1.66

1.98

5.0

4.9

59.52

47.40

ug/min

0.29

154

(3020876) Protein [Mass/time] in 24 hour Urine

211

1751

1.21

1.95

2.6

2.5

1.60

1.18

g/24h

1.23

103

819

(3008116) Ketones [Moles/volume] in Urine by Test strip

297

1.52

1.94

1.4

1.3

—

(3016888) Borrelia burgdorferi IgG Ab [Units/volume] in Serum

932

8557

1.09

1.93

1.3

61.56

55.07

au/ml

0.30

449

(3023323) Follitropin [Units/volume] in Serum or Plasma

458

4046

1.14

1.93

1.3

32.22

34.74

iu/l

0.89

401

3492

(3019284) Hepatitis B virus surface Ag [Presence] in Serum

1549

14520

1.07

1.92

1.6

1.5

—

(3010375) cycloSPORINE [Mass/volume] in Blood

564

1.37

1.92

24.1

27.4

109.22

112.08

ug/l

0.11

468

(3051651) Icteric interference index of Serum or Plasma

947

0.73

1.91

4.7

3.8

—

(3022914) Cancer Ag 19-9 [Units/volume] in Serum or Plasma

529

5919

0.89

1.90

3.0

3.3

690.07

1320.58

u/ml

0.64

444

5034

(3013139) Helicobacter pylori Ag [Presence] in Stool

1053

9729

1.09

1.90

1.2

—

(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma

525

5873

0.89

1.89

1.5

—

(3042602) Urea [Moles/volume] in Serum or Plasma --post dialysis

204

1.62

1.88

10.4

11.2

5.72

5.17

mmol/l

0.38

204

(3023351) European house dust mite IgE Ab [Units/volume] in Serum

211

1760

1.20

1.86

1.1

1.90

1.72

u/ml

0.06

865

(3049717) Cytology report of Urine Cyto stain

666

6028

1.11

1.86

2.6

2.7

—

(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid

141

1132

1.25

1.81

1.1

—

(3012568) Campylobacter sp identified in Specimen by Organism specific culture

174

2107

0.82

1.80

1.4

—

(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma

1004

0.75

1.78

1.3

1.5

—

(3048929) Epstein Barr virus Ab [Presence] in Serum

359

3140

1.15

1.78

1.3

1.2

—

(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture

107

834

1.28

1.76

1.2

—

(3013512) EKG study

4700

45549

1.04

1.76

4.2

—

(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum

255

2179

1.17

1.74

1.3

1.2

278.77

289.11

u/ml

0.24

177

1364

(3022493) Free Hemoglobin [Mass/volume] in Plasma

609

1.33

1.74

8.2

4.1

3357.16

797.48

mg/l

0.35

429

(40763476) Honey bee phospholipase A2 recombinant (rApi m) 1 IgE Ab [Units/volume] in Serum

2.50

1.73

1.0

—

(3023091) Interleukin 6 [Mass/volume] in Serum or Plasma

233

1.55

1.72

1.5

1.2

93.46

465.40

ng/l

0.58

164

(3005532) Lymphocytes/100 leukocytes in Pleural fluid

593

1.33

1.71

1.4

64.79

65.30

0.04

497

(3041918) Cholesterol [Moles/volume] in Pleural fluid

306

1.47

1.71

1.3

1.2

1.70

1.61

mmol/l

0.18

187

(3030558) Cytomegalovirus DNA [Units/volume] (viral load) in Specimen by NAA with probe detection

499

1.36

1.71

1.1

2.0

57366.78

48148.01

u/ml

—

(3036604) Creatine kinase isoenzymes [Interpretation] in Serum or Plasma by Electrophoresis

1.91

1.69

1.1

1.2

—

(3013727) Leukocytes other/100 leukocytes in Blood

501

1.36

1.67

3.1

3.6

54.81

53.81

0.13

482

(40763470) Parainfluenza virus 4 RNA [Presence] in Isolate by NAA with probe detection

190

1589

1.20

1.67

1.5

—

(40763324) Parainfluenza virus 1 RNA [Presence] in Isolate by NAA with probe detection

190

1589

1.20

1.67

1.5

—

(42870298) TPMT gene c.238G>C+460G>A+719A>G [Identifier] in Blood or Tissue by Molecular genetics method Narrative

149

1.68

1.66

1.1

1.0

—

(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection

171

2055

0.83

1.66

1.4

—

(44816844) Macroprolactin [Units/volume] in Serum or Plasma

126

1012

1.25

1.65

2.2

1.7

—

(3050129) First trimester maternal screen panel - Serum or Plasma

1148

0.77

1.64

1.5

1.4

—

(3007628) Bicarbonate [Moles/volume] standard in Venous blood

662

7251

0.91

1.64

4.9

4.1

24.08

24.21

mmol/l

0.57

646

7084

(3014300) Beta 2 glycoprotein 1 IgM Ab [Units/volume] in Serum

285

1.47

1.63

1.1

—

(3016914) Bacteria identified in Cerebral spinal fluid by Culture

161

1329

1.21

1.63

1.4

1.5

—

(3017354) Segmented neutrophils/100 leukocytes in Blood

134

1646

0.81

1.63

3.0

3.4

57.91

57.00

0.19

105

1366

(3025468) Yersinia sp identified in Specimen by Organism specific culture

170

2039

0.83

1.62

1.4

—

(3006999) Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum

408

3627

1.13

1.61

1.3

7.65

6.09

u/ml

0.28

598

(3027450) Sjogrens syndrome-B extractable nuclear Ab [Units/volume] in Serum

441

3939

1.12

1.61

1.3

29.94

41.13

u/ml

0.43

237

(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age

929

0.75

1.60

1.2

1.4

—

(3045683) HLA typing for celiac disease panel - Blood or Tissue

670

1.30

1.60

1.0

—

(3044242) Glucose [Moles/volume] in Arterial blood

767

1.28

1.60

2.4

2.0

—

(3016921) Smith extractable nuclear Ab [Units/volume] in Serum

403

3583

1.13

1.59

1.3

18.46

4.33

u/ml

0.89

389

(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma

928

0.75

1.59

1.2

1.4

—

(3008230) Borrelia burgdorferi IgM Ab [Units/volume] in Serum

1013

9424

1.08

1.59

2.5

2.4

25.91

25.68

au/ml

0.02

614

(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection

708

6489

1.09

1.58

1.8

1.7

—

(3009445) Proteinase 3 Ab [Units/volume] in Serum

721

6614

1.09

1.58

1.6

1.5

9.00

17.89

u/ml

2.38

168

(4281824) Cell count and differential, peritoneal fluid

152

1837

0.83

1.58

1.2

1.1

—

(3003694) ABO and Rh group [Type] in Blood

3733

36092

1.04

1.55

1.4

1.3

—

(3022192) Triglyceride [Mass/volume] in Serum or Plasma

612

1.31

1.55

2.5

—

(40758292) HTLV I+II Ab panel - Serum

208

0.48

1.55

1.5

1.4

—

(3012441) Differential panel - Pleural fluid

143

1734

0.82

1.54

1.4

1.5

—

(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection

171

2039

0.84

1.54

1.4

—

(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection

415

3707

1.12

1.53

1.8

—

(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight

932

0.76

1.52

1.2

1.4

—

(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection

969

9019

1.08

1.52

1.5

—

(3009306) Alpha-1-Fetoprotein [Mass/volume] in Serum or Plasma

340

1.41

1.51

2.3

2.2

—

(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal

699

6419

1.09

1.51

1.0

1.1

—

(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma

931

0.76

1.51

1.2

1.4

—

(3017461) Flecainide [Moles/volume] in Serum or Plasma

1.83

1.51

1.4

1.5

0.73

0.78

umol/l

0.15

(3014271) Vancomycin [Susceptibility]

986

0.77

1.50

3.0

—

(3024354) Oxygen [Partial pressure] in Venous blood

1260

11845

1.07

1.50

3.4

3.2

4.69

4.50

kpa

1.64

1212

11466

(37019676) Renin [Units/volume] in Plasma --supine

0.00

1.49

0.0

1.0

—

41.81

—

(3005988) Vibrio sp identified in Specimen by Organism specific culture

172

2042

0.84

1.49

1.4

—

(3035457) Cefaclor IgE Ab [Units/volume] in Serum

116

1.72

1.48

1.0

1.1

—

(3037441) Creatinine [Moles/volume] in Peritoneal dialysis fluid

2.22

1.46

6.4

5.7

532.90

400.60

umol/l

—

(3023383) Lactate [Moles/volume] in Pleural fluid

497

1.33

1.45

1.3

3.30

3.22

mmol/l

0.07

455

(3003329) Lymphocytes/100 leukocytes in Synovial fluid

173

1458

1.19

1.44

1.6

1.5

23.66

29.64

1.80

107

893

(3006257) Acetylcholine receptor Ab [Moles/volume] in Serum

101

806

1.25

1.44

1.1

13.44

7.44

nmol/l

0.29

172

(43055190) Macrophages [#/area] in Urine sediment by Microscopy high power field

1.92

1.43

1.3

1.00

1.07

u/field

—

(40761871) Peanut recombinant (rAra h) 3 IgE Ab [Units/volume] in Serum

1.97

1.43

1.0

0.07

0.03

u/ml

—

(42870365) C reactive protein [Mass/volume] in Blood by High sensitivity method

178

2097

0.85

1.42

2.1

21.59

26.10

mg/l

0.50

560

(36032269) Testosterone Free [Moles/volume] in Serum or Plasma by calculation

226

1951

1.16

1.41

1.8

179.77

194.25

pmol/l

1.54

206

1822

(3000060) B lymphocytes [#/volume] in Blood

303

1.42

1.41

2.3

1.9

147.00

635.06

e6/l

1.13

160

(3025130) Human papilloma virus identified in Specimen

175

1480

1.18

1.41

1.7

—

(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability

295

2598

1.14

1.40

1.2

1.3

—

(3042585) Pyridoxine [Moles/volume] in Serum or Plasma

363

1.38

1.39

1.1

1.3

82.64

135.85

nmol/l

4.85

260

(3043238) Trisomy 21 risk [Likelihood] in Fetus

794

0.75

1.39

1.3

1.5

—

(3021447) Carbon dioxide [Partial pressure] in Venous blood

1525

14463

1.06

1.39

4.1

3.8

5.79

5.83

kpa

1.02

1469

14055

(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction

1895

18084

1.05

1.38

4.0

4.2

242.26

247.07

u/l

0.77

1790

16997

(3012494) Peanut IgE Ab [Units/volume] in Serum

263

1.45

1.38

1.1

0.77

0.99

u/ml

0.16

130

(3039602) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Capillary blood

263

1.45

1.38

2.2

1.7

1.19

mmol/l

0.03

255

(40767665) Peanut recombinant (rAra h) 9 IgE Ab [Units/volume] in Serum

2.00

1.37

1.0

0.30

0.69

u/ml

—

(3020356) Listeria sp identified in Specimen by Organism specific culture

2.20

1.36

1.0

—

(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection

123

1491

0.82

1.36

1.6

1.7

—

(3051593) INR in Capillary blood by Coagulation assay

100

803

1.25

1.36

15.6

10.5

—

(3028714) Urate [Moles/time] in 24 hour Urine

2.94

1.36

1.2

1.1

—

(3047352) Trisomy 18 risk [Likelihood] in Fetus

768

0.75

1.36

1.2

1.4

—

(21494227) Amikacin free [Mass/volume] in Serum or Plasma

0.00

1.33

0.0

4.4

—

4.47

—

(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma

227

1971

1.15

1.33

1.2

1.3

—

(3009461) 5-Hydroxyindoleacetate [Moles/time] in 24 hour Urine

2.14

1.33

1.0

1.3

—

(3006571) Polymorphonuclear cells/100 leukocytes in Synovial fluid

226

1962

1.15

1.33

1.6

1.5

64.10

58.77

1.24

135

1220

(40761873) Peanut recombinant (rAra h) 1 IgE Ab [Units/volume] in Serum

1.91

1.33

1.0

0.05

0.23

u/ml

—

(3016650) Hepatitis A virus Ab [Presence] in Serum

236

2056

1.15

1.32

1.1

—

(3005033) Fetal Nuchal fold Thickness US

764

0.76

1.31

1.2

1.4

—

(3045424) Erythrocytes [Presence] in Urine

285

2518

1.13

1.31

1.7

1.5

—

(42869547) Procollagen type III.N-terminal propeptide [Mass/volume] in Serum

377

1.35

1.29

1.7

1.6

10.21

9.11

ug/l

0.81

377

(3002256) Pathology report gross observation

1891

19768

0.95

1.29

1.3

—

(3041184) Isoniazid [Presence] in Urine

2.78

1.28

2.6

2.9

—

(3053028) Streptococcus sp identified in Specimen by Organism specific culture

612

0.73

1.28

1.2

—

(40762814) Titanium [Mass/volume] in Blood

317

0.63

1.26

2.6

2.2

2.48

3.71

ug/l

—

114

(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay

265

2337

1.14

1.26

1.3

1.2

—

(3004383) Neutrophil cytoplasmic Ab.classic [Titer] in Serum by Immunofluorescence

338

3029

1.12

1.24

1.2

54.29

150.15

titre

—

(3045781) Inhibin B [Mass/volume] in Serum or Plasma

278

0.61

1.23

3.0

3.1

234.60

121.04

ng/l

—

(3047189) Immunofixation for 24 hour Urine

766

0.77

1.22

1.9

1.7

—

(3012544) pH of Venous blood

1574

15005

1.05

1.22

4.1

3.8

7.38

0.07

103

(3016284) Epstein Barr virus nuclear Ab [Units/volume] in Serum

2.63

1.21

1.8

1.1

—

(3002032) Base excess in Venous blood by calculation

1517

14450

1.05

1.21

4.1

3.8

1.96

1.98

mmol/l

0.05

1270

12320

(3016244) Insulin [Units/volume] in Serum or Plasma

620

1.26

1.19

2.5

3.0

17.13

24.82

mu/l

2.02

576

(3022689) Creatine [Moles/volume] in Urine

435

1.31

1.19

1.6

1.4

—

(3020148) Glutamate decarboxylase 65 Ab [Units/volume] in Serum

213

1860

1.15

1.19

1.1

3574.13

6479.33

iu/ml

0.18

387

(1175825) Sexually transmitted pathogens panel - Specimen by NAA with probe detection

2.31

1.18

1.2

1.1

—

(3051014) Leukocytes [#/area] in Urine sediment by Automated count

154

1313

1.17

1.18

2.0

2.2

2.13

2.29

u/field

0.13

511

(3029856) Leukocytes [#/volume] in Peritoneal dialysis fluid

1.88

1.17

6.5

12.4

164.57

312.58

e6/l

—

(1617658) Protocol used for examination of sentinel lymph nodes

106

1278

0.83

1.16

1.1

1.0

—

(3039162) Centromere protein B Ab [Units/volume] in Serum

204

1781

1.15

1.4

1.2

30.69

59.33

u/ml

1.75

131

(3050238) Crystals [Presence] in Synovial fluid by Light microscopy

460

4209

1.10

1.15

1.3

1.4

—

(3034770) Mitochondria Ab [Titer] in Serum

417

3798

1.10

1.15

1.2

922.67

864.46

titre

0.09

130

(3027953) Aldolase [Enzymatic activity/volume] in Serum or Plasma

101

831

1.22

1.14

1.5

5.75

6.06

u/l

0.21

692

(3037826) lamoTRIgine [Moles/volume] in Serum or Plasma

174

1.49

1.14

2.0

15.33

17.05

umol/l

0.33

174

(3042810) Amyloid beta 42 peptide [Mass/volume] in Cerebral spinal fluid

125

1050

1.19

1.14

1.0

796.57

714.95

ng/l

0.91

693

(3046426) Aquaporin 4 water channel IgG Ab [Presence] in Serum or Plasma

134

1.57

1.14

1.1

—

(3020073) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Specimen

466

1.29

1.12

2.4

1.9

—

(3018387) Mycoplasma pneumoniae IgG Ab [Units/volume] in Serum

205

1795

1.14

1.12

1.1

8.93

14.59

au/ml

0.64

(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma

752

1.22

1.12

1.8

1.7

—

(3033086) Enterovirus NOS Ab [Titer] in Serum

2.00

1.12

1.0

—

(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot

716

1.23

1.12

1.1

—

(3036525) Urea [Moles/time] in 24 hour Urine

1.71

1.11

2.3

3.0

—

(43055225) Phosphorylated tau 181 [Mass/volume] in Cerebral spinal fluid by Immunoassay

125

1054

1.19

1.11

1.0

40.72

42.87

ng/l

0.25

712

(3001501) Glucose [Moles/volume] in Capillary blood by Glucometer

337

1.34

1.09

3.5

2.2

7.50

7.48

mmol/l

0.01

213

(3008799) Glucose [Moles/volume] in Serum or Plasma --30 minutes post dose glucose

1.82

1.08

1.1

8.25

8.36

mmol/l

0.08

(3029713) Protein.monoclonal band 1 [Mass/volume] in Serum or Plasma by Electrophoresis

501

5430

0.92

1.08

2.3

2.5

1.26

0.96

g/l

0.78

405

4588

(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence

249

2215

1.13

1.08

1.2

1.1

—

(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count

2587

26733

0.96

1.07

2.9

2.8

1.25

1.21

e6/l

0.18

1670

15275

(3028433) Virus identified in Specimen by Culture

487

1.27

1.07

1.2

1.1

—

(3036086) Jo-1 extractable nuclear Ab [Units/volume] in Serum by Immunoassay

334

3022

1.11

1.07

1.3

1.2

3.00

12.59

u/ml

—

(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma

2505

24220

1.04

1.07

3.2

0.76

0.79

ug/l

0.47

1748

16819

(3000242) Tau protein [Mass/volume] in Cerebral spinal fluid

124

1049

1.18

1.07

1.0

400.57

320.64

ng/l

0.59

722

(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method

130

1525

0.85

1.06

1.3

—

(3030313) Adrenal Ab [Titer] in Serum

1.76

1.06

1.0

1.1

—

(3034891) Synovial lining cells/100 cells in Synovial fluid

739

1.22

1.06

1.6

1.5

5.83

3.49

0.36

163

(3011648) Oxygen content in Venous blood

130

1105

1.18

1.06

2.2

11.37

10.73

0.99

130

1105

(43055222) Platelet function.collagen + Adenosine diphosphate induced and EPINEPHrine induced panel - Blood

145

1.52

1.05

1.1

1.2

—

(3024928) Oxygen saturation in Venous blood

349

3170

1.10

1.04

3.6

3.1

—

(3012320) Pathologist interpretation of Cerebral spinal fluid tests

289

0.66

1.04

1.2

—

(3015401) Amylase [Enzymatic activity/volume] in Pleural fluid

212

1.42

1.03

1.3

21.44

204.78

u/l

0.68

150

(3048879) Bone marrow aspiration report

498

0.74

1.03

1.5

1.8

—

(1761482) Bacteria [#/volume] in Urine by Culture

398

4346

0.91

1.03

4.5

—

(3018980) carBAMazepine [Moles/volume] in Serum or Plasma

508

1.26

1.03

3.1

3.0

29.41

28.01

umol/l

0.48

384

(3027318) Ethylene glycol [Moles/volume] in Serum or Plasma

2.06

1.02

1.3

1.1

—

mmol/l

—

(3043649) Fibrin monomer [Presence] in Platelet poor plasma by Hemagglutination

2.06

1.02

1.0

1.1

—

(3006109) Coagulation factor IX activity actual/normal in Platelet poor plasma by Coagulation assay

264

0.64

1.02

1.2

101.65

111.22

0.57

248

(3008757) Leukocyte morphology finding [Identifier] in Blood

152

1755

0.86

1.02

3.5

3.8

—

(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum

306

3383

0.90

1.02

1.5

1.3

—

(3028334) Neisseria gonorrhoeae [Presence] in Specimen by Organism specific culture

106

1.60

1.02

1.5

1.7

—

(40760848) Basement membrane zone BP180 Ab [Units/volume] in Serum by Immunoassay

144

1239

1.16

1.02

1.7

1.6

22.06

24.95

u/ml

0.42

250

(3000492) Spirometry study

1225

12854

0.95

1.01

1.5

—

(3020717) Zinc [Moles/volume] in Serum or Plasma

635

1.23

1.01

1.4

21.37

25.51

umol/l

0.65

597

(3011335) Digoxin [Mass/volume] in Serum or Plasma

163

1.47

1.01

1.6

2.5

—

(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection

513

4751

1.08

1.01

1.3

—

(40766799) MGMT gene methylation score in Tissue by Molecular genetics method

106

0.47

1.00

1.0

—

(40761516) BRAF gene p.Val600Glu [Presence] in Tissue by Molecular genetics method

107

0.47

1.00

1.0

—

(3016701) Glucose [Moles/volume] in Serum or Plasma --2 hours post dose glucose

183

1605

1.14

1.00

1.2

7.86

7.61

mmol/l

0.53

170

1365

(3009466) Valproate [Moles/volume] in Serum or Plasma

213

1887

1.13

1.00

5.1

4.6

372.05

358.75

umol/l

0.60

191

1597

(3010503) CD19 cells [#/volume] in Blood

103

863

1.19

1.00

2.6

2.4

0.19

0.39

e9/l

0.87

826

(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma

1661

17285

0.96

0.98

2.8

2.6

9.22

8.74

umol/l

0.31

1410

15001

(3009214) Lutropin [Units/volume] in Serum or Plasma

274

2468

1.11

0.98

1.4

1.3

10.66

12.16

u/l

1.21

230

1996

(3027300) Silver Birch IgE Ab [Units/volume] in Serum

257

1.36

0.98

1.0

1.1

9.57

11.83

u/ml

0.28

138

(3004347) Hepatitis D virus Ab [Presence] in Serum

2.17

0.98

1.0

—

(3012989) Citrate [Moles/time] in 24 hour Urine

2.17

0.98

2.2

1.5

2.24

2.12

mmol/24h

—

(3035062) Alkaline phosphatase.liver 1 [Enzymatic activity/volume] in Serum or Plasma

100

839

1.19

0.97

1.1

78.39

86.94

u/l

0.76

753

(3018840) Calcitonin [Moles/volume] in Serum or Plasma

116

1.55

0.96

3.0

2.9

13.84

59.73

pmol/l

—

(3033799) Differential panel - Peritoneal fluid

491

0.75

0.95

2.0

1.8

—

(3006695) Toxoplasma gondii DNA [Presence] in Specimen by NAA with probe detection

182

1.43

0.95

1.4

1.9

—

(3037551) Cancer Ag 125 [Units/volume] in Serum or Plasma

769

8159

0.94

0.95

3.3

3.8

79.74

63.53

u/ml

0.17

734

7860

(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy

748

0.80

0.95

1.4

1.5

—

(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma

849

8978

0.94

1.8

—

(3044290) Cell count panel - Cerebral spinal fluid

297

2694

1.10

0.94

1.3

—

(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection

139

1602

0.87

0.94

1.5

1.6

—

(3004409) Coagulation factor X activity actual/normal in Platelet poor plasma by Coagulation assay

375

0.72

0.93

1.1

1.2

76.07

87.65

0.76

182

(3018562) Neutrophils/100 leukocytes in Cerebral spinal fluid

109

1.56

0.93

1.4

1.5

25.33

37.51

—

(3025245) SCL-70 extractable nuclear Ab [Units/volume] in Serum by Immunoassay

331

3022

1.10

0.92

1.3

1.2

9.38

4.22

u/ml

0.48

228

(3023183) Ammonium ion [Moles/volume] in Plasma

336

3070

1.10

0.92

2.5

30.97

33.30

umol/l

1.04

291

2733

(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma

1408

13498

1.05

0.92

1.8

1.7

1.53

1.49

0.80

1171

11539

(3019083) Insulin-like growth factor [Moles/volume] in Serum or Plasma

175

1.43

0.92

1.5

1.7

—

(3008994) Creatine kinase.BB [Enzymatic activity/volume] in Serum or Plasma by Electrophoresis

1.71

0.92

1.3

1.6

0.40

0.16

u/l

—

(3003245) Complement C1 esterase inhibitor [Mass/volume] in Serum or Plasma

428

1.26

0.90

1.2

0.32

0.31

g/l

0.44

341

(3035320) C reactive protein [Mass/volume] in Body fluid

126

1087

1.16

0.90

2.1

2.5

—

(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection

840

0.82

0.89

1.3

1.4

—

(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection

840

0.82

0.89

1.3

1.4

—

(3024263) Appearance of Synovial fluid

801

1.19

0.89

1.3

1.4

—

(4146454) Self-monitoring of blood glucose

195

1735

1.13

0.89

3.1

2.6

—

(3043109) Cytology report of Tissue fine needle aspirate Cyto stain

414

3826

1.08

0.89

1.3

—

(3009871) Measles virus Ab [Titer] in Serum

385

1.27

0.88

1.5

1.7

—

(3001850) Coagulation factor XI activity actual/normal in Platelet poor plasma by Coagulation assay

254

0.67

0.88

1.4

1.1

91.00

79.06

—

(3036185) Alkaline phosphatase.liver 2 [Enzymatic activity/volume] in Serum or Plasma

840

1.18

0.87

1.1

22.25

26.24

u/l

0.48

752

(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma

3079

30007

1.03

0.86

2.8

3.1

2.46

mmol/l

2.62

2694

26137

(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection

118

1364

0.86

0.85

1.5

1.6

—

(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection

118

1364

0.86

0.85

1.5

1.6

—

(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection

118

1364

0.86

0.85

1.5

1.6

—

(3039443) Prostate specific Ag panel - Serum or Plasma

171

1927

0.89

0.85

1.7

1.6

—

(3007566) Smooth muscle Ab [Titer] in Serum

409

3787

1.08

0.85

1.2

90.26

163.15

titre

2.26

321

(3036180) Methadone [Presence] in Urine

333

0.72

0.85

1.8

1.5

—

(3025018) Bordetella pertussis Ab [Titer] in Serum

668

1.20

0.85

1.3

—

(3025886) Oxalate [Mass/time] in 24 hour Urine

1.94

0.84

1.2

1.1

—

(3050898) Methicillin resistant Staphylococcus aureus [Presence] in Genital specimen by Organism specific culture

756

0.82

0.83

2.3

2.4

—

(40763634) TCRG gene rearrangements [Presence] in Bone marrow by Molecular genetics method

112

0.54

0.83

1.2

1.1

—

(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex

698

1.19

0.82

1.2

—

(3042517) Benzodiazepines panel - Urine

1.69

0.82

2.0

—

(3042010) Triglyceride [Moles/volume] in Pleural fluid

240

1.33

0.82

1.3

1.2

2.40

1.35

mmol/l

0.31

156

(43055514) Macroprolactin [Presence] in Serum or Plasma

180

1.39

0.81

1.7

1.5

—

(3008536) Aspergillus sp Ab [Presence] in Serum

295

0.71

0.80

1.8

1.9

—

(3011288) Drugs identified in Urine by Screen method

177

1578

1.12

0.80

2.5

—

(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection

287

2625

1.09

0.80

1.5

1.6

—

(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection

451

4204

1.07

0.80

1.4

1.3

—

(3035999) Lactate [Moles/volume] in Cerebral spinal fluid

121

1053

1.15

0.79

1.2

1.3

2.12

2.17

mmol/l

0.21

113

977

(3040562) Leukocytes [#/volume] in Peritoneal dialysis fluid by Manual count

1.82

0.79

8.2

9.4

—

(3005702) Mycobacterium sp identified in Specimen by Organism specific culture

322

3495

0.92

0.79

1.5

—

(3046299) Protein.monoclonal [Mass/volume] in Serum or Plasma by Electrophoresis

148

0.61

0.78

4.9

5.8

—

(3023199) Leukocytes [#/volume] in Pleural fluid

180

2009

0.89

0.78

1.4

1.5

5379.81

2260.45

e6/l

0.43

134

1436

(40763091) Bacteria identified in Peritoneal dialysis fluid by Culture

1.62

0.78

3.2

3.3

—

(3020013) Alkaline phosphatase.intestinal [Enzymatic activity/volume] in Serum or Plasma

121

1056

1.15

0.77

1.5

7.44

6.89

u/l

0.16

843

(40768795) Lymph node Pathology biopsy report

139

1574

0.88

0.77

1.2

—

(1002183) Plasma cells monotypic population [Identifier] in Bone marrow by Flow cytometry (FC)

221

0.68

0.75

1.1

1.2

—

(3028308) Erythrocytes [#/volume] in Pleural fluid

163

1824

0.89

0.75

1.4

1.5

83045.32

52255.47

e6/l

0.31

1066

(3001019) Free T4 and TSH panel - Serum or Plasma

473

5045

0.94

0.74

1.7

—

(3034099) Cytomegalovirus Ab [Titer] in Cerebral spinal fluid

2.08

0.74

1.0

1.1

—

(723474) SARS-CoV-2 (COVID-19) IgG Ab [Presence] in Serum or Plasma by Immunoassay

315

1.27

0.74

1.2

—

(3035637) Corticotropin [Mass/volume] in Plasma

191

1722

1.11

0.73

1.4

1.5

—

(40758558) Short blood count panel - Blood

3824

37482

1.03

0.73

6.4

7.0

—

(3005353) Prothrombin activity actual/normal in Platelet poor plasma by Coagulation assay

380

0.76

0.73

1.1

81.88

87.30

0.44

181

(3026051) Polymorphonuclear cells/100 leukocytes in Pleural fluid

397

1.23

0.72

1.4

15.85

22.95

1.53

336

(46234834) Bacteria identified in Bone by Anaerobe+Aerobe culture

108

0.56

0.72

1.0

1.1

—

(42529215) Follitropin [Units/volume] in Serum or Plasma by Immunoassay

159

1421

1.12

0.72

1.4

1.3

34.24

33.60

u/l

0.08

125

1154

(3001684) Respiratory syncytial virus Ag [Presence] in Specimen

237

1.31

0.72

1.2

1.1

—

(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection

762

7254

1.05

0.71

1.9

1.8

—

(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood

946

0.86

0.71

1.6

1.7

—

(42868647) JC virus Ab [Presence] in Serum or Plasma by Immunoassay

109

1.47

0.70

1.7

1.9

—

(3016293) Bicarbonate [Moles/volume] in Serum or Plasma

952

9118

1.05

0.70

6.0

6.7

24.80

24.89

mmol/l

0.33

944

9028

(21494814) CD8 cells/100 lymphocytes in Specimen

554

1.19

0.70

2.3

2.0

—

(3005812) Immunoglobulin light chains [Presence] in 24 hour Urine

144

0.62

0.69

3.7

3.0

—

(3036071) Salmonella sp Ab [Titer] in Serum

373

1.23

0.68

1.0

1.1

—

(3000991) Gas panel - Venous blood

1259

13053

0.96

0.68

7.1

7.8

—

(3019250) Coagulation factor VIII activity actual/normal in Platelet poor plasma by Coagulation assay

351

3768

0.93

0.68

2.6

2.3

196.16

199.56

0.30

328

3546

(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum

214

2345

0.91

0.68

1.4

1.2

—

(723473) SARS-CoV-2 (COVID-19) IgA Ab [Presence] in Serum or Plasma by Immunoassay

1.53

0.68

1.1

1.2

—

(3016273) Islet cell 512 Ab [Units/volume] in Serum

1.53

0.68

1.0

—

(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay

532

5632

0.94

0.68

3.0

2.9

0.36

u/ml

0.03

310

3216

(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal

100

1145

0.87

0.68

1.2

—

(42870308) Desmosome IgG Ab [Titer] in Serum by Immunofluorescence

118

1041

1.13

0.67

1.3

42.31

63.38

titre

0.69

(3042975) Streptococcus sp identified in Isolate by Organism specific culture

419

0.79

0.67

1.3

1.1

—

(3016184) Myelin associated glycoprotein Ab [Units/volume] in Serum

0.55

0.67

1.0

1.2

—

10925.00

—

(1001833) Epstein Barr virus DNA [Units/volume] (viral load) in Blood by NAA with probe detection

232

1.29

0.65

1.2

1.3

—

(3003284) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum by Immunofluorescence

544

5148

1.06

0.65

1.6

134.63

256.40

titre

1.89

225

(3005880) Parainfluenza virus 3 Ag [Presence] in Specimen

163

1.35

0.64

1.2

—

(3021578) Parainfluenza virus 2 Ag [Presence] in Specimen

163

1.35

0.64

1.2

—

(3010464) Parainfluenza virus 1 Ag [Presence] in Specimen

163

1.35

0.64

1.2

—

(3029075) Extractable nuclear Ab panel - Serum

377

1.22

0.63

1.1

1.0

—

(3034092) Cytoplasmic Ig cells/100 cells in Blood

172

1.34

0.63

8.9

9.0

—

(3023511) Choriogonadotropin [Units/volume] in Urine

108

953

1.13

0.63

1.3

—

(3002619) Bacteria identified in Specimen by Culture

314

0.76

0.62

1.5

1.3

—

(3035401) Herpes virus 6 DNA [Presence] in Specimen by NAA with probe detection

1.63

0.62

2.3

1.2

—

(3005570) Glucose [Moles/volume] in Urine

148

1639

0.90

0.60

2.2

1.9

—

1.54

—

(40771527) Human papilloma virus E6+E7 mRNA [Presence] in Cervix by NAA with probe detection

434

0.81

0.60

2.1

1.8

—

(3013201) Beta-2-Microglobulin [Mass/volume] in Serum or Plasma

137

1231

1.11

0.60

2.2

1.8

3.38

4.17

mg/l

2.48

131

1160

(3033093) Yersinia sp IgM Ab [Titer] in Serum

0.00

0.60

0.0

2.0

—

(3039817) Yersinia enterocolitica IgA Ab [Presence] in Serum

0.00

0.60

0.0

2.0

—

(3040944) Yersinia pseudotuberculosis 3 Ab [Titer] in Serum

0.00

0.60

0.0

1.0

—

(3042341) Yersinia pseudotuberculosis Ab [Presence] in Serum

0.00

0.60

0.0

2.0

—

(3038714) Yersinia pseudotuberculosis Ab [Titer] in Serum by Agglutination

0.00

0.60

0.0

1.0

—

(46236344) Yersinia enterocolitica O:9 IgG Ab [Presence] in Serum by Agglutination

0.00

0.60

0.0

1.0

—

(3013924) Clostridium tetani IgG Ab [Units/volume] in Serum

1.50

0.59

1.1

—

(3011325) HIV 1+2 Ab [Presence] in Serum

1.54

0.59

1.0

—

(1001926) Buprenorphine [Presence] in Urine by Screen method

204

1872

1.09

0.59

2.0

1.8

—

(3017569) Oxygen content in Arterial blood

751

1.15

0.59

2.6

2.2

—

(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

571

6000

0.95

0.59

2.2

2.4

2.83

2.97

g/l

2.74

501

5277

(3028371) Actinomyces sp identified in Specimen by Organism specific culture

166

1.33

0.58

1.0

1.1

—

(3018688) Ampicillin IgE Ab [Units/volume] in Serum

1.71

0.57

1.0

—

(3023465) Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis

572

5999

0.95

0.56

2.2

2.3

10.15

10.14

g/l

0.02

500

5241

(40761545) Erythrocytes.dysmorphic [Presence] in Urine sediment by Light microscopy

0.57

0.56

1.2

1.1

—

(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count

746

1.14

0.55

3.1

3.3

—

(3047007) Chlamydophila sp Ab [Presence] in Serum

156

1712

0.91

0.55

1.3

1.2

—

(3006270) Folate [Moles/volume] in Blood

145

1315

1.10

0.55

1.2

348.41

341.13

nmol/l

0.17

123

1050

(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay

344

3233

1.07

0.55

1.1

1.2

—

(3034603) RHD gene allele [Genotype] in Blood or Tissue by Molecular genetics method Nominal

228

0.75

0.54

1.6

1.5

—

(3013180) HIV 1 RNA [Units/volume] (viral load) in Serum or Plasma by Probe with amplification

633

0.85

0.54

5.1

4.6

1337.71

437.45

u/ml

—

(3001467) Alkaline phosphatase.bone [Enzymatic activity/volume] in Serum or Plasma

193

1777

1.09

0.54

1.2

57.55

62.65

u/l

0.71

168

1567

(44816893) Food Allergen Mix 50 (Kiwi+Pineapple+Banana+Mango) IgE Ab [Units/volume] in Serum by Multidisk

276

1.23

0.53

1.0

—

(40760847) Basement membrane Ab [Titer] in Serum by Immunofluorescence

120

1080

1.11

0.53

1.4

1.3

266.25

437.74

titre

—

(3046896) Herpes virus 6 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

386

1.19

0.53

1.1

—

(3035880) pH of Pleural fluid

103

920

1.12

0.52

1.4

1.3

—

(3044936) Clostridioides difficile toxin A+B [Presence] in Stool by Immunoassay

381

0.81

0.51

1.2

—

(3020229) Cytomegalovirus DNA [Presence] in Specimen by NAA with probe detection

452

1.17

0.51

1.1

1.2

—

(3025149) Bordetella pertussis IgA Ab [Units/volume] in Serum

752

1.13

0.51

1.0

1.1

6.56

10.49

iu/ml

0.87

160

(3043870) Heparin induced platelet Ab [Units/volume] in Serum

157

0.70

0.51

1.3

1.2

—

(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot

115

1037

1.11

0.50

1.3

1.1

—

(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot

115

1037

1.11

0.50

1.3

1.1

—

(3009343) pH of Capillary blood

991

9587

1.04

0.50

3.4

3.6

7.41

7.42

0.84

196

1213

(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing

289

3077

0.94

0.50

1.5

1.6

—

(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot

115

1038

1.11

0.49

1.3

1.1

—

(3026692) Albumin [Mass/volume] in Peritoneal fluid

389

1.18

0.49

1.7

1.4

13.93

13.76

g/l

0.04

301

(42868499) Enterovirus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay

162

1.30

0.49

1.0

1.1

—

(3046861) Legionella sp Ag [Presence] in Urine

1.43

0.49

1.0

—

(42868414) European tick borne encephalitis virus IgM Ab [Presence] in Serum by Immunoassay

576

1.15

0.49

1.1

—

(3020287) Protein C actual/normal in Platelet poor plasma by Coagulation assay

187

1730

1.08

0.48

1.1

123.53

118.30

1.20

161

1535

(3009613) Erythrocytes [#/volume] in Peritoneal fluid

497

0.84

0.48

2.4

1.8

4181.37

12602.48

e6/l

1.15

268

(3019174) dRVVT (LA screen)

108

0.65

0.48

1.0

1.2

—

(3006462) Nitrate [Presence] in Urine

764

0.88

0.48

4.3

3.6

—

(3017895) Helicobacter pylori Ab [Units/volume] in Serum

538

5146

1.05

0.48

1.6

—

(3032057) Clostridioides difficile [Presence] in Stool

377

0.82

0.47

1.5

1.7

—

(3027231) Wheat IgE Ab [Units/volume] in Serum

190

1.26

0.47

1.0

0.44

2.24

u/ml

0.66

153

(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma

157

1706

0.92

0.47

1.4

1.5

—

(3001556) Androgen free Index in Serum or Plasma

1.49

0.47

1.0

1.2

—

(3022058) Hepatitis B virus DNA [Presence] in Serum or Plasma by NAA with probe detection

333

0.81

0.47

1.1

1.2

—

(3026725) Estradiol (E2) [Moles/volume] in Serum or Plasma

137

1253

1.09

0.47

1.3

1.4

0.21

0.31

nmol/l

3.37

893

(3020393) Adenovirus Ag [Presence] in Stool

146

1.30

0.46

1.1

—

(3007302) Hemoglobin [Mass/volume] in Mixed venous blood

1.46

0.46

41.4

12.6

—

(3019768) Coxiella burnetii Ab [Presence] in Serum

1.41

0.46

1.0

1.2

—

(3029790) Creatine kinase.MB [Enzymatic activity/volume] in Serum or Plasma

111

1.35

0.46

1.1

5.13

10.99

u/l

1.33

111

(3031067) HIV 1 p24 Ag [Mass/volume] in Serum or Plasma by Immunoassay

1.43

0.46

1.0

—

(3037577) Monocytes/100 leukocytes in Cerebral spinal fluid

1.38

0.45

1.3

1.6

15.14

13.18

—

(3021788) Differential panel - Synovial fluid

276

2931

0.94

0.45

1.6

1.5

—

(3005895) Myoglobin [Mass/volume] in Serum or Plasma

527

5500

0.96

0.45

2.3

788.72

570.27

ug/l

0.24

493

5165

(40768800) Prostate Pathology biopsy report

261

2776

0.94

0.45

1.2

—

(3025378) Microscopic observation [Identifier] in Cervix by Cyto stain

120

0.67

0.45

1.3

1.1

—

(4212803) Bone marrow aspirate examination

153

0.72

0.45

1.2

1.0

—

(3024172) Erythropoietin (EPO) [Units/volume] in Serum or Plasma

257

2418

1.06

0.44

1.3

24.33

38.04

u/l

2.75

221

2089

(3035947) Staphylolysin Ab [Units/volume] in Serum

705

1.12

0.43

1.1

3.00

3.58

iu/ml

—

(3028707) Methadone [Presence] in Urine by Screen method

121

1106

1.09

0.43

2.4

2.2

—

(3032352) Blasts [#/volume] in Cerebral spinal fluid

131

0.69

0.43

1.9

1.8

—

(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection

692

0.88

0.42

1.3

—

(3012447) Hantavirus puumala IgG Ab [Titer] in Serum

132

1435

0.92

0.42

1.1

—

(3006418) Campylobacter sp identified in Tissue by Organism specific culture

443

4237

1.05

0.42

1.2

—

(3017312) HC gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method

0.65

0.42

1.3

1.1

—

(40759836) Histone Ab [Presence] in Serum by Immunoblot

113

1032

1.10

0.41

1.3

1.1

—

(3014007) Fractional oxyhemoglobin in Arterial blood

1021

9926

1.03

0.41

7.1

8.6

94.11

93.79

1.01

1015

9890

(3035929) Mycoplasma pneumoniae Ab [Units/volume] in Cerebral spinal fluid

158

1.27

0.41

1.0

1.1

—

(40765091) Chromosome analysis panel - Chorionic villus sample by G-banded

0.00

0.41

0.0

1.1

—

(3003531) Amoxicillin IgE Ab [Units/volume] in Serum

0.00

0.41

0.0

1.0

—

(3010156) C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method

392

4105

0.95

0.41

1.8

1.7

4.21

3.72

mg/l

0.45

306

3026

(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot

113

1033

1.09

0.41

1.3

1.1

—

(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot

113

1033

1.09

0.41

1.3

1.1

—

(3029536) Hepatitis C virus RNA [Units/volume] (viral load) in Specimen by NAA with probe detection

473

1.14

0.40

1.5

1.4

573617.50

1763186.13

iu/ml

—

(3025549) Creatine [Moles/time] in 24 hour Urine

141

1.28

0.40

1.5

1.4

—

(3008364) Apolipoprotein A-I [Mass/volume] in Serum or Plasma

730

0.89

0.40

1.3

1.56

1.58

g/l

0.27

730

(3020485) Acetaminophen [Moles/volume] in Serum or Plasma

606

1.12

0.39

1.7

1.8

157.61

116.60

umol/l

0.28

332

(3006804) Neuronal Ab [Presence] in Cerebral spinal fluid

101

0.69

0.39

1.0

—

(3049506) Microalbumin [Mass/time] in Urine collected for unspecified duration

787

1.11

0.39

2.3

2.1

73.41

134.72

ug/min

0.59

171

(3032743) Legionella sp IgG Ab [Presence] in Serum

104

0.67

0.39

1.1

—

(21494567) Legionella sp IgM Ab [Presence] in Serum

105

0.67

0.39

1.1

—

(3045788) Cell count panel - Pleural fluid

143

1542

0.93

0.39

1.4

1.5

—

(3008640) Bordetella pertussis IgG Ab [Titer] in Serum

0.00

0.39

0.0

1.1

—

(3009471) Fatty acids.nonesterified [Moles/volume] in Serum or Plasma

0.00

0.39

0.0

5.6

—

0.27

—

(3023410) Appearance of Cerebral spinal fluid

119

1293

0.92

0.39

1.3

1.5

—

(40766183) Gliadin peptide IgA Ab [Units/volume] in Serum by Immunoassay

167

1557

1.07

0.39

1.1

2.76

3.62

u/ml

0.28

589

(3003171) Aldosterone [Moles/volume] in Serum or Plasma --upright

378

0.85

0.39

1.1

1.2

474.45

302.41

pmol/l

0.51

261

(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection

361

3447

1.05

0.38

1.3

1.4

—

(3005011) Chlamydia sp Ab [Titer] in Serum

169

1.24

0.38

1.6

1.7

—

(42869858) Acute and chronic leukemia fusion transcript panel - Blood or Tissue by Molecular genetics method

133

1.28

0.38

1.1

—

(46235355) HIV 1 and 2 tests - Meaningful Use set

1686

16525

1.02

0.38

1.8

1.6

—

(3017315) Amylase [Enzymatic activity/volume] in Urine

789

1.10

0.38

1.1

1.2

192.92

347.97

u/l

1.71

733

(40758310) Human epididymis protein 4 [Moles/volume] in Serum or Plasma

321

3369

0.95

0.38

1.4

1.5

191.28

173.74

pmol/l

0.18

308

3282

(3023024) Carbon dioxide [Partial pressure] in Capillary blood

997

9708

1.03

0.38

3.4

3.6

5.15

5.16

kpa

0.08

943

9143

(3006217) Methemoglobin/Hemoglobin.total in Arterial blood

1015

9889

1.03

0.37

7.0

8.6

0.71

0.67

3.02

1010

9826

(42868417) European tick borne encephalitis virus IgG Ab [Presence] in Serum by Immunoassay

308

1.17

0.37

1.1

—

(3012984) Norclozapine [Mass/volume] in Serum or Plasma

1.30

0.37

5.0

7.9

—

(3035933) Granulocytes/100 leukocytes in Blood

268

0.82

0.37

1.4

1.6

—

(3038769) Chlamydophila pneumoniae IgG Ab [Units/volume] in Serum by Immunoassay

161

1.24

0.37

1.1

79.15

54.74

u/ml

0.54

154

(40771901) t(9;22)(q34.1;q11)(ABL1,BCR) b2a2+b3a2 fusion transcript/control transcript (International Scale) [# Ratio] in Blood or Tissue by Molecular genetics method

1.29

0.36

9.0

8.5

—

(3038515) Glucose [Moles/volume] in Venous blood

328

3435

0.95

0.36

3.7

3.4

7.90

7.61

mmol/l

0.91

319

3370

(3027570) Oxalate [Moles/time] in 24 hour Urine

1.27

0.36

1.1

1.5

297.67

327.83

umol/24h

—

(3012336) Haptoglobin [Mass/volume] in Serum or Plasma

769

7469

1.03

0.35

1.6

1.52

1.59

g/l

1.32

649

6363

(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain

195

2070

0.94

0.35

1.2

1.1

—

(3038177) Helicobacter pylori Ab [Presence] in Serum

221

2089

1.06

0.35

1.2

1.3

—

(3036670) Protein [Mass/volume] in Synovial fluid

523

0.88

0.35

1.2

1.3

39.31

39.61

g/l

0.05

270

(3009876) Amylase isoenzyme 3 panel - Serum or Plasma

1.31

0.35

1.0

1.2

—

(3003888) Timothy IgE Ab [Units/volume] in Serum

169

1585

1.07

0.35

1.1

4.22

3.85

u/ml

0.11

758

(3048402) Erythrocytes [#/area] in Urine sediment by Automated count

861

1.09

0.35

1.7

2.0

3.32

2.47

u/field

0.50

583

(42529406) Shigella sp [Presence] in Stool by Culture

446

4293

1.04

0.34

1.2

—

(3015916) Alpha-1-Fetoprotein [Units/volume] in Serum or Plasma

184

1954

0.94

0.34

2.3

2.5

746.43

899.41

u/ml

0.07

184

1929

(3043410) Blood group antigens tested for on Red Blood Cells

386

1.14

0.34

2.0

1.7

—

(3020951) Lymphocytes/100 leukocytes in Cerebral spinal fluid

209

1.20

0.33

1.2

1.4

53.50

51.00

—

(3031659) Enterovirus NOS Ab [Titer] in Cerebral spinal fluid

1.33

0.33

1.0

—

(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence

103

1116

0.92

0.33

1.2

—

(3028029) Mesothelial cells/100 leukocytes in Pleural fluid

256

1.17

0.33

1.3

1.4

26.00

11.10

—

143

(3022475) Manganese [Moles/volume] in Blood

0.69

0.33

1.0

1.3

—

(3010144) Erythrocytes [#/volume] in Synovial fluid

160

1503

1.07

0.32

1.2

1.4

265085.67

132089.90

e6/l

0.76

1029

(3008037) Lactate [Moles/volume] in Venous blood

347

3615

0.96

0.32

3.6

3.4

1.52

1.61

mmol/l

1.43

337

3539

(3015822) Parvovirus B19 DNA [Presence] in Serum by NAA with probe detection

1.28

0.32

1.0

1.1

—

(40767663) Brazil Nut recombinant (rBer e) 1 IgE Ab [Units/volume] in Serum

1.28

0.32

1.0

—

(3028531) Enolase.neuron specific [Mass/volume] in Serum or Plasma

191

2020

0.94

0.32

1.8

1.9

19.81

24.73

ug/l

1.39

183

1964

(42529201) Cancer Ag 19-9 [Units/volume] in Serum or Plasma by Immunoassay

329

3431

0.96

0.32

3.0

3.3

325.79

766.54

u/ml

1.11

301

3114

(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

621

6398

0.97

0.32

2.2

2.3

3.66

3.71

g/l

0.27

554

5683

(3002331) Protein [Mass/volume] in Peritoneal fluid

338

0.86

0.32

1.4

24.79

26.35

g/l

0.19

264

(3014051) Protein [Presence] in Urine by Test strip

420

4048

1.04

0.32

3.0

2.6

—

(43533860) Galactose-alpha-1,3-galactose (Alpha-Gal) IgE Ab [Units/volume] in Serum

128

1.25

0.31

1.1

1.0

0.00

0.42

u/ml

—

(3003434) Protein [Mass/volume] in Pleural fluid

214

2254

0.95

0.31

1.4

1.5

30.04

32.48

g/l

1.90

195

2014

(44816808) CXCL13 Ag [Mass/volume] in Cerebral spinal fluid

560

1.11

0.31

1.2

1.1

107.82

608.12

ng/l

1.67

129

(3045142) Bone marrow Pathology biopsy report

166

1761

0.94

0.31

1.4

1.3

—

(3000285) Sodium [Moles/volume] in Blood

219

0.82

0.31

1.4

1.1

—

(44816752) ERBB2 gene copy number/nucleus in Tissue by FISH

810

0.91

0.31

1.1

—

(3005136) Cladosporium herbarum IgE Ab [Units/volume] in Serum

104

964

1.08

0.31

1.0

0.14

0.52

u/ml

1.12

280

(3014444) EGFR gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal

153

0.78

0.30

1.1

1.0

—

(3021236) Streptolysin O Ab [Units/volume] in Serum or Plasma

523

1.11

0.30

1.1

187.27

163.15

iu/ml

0.24

515

(3000330) Specific gravity of Urine by Test strip

784

8041

0.97

0.30

3.8

—

(3013293) Extractable nuclear Ab [Presence] in Serum

221

1.18

0.30

1.5

1.6

—

(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

623

6410

0.97

0.30

2.2

2.3

—

(3005411) Squamous cell carcinoma Ag [Mass/volume] in Serum or Plasma

304

0.86

0.30

1.5

1.9

2.22

2.47

ug/l

0.10

168

(3047166) Epithelial cells [#/area] in Urine sediment by Automated count

207

0.82

0.30

3.1

2.8

0.24

0.67

u/field

2.07

207

(3022640) Eosinophils/100 leukocytes in Cerebral spinal fluid

1.31

0.30

1.2

1.4

1.60

1.54

—

(3037534) Parathyrin related protein [Mass/volume] in Serum or Plasma

334

1.14

0.30

1.4

1.5

124.51

117.05

ng/l

0.10

334

(3014765) Yersinia sp identified in Stool by Organism specific culture

443

4282

1.04

0.29

1.2

—

(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay

167

1767

0.94

0.29

1.1

—

(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

624

6417

0.97

0.29

2.2

2.3

7.46

7.49

g/l

0.17

555

5692

(3030136) 5-Hydroxyindoleacetate [Moles/volume] in Serum or Plasma

116

1083

1.07

0.29

2.6

3.5

159.28

151.48

nmol/l

0.07

116

1064

(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection

871

1.08

0.29

1.3

1.2

—

(3028167) CD3+CD4+ (T4 helper) cells [#/volume] in Blood

103

958

1.08

0.29

2.4

700.08

630.87

e6/l

0.80

908

(1176173) BK virus + JC virus DNA [Presence] in Specimen by NAA with probe detection

1.32

0.28

7.1

4.2

—

(3026048) Bordetella pertussis IgG Ab [Units/volume] in Serum

158

1.20

0.28

1.0

1.1

—

(3043453) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum

108

1156

0.93

0.28

1.3

1.2

78.24

174.05

titre

3.14

215

(3013005) Retinol [Moles/volume] in Serum or Plasma

498

1.10

0.27

1.5

1.6

2.09

1.99

umol/l

0.57

465

(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC

104

970

1.07

0.27

1.6

1.7

—

(3014791) Apolipoprotein B [Mass/volume] in Serum or Plasma

928

0.93

0.27

1.7

1.5

0.89

0.94

g/l

1.19

922

(21494890) Protein electrophoresis panel - 24 hour Urine

181

1720

1.05

0.27

2.3

2.0

—

(3026726) Creatinine [Moles/volume] in Specimen

121

0.74

0.27

2.6

172.67

394.38

umol/l

—

114

(3002621) Streptococcal DNAse B [Units/volume] in Serum

113

1.24

0.26

1.1

1.0

—

(3051101) Glucose [Moles/volume] in Cord blood

289

0.86

0.26

7.0

6.1

—

(3022621) pH of Urine by Test strip

1027

10072

1.02

0.26

3.6

3.1

—

(42868766) Dientamoeba fragilis DNA [Presence] in Stool by NAA with probe detection

377

1.11

0.25

1.4

1.2

—

(3043257) Herpes virus 6 IgG Ab [Presence] in Cerebral spinal fluid

0.72

0.24

1.0

—

(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation

944

9264

1.02

0.23

3.4

3.6

2.09

1.90

mmol/l

0.90

681

6950

(3036428) Adenosine deaminase [Enzymatic activity/volume] in Pleural fluid

113

1198

0.94

0.23

1.3

16.18

12.82

u/l

0.39

100

1095

(3007695) Herpes simplex virus 2 IgG Ab [Presence] in Cerebral spinal fluid

152

1.18

0.23

1.0

1.1

—

(40768804) Tissue Pathology biopsy report

5982

60181

0.99

0.23

2.2

—

(3019298) Eosinophils/100 leukocytes in Peritoneal fluid

1.32

0.23

1.8

1.4

0.48

0.30

—

(42868497) Enterovirus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

106

1.23

0.23

1.0

1.1

—

(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture

143

1504

0.95

0.23

2.4

2.9

—

(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection

882

1.07

0.23

1.3

1.2

—

(3014111) Lactate [Moles/volume] in Serum or Plasma

1345

13653

0.98

0.23

5.7

6.6

1.35

mmol/l

0.02

1313

13282

(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma

582

1.08

0.22

3.4

2.6

—

(3008401) Mugwort IgE Ab [Units/volume] in Serum

160

1526

1.05

0.22

1.0

1.1

1.03

1.09

u/ml

0.05

608

(3002670) Multiple inhalant allergen IgE Ab [Units/volume] in Serum

361

1.11

0.22

1.1

—

(3034368) Herpes virus 6 IgM Ab [Presence] in Cerebral spinal fluid

0.77

0.22

1.0

—

(3035510) Gentamicin [Mass/volume] in Serum or Plasma

1.19

0.21

2.8

6.0

0.68

0.87

mg/l

—

(3010937) Rubella virus Ab [Presence] in Serum

1.19

0.21

1.0

1.1

—

(3037377) Propoxyphene + Norpropoxyphene [Presence] in Urine by Confirmatory method

0.00

0.21

0.0

1.2

—

(1002224) Polysomnography panel

448

4597

0.97

0.21

1.1

—

(42528593) TIF1-gamma Ab [Presence] in Serum by Line blot

353

1.11

0.21

1.0

1.1

—

(3013637) Mi-2 Ab [Presence] in Serum

353

1.11

0.21

1.0

1.1

—

(42529582) MDA5 Ab [Presence] in Serum by Line blot

353

1.11

0.21

1.0

1.1

—

(42529598) SUMO-activating enzyme subunit 1 Ab [Presence] in Serum by Line blot

353

1.11

0.21

1.0

1.1

—

(3013676) Sertraline [Moles/volume] in Serum or Plasma

0.00

0.21

0.0

1.2

—

172.87

—

(40760435) Tropomyosin IgE Ab [Units/volume] in Serum

103

0.78

0.21

1.0

—

(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method

277

1.12

0.21

1.5

1.8

—

(3009992) Blasts/100 cells in Bone marrow

0.00

0.21

0.0

1.9

—

9.77

—

(40757349) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Blood

421

1.09

0.21

2.7

2.9

—

(3036535) Thyroglobulin [Mass/volume] in Serum or Plasma

925

1.06

0.20

5.4

6.2

—

(3032868) Hemoglobin electrophoresis panel in Blood

1.24

0.20

1.5

—

(3020123) Porphyrins [Interpretation] in Serum or Plasma

1.25

0.20

1.0

1.1

—

(37020271) Myelin oligodendrocyte glycoprotein Ab [Titer] in Serum by Cell binding immunofluorescent assay

1.25

0.20

1.0

1.1

—

(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay

103

1088

0.95

0.20

1.0

1.1

—

(3045066) Thymidine kinase [Enzymatic activity/volume] in Serum

418

0.91

0.20

2.2

2.0

20.18

38.10

u/l

1.27

387

(40768793) Breast Pathology biopsy report

350

3600

0.97

0.20

1.3

—

(3035400) Alkaline phosphatase.liver [Enzymatic activity/volume] in Serum or Plasma

110

1043

1.05

0.20

1.2

91.85

84.86

u/l

0.29

894

(3019497) Choriogonadotropin.beta subunit free [Moles/volume] in Serum or Plasma

297

1.11

0.20

1.2

1.7

—

(46234826) Other cells/100 leukocytes in Peritoneal fluid by Manual count

108

1.20

0.20

2.7

1.6

28.57

16.04

—

(3037677) Mycoplasma pneumoniae IgM Ab [Titer] in Cerebral spinal fluid

374

1.10

0.20

1.0

1.1

—

(3021879) Hepatitis B virus core Ab [Presence] in Serum

848

8335

1.02

0.20

1.4

—

(3016407) Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay

388

3982

0.97

0.19

2.6

2.4

3.63

3.62

g/l

0.02

373

3772

(3000093) Morphology [Interpretation] in Blood Narrative

144

1505

0.96

0.19

1.3

1.1

—

(3039355) Methicillin resistant Staphylococcus aureus [Presence] in Nose by Organism specific culture

193

1.14

0.19

1.9

2.0

—

(3025927) Herpes simplex virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

165

0.85

0.19

1.1

—

(3045684) Alkaline phosphatase.other fractions [Enzymatic activity/volume] in Serum or Plasma

107

1016

1.05

0.19

1.2

19.80

22.85

u/l

0.55

849

(3031072) Herpes simplex virus 1 IgG Ab [Presence] in Cerebral spinal fluid

146

1.16

0.19

1.0

1.1

—

(3016879) Cocaine [Presence] in Urine

232

2243

1.03

0.19

1.9

1.8

—

(46235760) Methicillin resistant Staphylococcus aureus [Presence] in Pharynx by Organism specific culture

184

1.14

0.19

2.0

2.1

—

(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection

117

1115

1.05

0.18

1.4

—

(3003740) Influenza virus B Ag [Presence] in Specimen

148

1419

1.04

0.18

1.1

—

(3009595) Pneumocystis jiroveci DNA [Presence] in Specimen by NAA with probe detection

124

1185

1.05

0.18

1.5

—

(3013945) Hepatitis B virus e Ab [Presence] in Serum

1.19

0.18

1.0

1.6

—

(3027974) Hepatitis B virus e Ag [Presence] in Serum

1.17

0.17

1.1

1.6

—

(36659890) Mycobacterial identification panel - Specimen by Molecular genetics method

119

1.18

0.17

1.5

—

(3020874) Milk IgE Ab [Units/volume] in Serum

532

1.07

0.17

1.0

0.46

1.52

u/ml

0.99

184

(3045209) Lutropin/Follitropin [Ratio] in Serum or Plasma

1.15

0.17

1.0

1.1

—

(3009804) Carcinoembryonic Ag [Mass/volume] in Pleural fluid

455

0.92

0.17

1.3

510.15

286.24

ug/l

0.21

249

(36306090) Helicobacter pylori [Presence] in Tissue by Organism specific culture

681

0.94

0.17

1.0

—

(3041678) Intrinsic coagulation system thromboelastography panel - Blood

1.22

0.17

1.0

1.3

—

(3025443) Phadiatop IgE Ab [Units/volume] in Serum

609

0.94

0.17

1.1

3.48

6.93

u/ml

0.90

(3033319) Streptococcus pyogenes Ag [Presence] in Throat

826

8387

0.98

0.17

1.3

—

(3038026) Centromere Ab [Units/volume] in Serum

127

1217

1.04

0.17

1.3

1.2

60.12

45.93

u/ml

—

(3000475) Leukocytes [#/volume] in Synovial fluid

380

3889

0.98

0.17

1.5

1.6

9531.11

14737.45

e6/l

3.40

287

2774

(3020629) Protein S Free Ag actual/normal in Platelet poor plasma by Immunoassay

126

1314

0.96

0.16

1.2

1.1

96.20

94.11

0.38

115

1218

(3014373) Corynebacterium diphtheriae Ab [Units/volume] in Serum

1.18

0.16

1.1

—

(3047826) Mullerian inhibiting substance [Mass/volume] in Serum or Plasma

631

1.06

0.16

1.7

1.6

5.84

4.72

ug/l

0.17

458

(3008832) Norclozapine [Moles/volume] in Serum or Plasma

546

0.93

0.16

14.7

11.3

809.02

832.24

nmol/l

0.16

519

(3002823) Mycoplasma pneumoniae IgG Ab [Units/volume] in Cerebral spinal fluid

370

1.08

0.15

1.0

1.1

—

(21493619) Chromosome 12 trisomy and chromosome region 11q22.3 and 13q14 and 17p13.1 deletion in Blood or Tissue by FISH

0.79

0.15

1.0

1.1

—

(3017509) Phencyclidine [Presence] in Urine

0.75

0.15

1.5

1.4

—

(46235689) Lupus anticoagulant aPTT, dRVVT and PT screening panel W Reflex

128

1231

1.04

0.15

2.3

—

(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection

118

1133

1.04

0.15

1.4

—

(37020300) Entamoeba histolytica DNA [Presence] in Stool by NAA with probe detection

497

1.07

0.15

1.4

1.2

—

(3026515) Parvovirus B19 IgM Ab [Units/volume] in Serum

338

0.92

0.15

1.1

—

(3023487) Leukocytes [#/volume] in Peritoneal fluid

564

0.94

0.14

2.3

2.0

8619.60

2688.86

e6/l

0.34

381

(3024869) Neuronal Ab [Presence] in Serum

296

0.91

0.14

1.2

1.1

—

(3050794) Legionella sp Ab [Presence] in Serum

129

0.85

0.14

1.1

—

(3002222) Hepatitis E virus IgM Ab [Presence] in Serum

840

0.95

0.14

1.1

—

(3016018) Differential panel - Cerebral spinal fluid

144

1391

1.04

0.14

1.3

1.4

—

(40765096) Chromosome analysis panel by Banding

450

0.93

0.14

1.2

1.1

—

(3015479) Mycobacterium sp identified in Blood by Organism specific culture

256

1.09

0.14

1.8

1.6

—

(3023365) Varicella zoster virus Ab [Titer] in Cerebral spinal fluid

212

0.90

0.14

1.1

—

(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma

124

1286

0.96

0.14

1.8

1.6

—

(1175553) Vedolizumab and Vedolizumab Ab panel [Mass/volume] - Serum or Plasma

100

0.80

0.13

1.8

2.4

—

(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay

349

3421

1.02

0.13

1.3

1.4

—

(37021073) Hepatitis C virus genotype in Serum or Plasma by Sequencing

106

0.85

0.13

1.3

1.2

—

(3027456) Digoxin [Moles/volume] in Serum or Plasma

360

3669

0.98

0.13

3.1

3.2

0.80

0.81

nmol/l

0.24

283

2845

(3044941) Cell count panel - Synovial fluid

254

2483

1.02

0.12

1.4

—

(3004809) Band form neutrophils/100 leukocytes in Blood

266

2602

1.02

0.12

3.1

3.4

1.75

1.57

0.28

235

2286

(3002523) Influenza virus A Ag [Presence] in Specimen

146

1416

1.03

0.12

1.1

—

(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection

247

2415

1.02

0.12

1.6

—

(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection

247

2415

1.02

0.12

1.6

—

(3042891) Cardiolipin IgM Ab [Mass/volume] in Serum

152

1.12

0.12

1.1

—

(3041423) Sjogrens syndrome-A extractable nuclear 60kD Ab [Units/volume] in Serum

122

1180

1.03

0.12

1.3

1.2

79.36

89.59

u/ml

0.20

(42868418) European tick borne encephalitis virus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay

158

0.89

0.12

1.1

—

(3004616) Nuclear Ab [Presence] in Serum

187

1822

1.03

0.12

1.3

—

(3027008) Opiates [Presence] in Urine

248

2426

1.02

0.12

1.9

1.8

—

(3026285) Alpha 1 antitrypsin [Mass/volume] in Serum or Plasma

186

1813

1.03

0.11

1.0

1.1

1.53

g/l

0.11

171

1640

(46235168) Fasting glucose [Moles/volume] in Blood

147

0.88

0.11

2.8

2.9

9.70

7.37

mmol/l

—

(3022756) Ceruloplasmin [Mass/volume] in Serum or Plasma

995

0.96

0.11

1.0

1.1

294.71

291.75

mg/l

0.17

887

(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method

185

1805

1.03

0.11

1.1

—

(3017732) Neutrophils [#/volume] in Blood

1008

9985

1.01

0.11

2.9

3.1

6.24

4.98

e9/l

1.01

796

7691

(3004437) Lymphocytes/100 leukocytes in Peritoneal fluid

134

1.12

0.10

2.5

1.7

61.20

60.25

—

(3044212) Herpes simplex virus 1+2 IgM Ab [Presence] in Cerebral spinal fluid

377

1.06

0.10

1.0

1.1

—

(3002067) Lambda light chains [Mass/time] in 24 hour Urine

249

0.92

0.10

3.4

2.6

—

(3041067) Sjogrens syndrome-A extractable nuclear 52kD Ab [Units/volume] in Serum

122

1185

1.03

0.10

1.3

1.2

20.33

41.35

u/ml

1.23

(3018301) Testosterone Free [Moles/volume] in Serum or Plasma

708

0.96

0.10

1.4

1.3

176.27

175.52

pmol/l

0.01

708

(42868421) Varicella zoster virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

378

1.06

0.10

1.0

1.1

—

(3028300) Cannabinoids [Presence] in Urine

248

2433

1.02

0.10

1.9

1.8

—

(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma

604

1.04

0.10

1.5

1.4

—

(3012741) Chlamydophila pneumoniae IgA Ab [Titer] in Serum

114

0.88

0.09

1.1

—

(3041449) Collagen crosslinked C-telopeptide [Mass/volume] in Serum or Plasma

428

1.05

0.09

1.7

1.6

0.28

0.38

ug/l

1.62

272

(3014891) Appearance of Pleural fluid

227

0.92

0.09

1.4

1.2

—

(4094501) Cardiovascular stress test using bicycle ergometer

398

3927

1.01

0.09

1.1

—

(3013742) Prealbumin [Mass/volume] in Serum or Plasma

1459

14498

1.01

0.09

2.0

2.2

0.21

g/l

0.36

1326

13469

(3029023) Hepatitis E virus IgG Ab [Presence] in Serum by Immunoassay

837

0.97

0.09

1.0

1.1

—

(3025547) Thyroglobulin Ab [Units/volume] in Serum or Plasma

130

1268

1.03

0.09

4.3

4.9

290.22

124.71

u/ml

0.46

379

(3035285) Chloride [Moles/volume] in Venous blood

212

2159

0.98

0.08

2.6

2.4

105.30

105.50

mmol/l

0.25

212

2141

(3041354) Potassium [Moles/volume] in Venous blood

212

2159

0.98

0.08

2.6

2.4

4.10

4.07

mmol/l

0.47

212

2141

(3029493) Herpes virus 6 DNA [Presence] in Blood by NAA with probe detection

1.05

0.08

3.8

1.5

—

(40768441) Liver Pathology biopsy report

102

1048

0.97

0.08

1.3

—

(37021550) Renin [Units/volume] in Plasma --upright

322

1.06

0.08

1.1

1.3

95.71

77.17

mu/l

0.14

226

(3044007) Cell count panel - Peritoneal fluid

440

0.95

0.08

2.2

1.8

—

(40757373) Influenza virus identified in Isolate

328

0.95

0.08

1.3

1.5

—

(40761872) Peanut recombinant (rAra h) 2 IgE Ab [Units/volume] in Serum

117

1.11

0.08

1.1

1.0

0.06

4.93

u/ml

—

(3041806) Other cells [#/volume] in Blood by Manual count

123

0.89

0.08

1.4

1.5

—

(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

754

0.97

0.08

1.1

—

(3001964) Herpes simplex virus Ag [Presence] in Specimen

411

1.05

0.08

1.4

—

(44816559) Phosphatidylethanol [Mass/volume] in Blood

216

2124

1.02

0.08

1.3

—

(44786800) Granulocytes/100 leukocytes in Body fluid

215

1.07

0.07

1.3

20.00

24.31

0.24

170

(3036489) Thrombin time

512

5171

0.99

0.07

2.1

1.9

22.10

21.73

0.41

440

4578

(40766048) U1 small nuclear ribonucleoprotein 70kD Ab [Units/volume] in Serum by Immunoassay

115

1123

1.02

0.07

1.2

2.00

7.63

u/ml

—

(3003985) Beta hydroxybutyrate [Moles/volume] in Serum or Plasma

137

1.09

0.07

3.2

2.2

0.49

1.04

mmol/l

—

(3027944) Amphetamines [Presence] in Urine

241

2374

1.02

0.07

1.9

1.8

—

(3001334) Neutrophil cytoplasmic Ab [Units/volume] in Serum

102

0.88

0.06

1.2

1.1

—

(3044009) aPTT.lupus sensitive (LA screen)

104

0.87

0.06

1.0

1.2

—

(40763082) Lactate dehydrogenase [Enzymatic activity/volume] in Pleural fluid by Lactate to pyruvate reaction

155

1524

1.02

0.06

1.3

390.51

438.45

u/l

0.14

146

1442

(3013784) Calcium.ionized [Moles/volume] in Serum or Plasma by Ion-selective membrane electrode (ISE)

325

1.05

0.06

1.2

1.3

—

(3029715) Chromosome analysis.interphase [Interpretation] in Bone marrow by FISH Narrative

264

0.95

0.06

1.1

1.2

—

(3000764) Benzodiazepines [Presence] in Urine

244

2409

1.01

0.06

1.9

1.8

—

(3013327) Hepatitis A virus IgM Ab [Presence] in Serum

216

2131

1.01

0.06

1.1

—

(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture

840

1.02

0.06

1.7

1.5

—

(43055458) Rivaroxaban [Mass/volume] in Serum or Plasma

172

0.93

0.06

1.2

73.20

114.59

ug/l

—

108

(3034274) Bile acid [Moles/volume] in Serum --fasting

850

1.02

0.06

1.4

1.7

6.04

9.93

umol/l

1.36

620

(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells

759

0.97

0.05

1.4

—

(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells

759

0.97

0.05

1.4

—

(3000515) Antithrombin actual/normal in Platelet poor plasma by Chromogenic method

412

4086

1.01

0.05

2.2

2.1

94.15

90.63

2.76

394

3902

(3028717) Thiamine [Mass/volume] in Blood

151

0.93

0.05

1.2

1.1

—

(3048469) 10-Hydroxycarbazepine [Moles/volume] in Serum or Plasma

564

1.03

0.05

2.3

2.2

53.62

52.13

umol/l

0.15

465

(3029396) Erythrocyte agglutination [Presence] in Blood

130

0.92

0.04

2.0

2.5

—

(3009041) Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay

185

1828

1.01

0.04

1.2

4.00

4.06

u/ml

0.03

807

(3037121) Protein [Mass/volume] in Urine

529

5323

0.99

0.04

3.2

3.0

0.51

0.30

g/l

1.93

245

2104

(21494434) Karyotype in Bone marrow

134

1358

0.99

0.04

1.1

1.2

—

(3017962) TCRG gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method

180

0.94

0.04

1.5

1.4

—

(3013166) Neutrophils/100 leukocytes in Synovial fluid

497

1.03

0.04

1.2

1.4

64.70

55.89

1.03

426

(3020491) Glucose [Moles/volume] in Blood

100

1016

0.98

0.04

1.6

2.0

7.20

7.01

mmol/l

0.21

700

(3014599) Egg white IgE Ab [Units/volume] in Serum

518

1.02

0.03

1.0

0.38

0.61

u/ml

0.83

137

(3033705) Calcium.ionized [Moles/volume] in Venous blood

211

2128

0.99

0.03

2.6

2.4

—

(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells

376

3780

0.99

0.03

1.7

1.6

—

(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

738

1.02

0.03

1.1

—

(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum

620

1.02

0.02

1.2

1.1

—

(3004716) Salmonella sp identified in Stool by Organism specific culture

619

6174

1.00

0.01

1.4

—

(3001729) Color of Synovial fluid

137

0.95

0.01

1.2

1.7

—

(3044927) Protein electrophoresis panel - Urine

173

1720

1.01

0.01

1.2

—

(3037692) Legionella sp identified in Specimen by Organism specific culture

552

1.01

0.01

1.2

1.4

—

(3005715) Vancomycin [Mass/volume] in Serum or Plasma

209

2099

1.00

0.01

6.0

6.5

12.34

12.06

mg/l

0.42

195

1894

(3034426) Prothrombin time (PT)

423

1.02

0.01

1.2

—

(3028009) Chlamydia trachomatis IgG Ab [Units/volume] in Serum

104

1.06

0.01

1.0

—

(3043525) Herpes simplex virus Ab [Presence] in Cerebral spinal fluid

206

0.97

0.00

1.1

—

(3014038) Collagen crosslinked N-telopeptide [Moles/volume] in Urine

226

0.97

0.00

1.5

—

(3011831) Apolipoprotein B/Apolipoprotein A-I [Percentile]

506

0.99

0.00

1.4

—

(3015183) Erythrocyte sedimentation rate

514

1.01

0.00

1.2

—

(3006922) Hepatitis E virus Ab [Presence] in Serum

904

1.01

0.00

1.1

—

(3036782) Glucose [Moles/volume] in Pleural fluid

151

1516

1.00

0.00

1.3

1.4

6.68

6.35

mmol/l

0.70

143

1391

(3041870) Hepatitis C virus IgG Ab [Presence] in Serum or Plasma by Immunoassay

204

0.98

0.00

1.1

—

(3048522) Glucose [Moles/volume] in Serum or Plasma --pre dose glucose

129

1.01

0.00

1.3

1.1

—

(3018851) Theophylline [Moles/volume] in Serum or Plasma

160

1.00

0.00

2.1

1.7

46.38

47.18

umol/l

0.02

160

(3015076) Soybean IgE Ab [Units/volume] in Serum

442

1.00

0.00

1.0

0.66

0.90

u/ml

—

124

(42868415) European tick borne encephalitis virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

333

0.99

0.00

1.1

—

(40760548) Muscle specific receptor tyrosine kinase Ab [Units/volume] in Serum by Immunoassay

220

1.00

0.00

1.0

—

(3009550) Parvovirus B19 IgG Ab [Titer] in Serum

281

1.00

0.00

1.1

—

(3044355) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum or Plasma by Immunoassay

189

1891

1.00

0.00

1.3

1.2

4.83

4.10

u/ml

0.22

623

(3004446) Plasmodium sp identified in Blood by Light microscopy

112

0.98

0.00

2.9

2.5

—

(3052649) Adenosine deaminase [Enzymatic activity/volume] in Serum or Plasma

117

1165

1.00

0.00

1.4

13.41

12.92

u/l

0.26

111

1116

(40760007) HIV 1+2 Ab+HIV1 p24 Ag [Presence] in Serum or Plasma by Immunoassay

194

0.98

0.00

1.2

1.1

—

(40765089) Chromosome analysis panel - Blood by G-banded

145

1.03

0.00

1.1

1.0

—

(40761849) Varicella zoster virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

354

0.99

0.00

1.0

1.1

—

(3030429) Borrelia sp DNA [Identifier] in Specimen by NAA with probe detection

495

1.01

0.00

1.1

—

(3016845) Adenovirus Ag [Presence] in Specimen by Immunofluorescence

286

1.01

0.00

1.3

1.2

—

(3041672) Baker's yeast Ab [Presence] in Serum

0.96

0.00

1.0

—

(3040794) Aluminum [Moles/volume] in Urine

0.00

-0.00

0.0

1.3

—

(3022670) pH of Venous cord blood

0.00

-0.00

0.0

1.2

—

(3008343) Lysozyme [Mass/volume] in Urine

0.00

-0.00

0.0

1.0

—

0.44

—

(3051596) Benzodiazepines [Presence] in Serum or Plasma by Screen method

0.00

-0.00

0.0

1.0

—

(3033463) Neutrophils [#/volume] in Cerebral spinal fluid

0.00

-0.00

0.0

1.0

—

(3014178) Parietal cell Ab [Units/volume] in Serum

0.00

-0.00

0.0

1.2

—

(3002853) Influenza virus B Ab [Titer] in Serum

0.00

-0.00

0.0

1.0

—

(3029612) Listeria sp Ab [Titer] in Serum

0.00

-0.00

0.0

1.1

—

(3019529) Immunofixation for Cerebral spinal fluid

0.00

-0.00

0.0

1.2

—

(3003157) Bacteria [#/volume] in Mother's milk

0.00

-0.00

0.0

8.0

—

(3007147) Virus identified in Stool by Electron microscopy

0.00

-0.00

0.0

1.0

—

(3035153) Lemon IgE Ab [Units/volume] in Serum

0.00

-0.00

0.0

1.0

—

(3008896) Cortisol [Moles/volume] in Urine

0.00

-0.00

0.0

1.0

—

(40763480) Human metapneumovirus Ag [Presence] in Specimen

0.90

-0.00

1.8

1.3

—

(40761593) Coagulation factor VIII Ab [Presence] in Platelet poor plasma by Immunoassay

0.00

-0.00

0.0

1.4

—

(3032995) BK virus DNA [#/volume] (viral load) in Cerebral spinal fluid by NAA with probe detection

0.00

-0.00

0.0

1.1

—

(3042628) Porphyrins [Moles/volume] in Urine

0.00

-0.00

0.0

1.0

—

(3008092) Baker's yeast IgG Ab [Units/volume] in Serum

0.85

-0.00

1.0

—

25.56

—

(3016426) Methylmalonate [Moles/volume] in Serum or Plasma

1.00

-0.00

1.0

1.1

203.67

255.20

nmol/l

—

(3004593) Baker's yeast IgA Ab [Units/volume] in Serum

0.85

-0.00

1.0

—

22.54

—

Mortality – FinRegistry

↥

Association

Association between endpoint H7_GLAUCSUSP and mortality.

Females

Parameter	HR [95% CI]	p-value
H7_GLAUCSUSP	0.885 [0.81, 0.96]	0.004
Birth year	0.993 [0.98, 1.0]	0.071

During the follow-up period (1.1.1998 — 31.12.2019), 9216 out of 55203 females with H7_GLAUCSUSP died.

Males

Parameter	HR [95% CI]	p-value
H7_GLAUCSUSP	0.912 [0.83, 1.0]	0.058
Birth year	0.987 [0.98, 1.0]	0.003

During the follow-up period (1.1.1998 — 31.12.2019), 6277 out of 32273 males with H7_GLAUCSUSP died.

Mortality risk

Mortality risk for people of age

years, who have H7_GLAUCSUSP.

N-year risk	Females	Males
1	0.079%	0.157%
5	0.477%	1.024%
10	1.123%	2.475%
15	2.312%	4.865%
20	3.797%	8.204%

Relationships between endpoints

↥

Index endpoint: H7_GLAUCSUSP – Glaucoma suspect

GWS hits: 54

Endpoint

Case Overlap

Survival Analysis

Genetic Correlations

Genetic Signals

N (Jaccard index)

HR [CI]

rg [CI]

Hits

Coloc Hits

FinRegistry

FinnGen

FinRegistry

FinnGen

Loading data

Glaucoma suspect

Endpoint definition

Endpoint definition steps

FinnGen

Phenotype data

1. Apply sex-specific rule

2. Check conditions

3. Check pre-conditions, main-only, mode, registry filters

4. Check minimum number of events

5. Include endpoints

6. Filter based on genotype QC (FinnGen only)

Similar endpoints

Case counts by codes

Summary Statistics

-FinRegistry-

Key figures

-FinnGen-

Key figures

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

CodeWAS

Matched cohort

LabWAS

Mortality – FinRegistry

Association

Females

Males

Mortality risk

Relationships between endpoints